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SUMMARY
This study addresses the putative role of Bacteroides forsythus heat shock 
protein 60 (hsp60) as a pathogenicity factor in periodontal disease by defining 
the molecular identity and antigenicity of the protein.
The gene encoding the heat shock protein 60 (hsp60) of B. forsythus was 
identified by PCR using degenerate hsp60 oligonucleotide primers, and by 
Southern blot hybridisation using probes derived from the E. coli hsp60 DNA 
sequence. The DNA sequence of the B. forsythus gene was determined, and 
was predicted to encode an amino acid of 544 amino acids with a molecular 
weight of 62kDa. The DNA and protein sequences displayed extremely high 
levels of conservation with hsp60 homologues from a range of other species, 
including those from other oral bacterial pathogens and human hsp60. The 
hsp60 gene of Prevotella intermedia was similarly identified, and the DNA 
sequence of the C terminal portion of the gene determined.
Bacterial hsp60 from a range of different species has been implicated in the 
pathogenic mechanisms of a wide range of diseases, and it is suggested that 
they may instigate autoimmune reactions in the host as a result of the high level 
of molecular conservation shared between bacterial and human hsp60 
homologues. With the aim of evaluating the potential role of B. forsythus hsp60 
in periodontitis, recombinant B. forsythus hsp60 was expressed in E. coli and 
it’s immunoreactivity determined by screening with 13 healthy adult and 11 
chronic adult periodontitis serum samples. Both patient groups displayed a low 
level of IgG antibody reactivity with B. forsythus hsp60. The antibodies 
recognising the B. forsythus protein were cross-reactive with E. coli hsp60, and 
may have been initially raised against this species. These results indicate that
X IV
B. forsythus hsp60 is immunogenic, but do not suggest that this protein has an 
important role in the pathogenesis of adult periodontitis.
A B. forsythus genomic library was constructed in pUC18 and screened using a 
variety of techniques with the aim of identifying further immuno-reactive proteins 
of this species. Of the clones analysed, periodontitis patient serum did not 
display any reactivity. Random clones were selected for further analysis by DNA 
sequencing, and a clone carrying part of the lac operon of B. forsythus 
identified.
This thesis constitutes an original report on the molecular characterisation of 
part of the genome of the putative periodontal pathogen Bacteroides forsythus, 
and a preliminary investigation of host immune responses to a recombinant 
antigen of this species.
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CHAPTER 1 
Introduction
Anatomy of the periodontium
The term ‘periodontium’ describes the supporting tissues of the teeth whose 
main function is to dissipate forces applied to the dentition. These anatomical 
structures include the gingiva, periodontal ligament, cementum and alveolar 
bone. The gingiva is the oral mucosal lining which surrounds the teeth and 
covers the alveolar processes of the jaws. As well as withstanding masticatory 
forces, the gingiva functions as a protective seal around the teeth which 
prevents potentialy pathogenic organisms from gaining internal access to the 
human body. Uniquely to the peripheral body defences (i.e. skin and 
gastrointestinal mucosa) that provide the continuous surface lining of the body, 
the gingiva is perforated (by teeth) which compromises its protective potential. 
Thus the tissues proximal to the teeth are appropriately designed to provide a 
tight seal around the teeth, and have developed repair and healing processes to 
cope with infections of the lining tissues (Schroeder and Listgarten, 1997; 
Jenkins and Allan, 1994). Cementum is specialised calcified tissue with collagen 
fibres, which forms the outermost covering of tooth roots. The periodontal 
ligament anchors in the root cementum and stretches to the alveolar bone that 
supports tooth sockets, linking and attaching teeth to bone. The main 
component of this connective tissue is collagen, but it also consists of several 
different cell populations (Beersten et ai, 1997; Jenkins and Allan, 1994).
The healthy periodontium is characterised by a firm, pale pink gingiva that 
entirely fills the space between neighbouring teeth and does not bleed on 
probing. Alveolar bone is located 1 mm short of the cemento-enamel junction
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(Jenkins and Allan, 1994) and the gingiva is free from inflammation. However, 
as bacterial plaque is constantly accumulating at the gingival margin and can 
only be temporarily removed by oral hygiene measures, a limited amount of 
inflammatory exudate comprising of immune system components can be found 
in clinically healthy gingiva (Seymour et al, 1983).
Periodontal disease
Strictly speaking, periodontal disease describes a range of conditions affecting 
the various tissues which form the periodontium. Generally though, periodontal 
disease refers to periodontitis and gingivitis which are inflammatory and 
immune mediated reactions to microbial dental plaque. Gingivitis is the more 
common form of periodontal disease, with pathologic occurrences limited to the 
gingiva. The disease is clinically represented by the rubor and tubor 
characteristic of any inflammatory response and the gingival tissue is likely to 
bleed upon gentle probing (Taichman and Lindhe, 1989). Periodontitis is a far 
more invasive disease with alveolar bone, periodontal ligament and root 
cementum affected by the disease processes. Clinically, periodontitis is 
manifested by the formation of open pockets around the teeth and advanced 
cases result in alveolar bone resorption resulting in loosening, and loss of, teeth 
(for a more detailed description of clinical features see Kinane and Lindhe, 
1998). The World Workshop in Clinical Periodontics (1989) classified different 
forms of periodontitis as listed:
1) Adult periodontitis
2) Early onset periodontitis: i) prepubertal periodontitis (localised and
generalised)
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ii) juvenile periodontitis (localised and generalised)
iii) rapidly progressive periodontitis
3) Periodontitis associated with systemic disease
4) Necrotising ulcerative periodontitis
5) Refractory periodontitis
The differences between the age-of-onset groups are self evident, although 
there also appears to be variances in the microbial complexes that are 
associated with these diseases (Genco et al, 1988). Adult periodontitis is the 
most common form of periodontitis. Cases of periodontitis which are associated 
with systemic disease are thought to be symptoms attributable to an underlying 
diease or disorder which might predispose the individual to disease. Necrotising 
ulcerative periodontitis describes a rapidly progressive condition that may result 
in severely advanced periodontitis, and is associated with spirochaetal 
populations in microbial plaque. Refractory periodontitis refers to a disease type 
that does not respond to treatment that is effective against other forms of the 
disease.
Pathogenesis of periodontitis
Current research inplicates plaque associated micro-organisms in provoking 
inflammatory and immune responses that may lead to periodontal disease. 
Whilst bacteria may exhibit factors that are directly pathogenic, such as the 
expression of toxins, it is commonly held that it is unchecked host immune and 
inflammatory processes, initially raised as a protective response against 
bacteria, that are accountable for the injury to tissues seen in periodontal 
disease. As only a small subset of the periodontitis population develop
3
advanced periodontal destruction (Jenkins and Kinane, 1989; Loe etal, 1986) 
periodontal disease is thought to be subject related, with those few individuals 
who experience extensive destruction of the periodontium thought to have a 
localised imbalance in the host response to micro-organisms that renders them 
susceptible to disease (Kinane, 1997). It is not as yet clearly understood why 
some patients will develop advanced disease affecting several teeth whilst 
others will suffer only from mild lesions at the gingiva which do not affect 
connective tissue or supporting bone. However a number of host factors, such 
as age and smoking and drinking habits, are known to increase the likelihood of 
a person developing periodontal disease. Host factors alone though do not 
cause periodontal disease; the root cause, undeniably, is the mixed microbial 
population thriving at the gingival margin which constitutes dental plaque.
Aetiology o f periodontal disease
i) Problems
Attempts to determine the aetiologic agents of periodontal disease have been 
hindered by a number of problems. The term ‘periodontal disease’ 
encompasses a range of clinically different diseases such that patients 
presenting with similar symptoms might not necessarily be suffering from the 
same microbial infection, and this makes classification of disease types and 
status difficult. Although periodontal disease is regarded as a microbial infection 
of discrete sites of the periodontium, a range of host factors also significantly 
contribute to disease progression. Thus the aetiology of periodontitis is 
attributed to a combination of both microbial and host factors.
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ii) Microbial factors
Data evidencing a primary role for bacteria causing periodontal disease is 
virtually conclusive. Reports to support this microbial paradigm come from a 
large number of studies demonstrating:
i) a strong association between the amount of bacterial plaque and the 
severity of periodontitis and level of bone loss
ii) rigorous plaque control procedures, such as mechanical removal of 
plaque, can successfully treat disease
iii) the success of antibiotics targeted at microbial plaque at controlling 
different forms of periodontal infections.
Problems arise when attempts are made to define which of the 400 species that 
may be present in periodontal pockets are pathogenic. Further difficulties are 
imposed by the inability to culture some species of bacteria in the laboratory, 
the difficulty in identifying which pathogens are secondary opportunistic 
invaders, and determining which strains of specific species are the most 
virulent. As mentioned later, strong evidence exists to indicate mixed infections 
as crucial in the etiology of the disease. This further impedes the 
microbiologist’s ability to pin-point pathogenic species as all the potential 
bacterial pairs or mixed populations have to be considered.
iii) Host factors
Although micro-organisms are necessary for periodontal disease to occur, it 
appears that they alone are not sufficient to cause disease. Several host factors 
make an important contribution to the disease process. These include the 
genotype of the host. Some genotypes, by means of family studies, have been
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noted to be particularly susceptible to periodontal diseases (Genco, 1996). 
Other risk factors that affect the likelihood of an individual developing these oral 
afflictions include gender, age, stress, diabetes mellitus and cigarette smoking 
(Genco, 1996; Zambon etal, 1996a).
The role of bacteria in periodontal disease
Specific aetiologic agents of periodontal infections have been sought for over a 
century. Opinion on what these causative agents may be, and their role in 
disease pathogenesis, has vacillated during this period.
i) Non specific plaque hypothesis
From the mid 1920s until the 1960s, little work was done to identify species of 
bacteria involved in periodontal infections. Generally, bacteria were thought to 
play some role in the pathogenic process, and the need for plaque control to 
prevent and treat disease was recognised. However, no specific microbial 
organisms were targeted as causative agents. This adheres to the ‘non specific 
plaque hypothesis’, which holds that any sufficiently large population of micro­
organisms at the gingival margin could provoke an inflammatory reaction, 
irrespective of the microbial composition of the plaque. According to this 
hypothesis, bacteria are deemed to act only as triggers of an inflammatory 
response that would eventually lead to the destruction of the periodontium 
(Socransky and Haffajee, 1992).
ii) Specific plaque hypothesis
Since the 1960s, opinion on the possible cause of periodontal infections has 
swayed once again, and now favours the ‘specific plaque hypothesis’, a
6
supposition that had once been held at the beginning of the century also. The 
main tenet of this hypothesis is that specific micro-organisms relate to the 
aetiology of different periodontal diseases. Supporting this argument for an 
intrinsically pathogenic role for specific species are studies that attempt to 
elucidate the composition of bacterial plaque in periodontal infections. 
Differences in the microbial population have been found in varying forms of 
periodontal disease, and also major distinctions between the microbiota of 
healthy sites as compared to diseased ones have been noted.
Distinct problems are encountered when attempts are made to identify and 
define specific periodontal pathogens. Some of these are technical difficulties; 
obtaining samples from the correct periodontal site without contamination form 
other microbial populations, the need to perhaps keep the sample in a strictly 
anaerobic environment, the inability to culture all species present. Should a 
sample be successfully cultured, the even more daunting prospect of 
recognising a pathogenic species, which may also be part of the normal 
microbial flora, from the approximately 400 other species in subgingival plaque 
yet remains.
Despite these hindrances, current consensus recognises a number of species 
as periodontal pathogens, playing a crucial role in the course of the disease. 
This list includes Actinobacillus actinomycetemcomitans, Porphyromonas 
gingivalis, Bacteroides forsythus, Prevotella intermedia and Fusobacterium 
nucieatum as the main suspects, but includes many less studied species as 
well.
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Pathogenic synergism
Bacteria isolated from dental plaque are always part of a mixed and variant 
microbial population. This can incur advantages to an organism that requires 
prior colonisation of a site by another species before it can establish itself.
Alternatively, a species possessing antibiotic resistance or the ability to 
withstand the battery of host immune defences can shield a more vulnerable 
pathogen from attack.
Periodontopathogens
i) Actinobacillus actinomycetemcomitans
Actinobacillus actinomycetemcomitans is a non-motile, Gram negative saccharolytic 
rod. It’s strong association with periodontal disease is reflected in the large numbers of 
publications that implicate this species as an aetiologic agent of various forms of 
periodontal disease (reviewed by Haffajee and Socransky, 1994). The bacterium 
appears to be most strongly associated with juvenile forms of periodontal disease, as 
evidenced by a marked increase in frequency of detection and higher numbers of the 
bacterium in lesions from LJP patients as compared to samples from inactive sites or 
from healthy controls (Haffajee et at, 1984; Mandell et al, 1981; Tanner et al, 1984; 
Zambon et al, 1996b). A. actinomycetemcomitans is isolated less frequently in 
samples from adult periodontitis patients in which other putative pathogens seem to 
dominate (Rodenburg et al, 1990).
Elevated antibody levels to A. actinomycetemcomitans in both localized juvenile and 
some adult periodontitis serum and saliva samples also suggest that A. 
actinomycetecomitans plays a pathogenic role in various types of periodontitis 
(Ebersole etal, 1987; Ebersole etal, 1991; Haffajee and Socransky, 1994).
ii) Porphyromonas gingivalis
Another microorganism frequently cited as a likely periodontal pathogen is 
Porphyromonas gingivalis. P. gingivalis is a Gram negative, anaerobic asaccharolytic 
non-motile bacterium that forms black colonies when grown on blood agar. P. 
gingivalis is a member of the Bacteroidacae group of microorganisms, and was 
previously classified as Bacteroides gingivalis (Haffajee and Socransky, 1994). P. 
gingivalis has been associated with various forms of periodontitis, as assessed by 
bacterial numbers and frequency of detection (Choi et al, 1990; Haffajee et al, 1988a; 
Slots et al, 1986; White and Mayrand, 1981). However, as is the case with all other 
putative periodontal pathogens, patients with periodontitis frequently present who are 
not infected with this organism (Moore and Moore, 1994). A host antibody response to 
P. gingivalis in periodontitis patients has been widely demonstrated (Haffajee and 
Socransky, 1994).
The organism is also a focus of interest due to the high number of virulence factors it 
appears to possess. These include an IgG degrading protease (Grenier et al, 1989), 
collagenase (Uitto et al, 1988) and bone resorbing factors (Bom-van Noorloos et al, 
1989).
iii) Prevotella intermedia
Prevotella intermedia, similar to P. gingivalis, is a black pigmented anaerobe of the 
Bacteroides group. It’s name and classification derive from the fact that within the 
Bacteroides group, species were identified which were neither asaccharolytic (such as 
P. gingivalis) or highly saccharolytic (such as Prevotella melaninogenica), but 
fermented carbohydrates at an ‘intermediate’ level (Haffajee and Socransky, 1994).
9
Elevated levels of P. intermedia have been demonstrated in various forms of 
periodontitis (Dzink et al, 1985; Dzink etal, 1988; Socransky and Haffajee, 1992), 
notably so in lesions of acute necrotizing ulcerative gingivitis (Loesche et al, 1982). 
Serum antibody titres to this species are raised in some subjects (Haffajee et al, 
1988b).
iv) Fusobacterium nucleatum
Another Gram negative anaerobic rod, F. nucleatum is a well recognised frequent 
pathogen of other sites in the human body, and is recovered from infectious abscesses 
of the brain and other vital organs (Moore and Moore, 1994). F. nucleatum is the most 
frequently isolated species in subgingival plaque samples (Dzink etal, 1985; Dzink et 
al, 1988). It is invariably detected in sites with low gingival disease scores, which 
indicates that this species is a major role player in the initiation of periodontal disease 
(Moore and Moore, 1994). F. nucleatum is proposed to be part of a microbial complex 
of species that are commonly isolated in association with each other. It appears to be 
necessary for the F. nucleatum complex to be present at a periodontal site before 
other species can become established (Socransky et al, 1988), and this supports the 
idea that F. nucleatum is a primary coloniser of periodontally diseased sites.
v) Other species
A range of other microbial species have been implicated as periodontal pathogens. 
Many of these have only been recently characterised or new subspecies have been 
differentiated after molecular taxonomic studies such as 16S ribosomal RNA 
sequencing. Due to this, data to suggest their role as aetiologic agents of periodontal 
disease are more limited than they are for the bacteria previously mentioned. These
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lesser-studied species include Eikenella corrodens, Campylobacter rectus, Wolinella 
recta, Peptostreptococcus micros and Eubacterium and Selenomonas species 
(Haffajee and Socransky, 1994; Socransky et al, 1998; Tanner et al, 1987a). It is likely 
that ongoing work to evaluate their pathogenic role will substantiate preliminary data 
that finds these species more frequently and in higher numbers in active disease sites 
of patients as compared to healthy sites.
Bacteroides forsythus
Bacteroides forsythus is a strictly anaerobic Gram negative bacillus. Tanner et 
al first described it as a ‘fusiform’ Bacteroides in 1979, when it was isolated from 
patients with advancing periodontitis. The bacterium fitted descriptions for 
Fusobacterium nucleatum, but differences in growth requirements, dye and 
antibiotic sensitivities led the group to believe that the bacterium was a new 
species. Tanner went on to describe the new species, Bacteroides forsythus, in 
1986 (Tanner etal, 1986).
Identification of B. forsythus
i) Culture techniques
B. forsythus is a slow growing organism, and produces very small colonies that 
are only detectable by culture after 7-14 days incubation. The bacterium has 
fastidious growth requirements, requiring the addition of N-acetyl muramic acid 
to the culture medium to enhance growth (Wyss, 1989). For these reasons the 
bacterium is difficult to isolate by culture and has perhaps been under 
represented in studies attempting to identify and enumerate aetiologic agents of 
oral infections by standard culture methods alone.
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In studies from an era prior to molecular and immunological detection methods, 
which depended on less sensitive culture techniques, 8. forsythus or ‘fusiform’ 
Bacteroides was isolated from active destructive periodontal lesions but was not 
found at inactive periodontitis sites (inactive sites had comparable pocket depth 
to active sites, but the attachment level did not alter during the monitoring 
period) (Dzink et al, 1985). Fusiform Bacteroides were detected in some 
samples from advancing periodontitis sites (Tanner et al, 1979), but as the 
species had not been classified at this stage it is likely that these figures are 
inaccurate.
Although the organism was detected more frequently and in higher numbers at 
sites of active and destructive periodontitis lesions as compared to inactive and 
healthy sites (Dzink etal, 1985; Lai etal, 1987), initial indications were that B. 
forsythus was a fairly uncommon inhabitant of the diseased periodontium. From 
119 lesions studied, Dzink et al (1985) detected only 8 B. forsythus positive 
samples. Socransky et al (1988) studying a different group of patients, found 
only 10% of sites sampled to be 8. forsythus positive.
Despite the apparently low prevalence of the organism, interest in the species 
persisted as up until this time 8. forsythus was only associated with active 
periodontitis sites. This strongly indicated a role for the bacterium in the 
pathogenesis of active destructive periodontal lesions.
ii) Serological techniques
The development of molecular and immunological techniques replace culture 
techniques for the assessment of the prevalence of 8. forsythus in clinical 
samples. These new methodologies include the use of serological agents, for
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example monoclonal antibodies, whose specificity for a given species can be 
utilised to indirectly detect micro-organisms.
Several groups have utilised immunological techniques such as the enzyme 
linked immuno-sorbent assay (ELISA) and indirect immunofluorescence 
microscopy to identify 8 . forsythus in various periodontitis samples (Califano et 
al, 1992; Di Murro etal, 1997; Gmur etal, 1989; Lai et al, 1987; Tanner et al, 
1998; Wernerfelmayer et al, 1988).
Indirect immunofluorescence microscopy performed soon after the new 8. 
forsythus species had been characterised extended earlier observations and 
showed 8. forsythus to have a strong positive association with subgingival 
plaque of severe gingivitis and untreated adult periodontitis as well as recurrent 
periodontitis (Lai et al, 1987). Few healthy subjects appeared to be infected with 
the species at this time.
Hi) Molecular techniques
Of greater sensitivity, with the ability to detect microbial DNA from as few as 103 
cells, are the molecular techniques of DNA hybridisation (Southern and dot 
blotting) and the polymerase chain reaction (PCR). The use of PCR (Goncalves 
and Mouton, 1998; Meurman et al, 1997) and DNA hybridisation (Lai et al,
1987; Socransky et al, 1998; Tanner et al, 1998) for identifying periodontal 
bacteria in clinical samples is well documented.
The advent of molecular DNA detection methods for identifying 8. forsythus has 
been recent enough to mean that data describing results from molecular studies 
constitutes the basis of many current publications. Genomic probes allow direct 
detection of the species, and so far have identified 8. forsythus in 73% of 614
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subjects with deep periodontal pockets (Lotufo et al, 1994). Studying a 
prodigious number of samples, Listgarten et al (1995) identified 84% of 993 
plaque samples to be positive for B. forsythus.
For such a fastidious organism that requires a supplemented growth medium 
and anaerobic sampling and culturing to be successfully isolated, molecular and 
immunological detection methods appear to perform far better than culture 
techniques. In a study comparing culture and molecular methods for their ability 
to detect microbial anaerobic periodontal pathogens, Loesche et el (1992) 
found the prevalence of P. gingivalis and 8 . forsythus to be 89% and 64% 
respectively, as assessed by ELISA. Culture of the same plaque samples 
identified P. gingivalis in only 43%, and 8. forsythus in 25% of the samples. 
Improved detection methods have resulted in more recent reports highlighting 
the realisation that 8. forsythus is a far more common constituent of diseased 
and healthy periodontal flora than was previously held to be the case.
The technique of counting fluorescent immunologically labelled cells by aid of 
microscopy was applied to a group of patients who maintained a high level of 
oral hygiene, and were deemed unlikely to suffer from active periodontal 
destruction. 8. forsythus was found to be present in up to 50% of sites sampled 
over a 12 month period. The organism was isolated from shallow gingival 
pockets, unaffected by attachment loss or alveolar bone loss (Gmur et al,
1989). Thus the opinion that the mere finding of 8. forsythus in a periodontal 
pocket may be suggestive of progressing disease could no longer hold. This 
fact was consolidated by evidence that showed 8. forsythus could be isolated 
from the supragingival plaque of subjects with excellent oral health and hygiene
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(Gmur and Guggenheim, 1994). However, Gmur’s study showed that B. 
forsythus colonisation levels increased proportionally with the probing depth of 
periodontal lesions (Gmur etal, 1989).
The most recent studies find B. forsythus to be a major species in active 
periodontitis lesions, and also find it present at lower levels in healthy sites. 
Surprisingly, some of this data is still obtained via culture techniques (Tanner et 
al, 1998) despite the fact that the general consensus of opinion seems to deem 
this method as lacking sufficient sensitivity for accurate reports.
Mutual association of B. forsythus with other species
It has been ascertained that B. forsythus frequently occurs in periodontitis 
associated with other species of bacteria. A number of studies report P. 
gingivalis to be commonly identified with B. forsythus in periodontitis. Lotufo et 
al found concurrently growing B. forsythus and P. gingivalis in 55% of patients 
sampled (Lotufo et al, 1994). Listgarten’s study of 993 plaque samples from 
periodontitis sites similarly found 84% to be B. forsythus positive and 63% P. 
gingivalis positive (Listgarten et al, 1995).
Other studies have found B. forsythus to be co-isolated from infected sites with 
F. nucleatum. Tanner et al found 12 out of 13 B. forsythus positive sites were 
colonized by F. nucleatum, and it has been demonstrated that F. nucleatum 
boosts the growth of B. forsythus in culture (Tanner et al, 1986).
Using DNA probes to identify positive sites, Rams et al (1996) sampled 329 
moderate-severe periodontitis patients. 77.5% of the patients they studied had 
sites infected by P. gingivalis and 76.3% were positive for B. forsythus, 
establishing a significant joint association in the occurrence of the two species.
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Socransky et al (1998) also used genomic DNA probes to determine the 
prevalence of and associations between 40 subgingival species in 13,261 
plaque samples collected from 185 subjects. Data was subjected to statistical 
analysis (multiple cluster and community ordination analyses). Results revealed 
that the putative periodontal pathogens formed 5 major microbial complexes, 
and that species consistently formed the same complexes irrespective of the 
analytical method employed. One complex consisted of B. forsythus, P. 
gingivalis and Treponema denticola. Although isolated alone from a proportion 
of sites, B. forsythus was more frequently identified at sites also inhabited by P. 
gingivalis and T. denticola. B. forsythus was more likely to be detected in the 
absence of P. gingivalis than P. gingivalis was to be found without S. forsythus. 
Members of this complex were found more commonly and in higher numbers in 
deeper periodontal pockets, and their prevalence also showed a marked 
relation to bleeding on probing. A second microbial complex contained, 
amongst other species, F. nucleatum. The data indicated that members of the 
first complex (i.e. B. forsythus, P. gingivalis and T. denticola) were rarely found 
in the absence of members of the F. nucleatum complex. However the P. 
nucleatum complex could be found without members of the first complex being 
present. This would suggest that the F. nucleatum complex pre-colonises sites 
prior to the B. forsythus complex. These findings offer a feasible explanation for 
earlier reports of B. forsythus being associated in infected periodontal sites with 
both P. gingivalis and P. nucleatum.
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Evidence implicating B. forsythus in periodontal disease
Since Koch described a microbial etiologic agent of tuberculosis in 1882, 
‘Koch’s postulates’ have been applied as the dogma for identifying a causative 
agent of any infection. According to his postulates, a link between an infectious 
agent and disease can be proven when
i) the causal agent can be isolated from every case of the disease
ii) the agent is not identified in other forms of the disease, or non 
pathogenically
iii) pure cultures of the organism in vitro can induce disease when 
experimental animals are infected with it in vivo.
The high number of species implicated in the aetiology of periodontal disease, 
some of which may be part of the normal periodontal flora, along with the fact 
that a good animal model of periodontal disease is still lacking, means that 
currently Koch’s postulates would not serve well to identify the infectious agent 
of periodontal disease. In an attempt to overcome these difficulties, Socransky 
proposed alternative criteria to use when identifying periodontal pathogens 
(Socransky, 1977). As applied to B. forsythus, these are as follows:
i) The putative pathogen is present in high numbers in disease, but low
numbers in health.
A considerable number of reviews looking at microbiological samples have 
shown that the number of bacterial cells present in the plaque of the healthy 
gingiva is low, with Gram positive species predominating. With the onset of 
periodontal disease, bacterial numbers increase and the population shifts to a 
predominately Gram negative one (Moore and Moore, 1994).
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Studies showing that levels of B. forsythus increase in patients with periodontal 
disease have been well documented (Dzink et al, 1988; Gmur et al, 1989; Lai et 
al, 1987; Lotufo et al, 1994; Tanner etal, 1979; Tanner et al, 1998).
ii) Patients infected with the suspected pathogen develop high antibody 
titers in serum, saliva and gingival crevicular fluid.
Ebersole et al (1987) presented evidence that elevated serum antibody 
responses show a close association with the species eliciting the periodontal 
infection in question. A review of the literature that indicts some of the 
periodontal pathogens in such a manner can be viewed in Ebersole and 
Taubman, (1994).
The first reports measuring the serum concentration and frequency of 
seropositivity for IgG antibodies reactive with B. forsythus in periodontitis 
patients have been published recently. Gu et al (1997), report that patients with 
rapidly progressing periodontitis do not mount an antibody response to the 
antigens of B. forsythus, although antibody titers to other periodontal pathogens 
in these patients were elevated. Similarly, Califano and colleagues have 
reported that levels of IgG antibody to B. forsythus do not increase significantly 
in periodontitis patients, and that the percentage of patients seropositive for 8. 
forsythus was the same in both periodontitis and non-periodontitis patients 
(Califano etal, 1992).
The absence of a strong antibody response to B. forsythus did not indicate an 
absence of 8 . forsythus in the periodontal microbiota (Gu et al, 1997). The lack 
of a humoral antibody response to the pathogen could be explained if the 
organism had poor ‘invasive potential’, thus confining the antigens to the
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periodontal pocket. Alternatively, the organism may have the ability to invade 
host cells, but the antigens it expresses are not good immunogens.
It is possible the B. forsythus can invade host cells, yet manages to escape 
antibody recognition via an as yet unknown evasion mechanism. Should this be 
the case, the organism would have impressive pathogenic potential, and would 
be a good risk factor for disease.
Hi) The micro-organism can demonstrate in vivo production of virulence 
factors that can be correlated with disease.
B. forsythus produces a trypsin-like enzyme (Tanner et al, 1985) and a sialidase 
(Holst and Bramanti, 1991), both of which may be virulence factors that have a 
pathogenic role in periodontal disease. The organism has also been shown to 
express a surface layer (S-layer) of crystalline protein, formed from serrated 
subunits (Kerosuo, 1988). It is thought the S-layer may function to strengthen 
the bacterial cell wall, and speculatively, may also contribute to the virulence of 
the organism as other oral bacteria possessing an S-layer have been isolated 
from acute oral infections.
B. forsythus has been shown to be capable of invasion; a small number (~1%) 
of epithelial cells harvested from periodontal pockets were found to contain B. 
forsythus cells (Dibart et al, 1995).
iv) Experimental implantation of the organism into an animal model should 
result in expression of some of the characteristics of the disease.
Several animal models for periodontitis currently exist, these include systems in 
rodents, dogs and non-human primates (Haffajee and Socransky, 1994). It
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should be noted that problems exist with animal models of periodontitis: 
periodontal disease does not spontaneously occur in many species of animals, 
or only becomes established in very old animals. Differences between the 
indigenous oral micro-flora of humans and laboratory reared experimental 
animals may affect the interpretation of some studies. Also, bacterial species 
may have a preference for specific adherence factors on epithelial tissue or on 
other oral bacteria. It is likely that these ligands neccessary for successful 
attachment of an invading organism vary significantly between genera.
Studies in monkeys have shown that numbers of Gram negative anaerobes, 
including Bacteroides species, increase at sites of periodontal loss in animals 
(Kornman etal, 1981; Slots and Hausmann, 1979). An analysis of the 
subgingival micro-flora of 16 Macaca nemestrina monkeys with naturally 
occurring gingivitis revealed that all the animals harboured B. forsythus, along 
with P. gingivalis and F. nucleatum. A. actinomycetemcomitans was only found 
in the younger animals within the group studied (Persson et al, 1993).
v) Treatment that removes the suspected pathogen from the infected sites
results in clinical improvement
Treatment of periodontitis involves destruction of the infectious subgingival 
microbiota, either via antibiotic therapy or by mechanical means such as 
subgingival scaling. Whilst both methods can be extremely efficacious, their 
methods of attack are not targeted at specific micro-organisms, but at the whole 
microbial plaque population. Disruption of the structure of the polluting biofilm, 
that often requires close physical proximity between cells for successful 
symbiosis, may be sufficient to terminate disease.
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In a study of patients with refractory perodontitis, a group of subjects who did 
not appear to respond to therapy were found to be infected with 8. forsythus 
(Haffajee et al, 1986). In these cases, it is possible that the patient’s ‘non­
specific’ treatment was not sufficient to remove B. forsythus, and led to a 
worsening of their condition. Thus there is a cause for the development of 
species-specific therapies for the treatment of some cases of periodontitis.
In conclusion, that data available presents convincing evidence that 8. forsythus 
is a periodontal pathogen. A brief perusal of current papers on the microbiology 
of periodontitis highlights the diversity of micro-organisms implicated in the 
disease, and several differing reports on the microbial flora have been reported. 
These varying reports may be due to differences in sampling sites, sampling 
techniques and methods used to identify isolates.
8. forsythus may be present as part of a symbiotic relationship, as indicated by 
reports on its mutual association with other species. It may also be an 
opportunistic pathogen, only becoming established after the disease process 
has been initiated.
Heat shock proteins
The heat shock proteins represent a large group of proteins, within which 
individual heat shock protein (hsp) families are defined by their apparent 
molecular weight. The main families of hsp are hsp90, hsp70, hsp60 and small 
hsps. The different families all have in common the ability to act as a chaperone 
to other cellular proteins. This functional conservation is refelected at the
21
genomic level, with a measure of sequence conservation maintained throughout 
the group. The families differ with regards to their binding specificities. For 
example, the hsp90 proteins have an affinity for steroid receptors, and bind to 
them to prevent untimely interactions between the steroid receptors and DNA. 
Hsp70 proteins are known to be involved with protein translocation and the 
assembly of immunoglobulins. Hsp60 predominantly functions to fold and unfold 
polypeptides to ensure the correct assemblage of oligomeric protein complexes 
and to maintain proteins to be transported in a format compatible with 
translocation (see reviews in Kaufmann, 1990; Ellis and Vandervies, 1991). As 
chaperones, each family of proteins acts to prevent incorrect protein 
interactions, or the formation of protein aggregates. None of the chaperones 
possess the steric information that their charges require to fold or interact 
correctly, nor are the chaperones incorporated into the final protein structures 
and complexes, but dissociate when the time or place is appropriate.
Heat shock protein 60
The term ‘molecular chaperone’ was first used to describe a protein identified in 
Xenopus eggs that bound histones and transferred them to DNA to form 
nucleosomes. The binding of the chaperone prevented incorrect interactions 
between histones and DNA occurring, and allowed only selected interactions to 
take place (Laskey et a/, 1978). After this time, proteins found to share a similar 
role in the assembly of other multi-protein complexes were identified in E. coli 
and in plant chloroplasts. The groE protein of E. coli was found to be essential 
for the correct assembly of T4 bacteriophage in the bacterium (Hendrix, 1979), 
whilst a chloroplast protein was found to be necessary for the assembly from
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sub-units of the photosynthetic C02-fixing enzyme, ribulose bisphosphate 
carboxylase-oxygenase (Barraclough and Ellis, 1980). Thereafter, Ellis 
proposed that these proteins from seemingly disparate organisms belonged to a 
class of cellular proteins, whose common function was to aid the correct folding 
and formation of polypeptide chains and multimeric structures (Ellis, 1987). The 
protein family was the hsp60 group of chaperones, also referred to as 
chaperonins and groEL-like proteins. The hsp60 proteins are thought to 
function by maintaining cellular proteins in an unfolded conformation, until such 
time that they are released from the chaperone and are able to undergo intra- or 
inter-molecular folding. By maintaining proteins in an unfolded conformation, 
hsp60 is also able to aid protein translocation and export (Zeilstra-Ryalls et al, 
1991). Hsp60 also possesses the ability to unfold a protein or protein complex 
that has already adopted a tertiary structure, such that hsp60 can cause 
incorrectly formed protein aggregates to dissociate, and can cause a ready 
folded protein to assume a comformation more amenable for export. The variety 
of protein substrates that hsp60 can bind is known to be very large, but is not 
fully defined (Zeilstra-Ryalls etal, 1991).
Cellular stress, such as heat shock, typically causes protein to denature. Hsp60 
can therefore protect cells from the adverse effects of stress by reducing the 
amount of free, denatured protein in the cell, and aiding the re-formation of 
functional protein structures. Many oligomeric structures in cells are required for 
essential biological functions to occur, such as the biosynthesis of amino acids, 
RNA synthesis, DNA replication and protein translocation. As these structures 
would not be able to form without the aid of hsp60, these molecular chaperones 
are essential for cell viability even in non-hostile conditions (Craig et al, 1993).
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Hsp60 expression and regulation
Heat shock proteins are amongst the most abundant proteins in the biosphere 
(Kaufmann, 1990). Constitutively expressed, they account for up to 5% of all 
proteins present in bacteria under normal conditions, and up to 40% of total 
protein expressed following cellular stress (Kaufmann et al, 1991; DeBruyn et 
al, 1987). The term ‘heat shock' protein is something of a misnomer, as various 
cellular insults induce the increased expression of hsp60 proteins. These 
stresses include pH decrease, exposure to reactive oxygen metabolites and 
starvation (Buchmeier and Heffron, 1990).
The level of hsp60 expression within a cell is thought to be determined by a 
feedback loop that indicates the equilibria in the cell between folded and 
unfolded proteins, and between protein-associated and free hsp60 molecules. 
Following cell stress, the level of unfolded, denatured proteins in the cell 
increases, and the amount of free hsp60 decreases correspondingly. This 
decrease in free hsp60 is thought to enable a heat shock transcription factor to 
bind to a heat shock gene promoter, thus causing an increase in the expression 
of the gene product such that the level of free hsp60 will rise again within the 
cell. When the free hsp60 level is adequate, the heat shock transcription factor 
is bound by hsp60 and is unable to induce high levels of hsp60 synthesis 
(Kaufmann, 1994).
Hsp60 and disease
A prodigious and ever increasing number of observations implicate hsp60
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involvement in a wide range of clinical situations. These range from bacterial 
infections where the hsp60 is a common antigen expressed by bacterial 
species, and flags potential pathogens for rapid attack by the host immune 
response (Kaufmann, 1991; Kaufmann e ta l, 1991; Kaufmann, 1992b; Shinnick, 
1991), to organ specific inflammatory diseases, such as arthritis (Boog etal, 
1992; DeGraeff Meeder et al, 1991; Gaston et al, 1990), peptic ulcer disease 
(Amini etal, 1996; Yamaguchi etal, 1997), chlamydia (Horner et al, 1996; 
Morrison et al, 1989; Taylor et al, 1990), kidney disease (Warr et al, 1997), 
heart and vascular disease (De Stefano et al, 1993; Desvarieux et al, 1999; 
Hopplicher et al, 1996; Matilla et al, 1989; Wu et al, 1999) and a number of 
autoimmune disorders (Cohen, 1992; Georgopoulos and McFarland, 1989; 
Jones et al, 1993; Kaufmann, 1994). More recently the potential role of hsp60 
in diseases of the nervous system, such as myasthenia gravis (Astarloa et al,
1996),Alzheimer’s disease (Hamos et al, 1991) and multiple sclerosis (Raine et 
al, 1996), and in cancer (Hsu and Hsu et al, 1998; Ito et al, 1998) has been 
studied. Each study confirms the highly antigenic nature of hsp60. Of particular 
relevance to this study are the hsp60 studies undertaken by others with regard 
to inflammatory diseases and autoimmune diseases. The most extensive work 
by far has been done on arthritis. Interestingly, arthritis and periodontitis share 
a number of similarities. Both are chronic inflammatory diseases, and result in 
bone resorption, possibly as a result of autoimmune reactions. Thus the 
literature on hsp60 and arthritis will be studied more closely below. Literature 
on hsp60 and autoimmune disease will also be examined.
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Hsp60 and arthritis
The pathogenic role of the 65 kd hsp of M. tuberculosis (mycobacterial 65-kD 
hsp, Mb hsp65; an hsp60 homologue) in arthritis has been widely studied. In 
humans, both cellular and humoral reactions to Mb hsp65 have been reported 
in rheumatoid arthritis (RA) and juvenile chronic arthritis (JCA) patients (Boog et 
al, 1992; DeGraeff-Meeder etal, 1990; Haregewoin etal, 1989; Holoshitzetal, 
1989; Kaufmann et al, 1990). T cell clones isolated from the synovial fluid of 
patients with inflammatory arthritis proliferated in response to Mb hsp65 to an 
extent greater than the patient’s peripheral blood (Gaston, 1990). Similarly, 
mononuclear cells from synovial fluid of patients with juvenile chronic arthritis 
demonstrated a substantial proliferative response to purified fractions of hsp60 
(DeGraeff-Meeder et al, 1991).
At a humoral level, patients with rheumatoid arthritis have been reported to 
possess IgG and IgA antibodies to Mb hsp65 at a level higher than found in 
samples from healthy individuals (Rudolphi etal, 1997; Tsoulfa et al, 1989). 
These responses have been mirrored in animal models of rheumatoid arthritis, 
for example, adjuvant arthritis in Lewis rats (DeGraeff-Meeder et al, 1990).
Current reports conflict as to whether these immune components are reacting to 
mycobacterial specific epitopes or to conserved hsp65 epitopes presented on 
the hsp65 proteins from different species. The T cell clones isolated by Gaston 
et al (1990) recognised epitopes at the NH2 terminus of the protein that were not 
conserved between species. However, equally strong evidence persists to 
demonstrate that immune system components recognise conserved epitopes of 
the hsp65 (Handley et al, 1996; Krenn et al, 1996; Munk et al, 1989). It is most
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likely that antibodies are raised against both species-unique and common 
cross-reactive epitopes (Ivanyi et al, 1983). Hsp60 cross-reactive antibodies are 
the more probable of the two classes to be involved in the pathogenesis of 
arthritis, possessing the potential ability to recognise autologous human hsp60 
and to induce an immune reaction against human tissue. The existence of 
cross-reactive immune cells has been demonstrated by Boog et al (1992). A 
monoclonal antibody was developed that recognised an hsp65 epitope 
expressed by human and bacterial hsp65. This monoclonal antibody was able 
to bind to the synovial membrane of JCA patients. A monoclonal antibody with 
unique specificity for human hsp60 was also able to bind to the synovial 
membrane of these patients. This illustrated that levels of endogenous hsp60 
are raised in the chronic inflammatory environment, and that these self antigens 
may then become targets for an immune response.
The substantial evidence linking the Mb hsp65 to arthritis has recently been 
opened to speculation by the presentation of major evidence that that questions 
the accountability of previous work in this field. Handley et al, (1996) showed 
that levels of antibodies to groEL (i.e. anti E.coli hsp65) were higher than 
antibody levels against Mb hsp65 in patients with rheumatoid arthritis. Jarjour 
et al (1991) argue against a role for autoantibodies to hsp65 in rheumatoid 
arthritis, by claiming that these antibodies could not be detected in patients with 
rheumatoid arthritis. Furthermore, they found titers to bacterial hsp65 were so 
low that their role in the pathogenesis of rheumatoid arthritis could be disputed. 
It has been suggested that previous interpretations of ELISA for antibodies to 
Mb hsp65 in rheumatoid arthritis patients should be completely re-evaluated,
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after the finding that IgM rheumatoid factor (present in patient sera) could lead 
to false-positive ELISA results by cross-linking of the primary and secondary 
antibodies used in the technique (Lim and Sharif, 1996). Removal of IgM RF 
from sera significantly reduced ELISA OD levels. Recently it has also been 
shown that hsp60 levels alter with age (Faulds et al, 1995). As this has not 
been accounted for in the majority of rheumatoid arthritis antibody studies, this 
again queries the viability of previous work.
Hsp60 and immunodominance
It has been suggested that the strength and uniformity of immune responses to 
hsps is due to the immune system being pre-programmed to react to this, and 
other, immunodominant antigens (Cohen, 1992; Cohen and Young, 1991). This 
would explain why healthy control patients have hsp reactive B and T cells. 
Having an immune response to dominant antigens that is pre-programmed has 
various advantages: it reduces the chaos element of developing an immune 
repertoire, and dominance to selected self antigens creates essential self 
tolerance to other self antigens due to their being part of a field of weak 
‘background’ antigens. For these programmed immune cells recognising 
dominant antigens there is also a network of ready-made connections to the 
rest of the immune system, allowing both control and homeostatic regulation of 
responses, and also allows for ready-made T-help. This instantly available T- 
help means that programmed B and T cells recognising microbial hsp elicit a 
stronger, faster immune response than do other competing exogenous 
antigens. An efficacious immune response to hsp confers obvious advantages, 
considering the ability of hsps to be used as a common antigenic flag expressed
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by invading micro-organisms and by inflamed and dam aged host tissue.
Cohen’s attractive theories go a long way to explaining many of the features 
pertinent to hsp 60s ie. their potent immuno-stimulatory powers, 
immunodominance, and widespread expression of hsp60 reactive T and B cells 
in vast range of disease patient groups and healthy controls. His ideas also 
greatly assist the onerous task of interpreting much of the conflicting and 
ambiguous papers presenting hsp studies.
Hsp60 and autoimmunity
As previously mentioned, hsp60 is expressed in virtually all cell types and is 
essential for cell viability (Zeilstra-Ryalls et al, 1991). As such, it is expressed 
constitutively in bacterial cells and in the mitochondria of human cells. Despite 
its apparent intracellular localisation, mammalian hsp60 has been found to be 
expressed on cell surfaces (Jarjour etal, 1990; Soltys and Gupta, 1996). 
Antibodies against conserved epitopes of hsp65 have been shown in 
innumerable studies to be highly cross-reactive (Handley et al, 1996; Jones et 
al, 1993; Nakano etal, 1995). Hsp60 presents as an ideal candidate for 
stimulating an autoimmune response via antigenic mimicry: an invading 
organism presents elevated levels of extremely immunogenic hsp 60 antigen, 
against which an immune response is quickly launched. The elevated 
temperature of the site of infection, or any concomitant inflammatory reactions 
stress self cells, resulting in elevated levels of endogenous hsp60 also being 
expressed at the immune reactive site. Those T cell clones and antibodies 
raised against conserved sites of the stimulating hsp60/65 can potentially bind
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the shared epitopes on the self antigen, and an auto immune reaction is 
initiated. Theories similar to this are currently cited in literature linking hsp60 to 
autoimmune disease. According to this concept, the overwhelming presentation 
of shared hsp epitopes to the immune system would eventually break down self 
tolerance to self hsp, and auto immune disease would ensue.
The existence of reactive T cells and antibodies that recognise self hsp has 
been demonstrated by many groups studying a range of diseases (Ellis and 
Vandervies, 1991; Handley e ta l, 1995; Kaufmann e ta l, 1990; Kaufmann, 1994; 
Kiessling et al, 1991). These studies, mostly immunoassays, have been further 
bolstered by the development of new techniques that allow elution and 
subsequent identification by microsequencing of peptides naturally processed 
and presented by magor histocompatability complex (MHC) gene products 
(Jardetsky et al, 1991). These studies have proved conclusively that hsp 
derived peptides are presented through both MHC class I and II pathways, and 
that it is often a conserved region of the hsp that is presented. Along with the 
identification of T cell clones that recognise synthetic peptides representing 
‘shared’ hsp domains (Kaufmann et al, 1990), these data indicate that self hsp 
epitopes can be targeted by an immune response. This goes well to support 
the idea that such an immune response would cause auto immune disease -  
were it not that healthy control patients appear to possess auto-immune T cell 
clones and antibodies with the same specificity for self hsp (Handley et al, 1996; 
Munk etal, 1988; Munk etal, 1989).
Autoimmunity cannot be assumed to be indicative of auto immune disease. In a
30
view put forward by Cohen and Young (1991), autoimmune reactions are 
necessary to the host for the recognition and removal of aberrant host cells. As 
hsp expression is known to increase after a variety of cellular insults, for 
example during inflammation, transformation or infection, it appears as an ideal 
universal marker of stressed cells. Hsp reactive T cells have also been shown 
to recognise activated immune cells (Koga etal, 1989), and Cohen suggests 
that this reaction may be part of a homeostatic pathway to down-regulate 
immune responses, preventing immune hyper-reactivity. The non-pathogenic 
nature of an immune response to hsps is further supported by evidence 
indicating that some y5 T cell populations have a particular predilection for hsps. 
A high proportion of y8 T cells develop extra-thymically, and thus avoid thymic 
silencing of lymphocytes that are self reactive (Haas et al, 1993). y5 T cells are 
also thought to have a limited diversity of antigen recognition genes (Asarnow et 
al, 1988). As studied in the mouse, many y5 T cells are found localised in the 
epithelial layer. As such, they represent the first barrier an invading pathogen 
has to overcome when attacking the host (Asarnow et al, 1988; Janeway et al, 
1988; Janis et al, 1989). Their role is principally thought to be one of immune 
surveillance, and it follows that they should have the ability to recognise any 
stressed, aberrant or infecting cell. As mentioned previously, hsp expression is 
a perfect ‘flag’ for stressed cells, whether microbial or of host origin, and y8 T 
cells have been widely demonstrated to recognise this ubiquitous antigen (Fisch 
etal, 1990; Haregewoin etal, 1989; Kaufmann and Kabelitz, 1991; Saito etal,
1997).
Collectively, these reports highlight the fact that autoimmune reactions to self
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hsp are not necessarily detrimental to the host; rather, they are probably of 
significant benefit to the host. This has caused a recent re-evaluation of the link 
between hsps and autoimmune disease. It is still commonly held that there is a 
connection, as can be confirmed by the finding of sequence homologies 
between hsp60 and other known auto antigens (Jones et al, 1993). However, 
the identification of hsp60 reactive lymphocytes within autoimmune lesions is as 
likely to be representative of a healthy homeostatic down-regulation of 
acitivated immune cells or a primary response to infection as it is an indicator of 
self destructive processes.
Hsp reactive lymphocytes are more likely to feature in autoimmune disease 
when the healthy anti-hsp immune response becomes imbalanced, or 
homeostatic control of it fails (Cohen, 1992; Cohen and Young, 1991). Antigenic 
mimicry of hsp60s could be responsible for initiating autoimmune disease, if an 
aggressive immune reaction to exogenous bacterial hsp60 antigens was not 
properly controlled by suppressor elements of the immune system, and the 
aggressive reaction was misdirected to host organ-specific antigen. This would 
account for the organ-limited, as opposed to systemic, nature of autoimmune 
diseases.
Alternatively, hsp60 cross-reactive lymphocytes may arrive at the afflicted site 
secondarily, after inflammation had already been established (Anderton et al, 
1993). In this situation stressed host cells of the target organ could become 
targets for an anti-hsp60 immune response. Again, if homeostatic control of the 
immune response to hsp60 failed, antigenic mimicry could lead to autoimmune
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disease. As more organ-specific tissue was challenged by the immune 
response, host cells would face further stress and increased production of self- 
hsp60, perpetuating the cycle of self-attack.
Hsp60 as diagnostic and prognostic indicators
As previously discussed, the role of hsp60 in the pathogenesis of disease has 
recently been reviewed and the current ideas on the concept are still 
speculative. Critical reviews by Jarjour et al (1991), Tishler and Shoenfeld 
(1996) and Lim and Sharif (1996), have questioned the viability of previous 
studies which were quick to brand hsp60 as a pathogenic protein after an 
immune response to hsp60 had been demonstrated. Perhaps because of this, 
recent papers that have highlighted antibody responses to hsp60 in patient 
groups have been cautious with the interpretation of their findings. Rather than 
attempt to implicate these hsp60 specific antibodies as being involved in a 
pathogenic role in autoimmune disease, Gruber e ta l (1996) have instead used 
hsp60 antibodies to identify and define patient sub-groups within a large 
disease group. Studying patients with vasculitis, they suggest that the 
identification of a sub-group of patients that has raised antibody titres to 
mycobacterial hsp65 may hi-light vasculitis cases that have an underlying 
bacterial infection of the arteries. They suggest that the presence of antibodies 
to Mb-hsp65 could distinguish those patients within the vasculitis group that 
have (or have had) an underlying infection of the arteries.
Portig et al (1997) proposed the same in their study on patients with 
cardiomyopathy, and also suggest that after the patient sub-group had been
33
defined, (i.e. those with high titers to hsp60), therapy could be targeted more 
effectively with specific anti-inflammatory treatment.
Investigation of antibodies to hsp60 in patients with rheumatoid arthritis persists. 
Prakken et al (1996), suggest that hsp60 reactive antibodies be used for the 
prognosis of oligoarticular juvenile rheumatoid arthritis, after they found that 
patients with a positive antibody response to human hsp60 developed disease 
remission within 12 weeks. Similarly, Peeling et al (1997) found that the 
presence of antibodies to recombinant chlamydial hsp60 within a group of 280 
female sex workers in Africa predicted a 2-3 fold increased risk for chlamydial 
pelvic inflammatory disease, and it is suggested that the chlamydial hsp 60 
antibodies can be an aid to prognosis of this disease.
Initial work has been carried out to identify antibodies to hsp60 in periodontitis 
and gingivitis patients that may aid diagnosis (Schett et al, 1997). Both these 
groups, and healthy patients, carried anti-hsp antibodies in their sera, but only 
the gingivitis group had a high level of antibodies against a cross-reactive hsp60 
epitope in their saliva. Schett and colleagues propose the measurement of 
levels of salivary anti-hsp60 as a diagnostic marker for gingivitis, whilst high 
serum antibody titres to hsp60 are more frequently associated with periodontitis.
Hsp60 and vaccines
Hsp60s have been the focus of interest in vaccine development for two 
reasons: i) the development of anti-hsp vaccines to treat disease in which hsp 
60 immune reactivity is thought to play a role (Prakken et al, 1998) and ii) use of 
hsps as stimulatory adjuvants for the development of novel vaccines in other
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unrelated diseases (Jindal, 1996).
It has been demonstrated that bacterial hsps have the ability to prevent 
experimental arthritis in animal models following prior immunisation 
(Bloemendal e ta l, 1997). The protective mechanism of these vaccines is 
thought to be via induction of tolerance or via the induction of regulatory T cells 
that function in re-establishing homeostatic control of immune reactions against 
hsp60. Oral administration of a potential vaccine was shown to have a far better 
protective capacity than parenteral delivery of the same vaccine. This is thought 
to be due to the vaccine stimulating proliferative responses in different T cell 
types. Stimulation of T-helper 1 (Th1) T cells provokes an aggressive, non- 
protective response, whereas Th2 T cells, stimulated by oral administration of 
the vaccine, are regulatory (Tian and Kaufman, 1998).
By increasing numbers of regulatory cells (eg. anti-idiotypic cells) the 
autoimmune effector cells could be ‘reigned-in’ and healthy control of the 
immune response against hsp60 re-established (Cohen, 1992). Presumably 
altered T cell lines capable of aiding immune control could be produced in vitro 
and supplied as a passive vaccine, eliminating the risk of producing an 
aggressive response that may result from vaccination with bacterial hsp60 
antigens directly.
The immunogenicity of hsp 60s and their ability to elicit a rapid immune 
response has caused a recent investigation into the ability of hsps to act as 
adjuvants (Jindal 1996; Lussow et al, 1991). Initial results show that hsp60 of E. 
coli and M. bovis behave as carrier molecules that can induce anti-peptide 
antibodies (in mice) without requiring the presence of other adjuvants.
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Further work is necessary to assess the risk of stimulating responses against 
self-hsp with these vaccines, but it seems that there is potential for the 
development of vaccines against novel peptides by fusing peptides to hsp 60s 
via recombinant technology. This is creating interest in tumour research, with 
peptides associated with tumour cells being used to develop vaccines against 
homologous tumours.
Autoimmune processes in periodontal disease
As mentioned previously, human periodontitis is an infectious process mediated 
by a wide range of Gram negative bacteria (Moore and Moore, 1994). The 
infection leads to chronic inflammation which results in degradation of the 
supporting structures of the teeth, and eventually tooth loss.
Periodontal disease describes a manifestation of symptoms that are similar 
between patients. Numerous models for the pathogenesis of the disease have 
been proposed, but no definite evidence currently exists to support any one 
particular hypothesis as the periodontal paradigm. It seems likely that for a 
disease as complicated as periodontal disease is, and involving as many 
potential pathogens and risk factors as it does, that there is no one true cause 
or course for the disease and that many pathogenic processes occur 
concomitantly.
A role for autoimmunity in periodontal destruction was implicated over 25 years 
ago. It was first realised that cellular immunity played a role in periodontal 
destruction in 1970, when lymphocytes were shown to respond to bacterial 
antigens present in periodontal disease (Ivanyi and Lehner, 1971). Also,
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periodontal disease has been seen to share characteristics with other 
inflammatory diseases in which autoimmunity is thought to be a component of 
the disease progression (Snyderman and McCarty, 1988). Whilst the idea of 
autoimmunity as a factor in periodontitis is still not conclusive, studies continue 
to support this concept and more sophisticated autoimmune models are 
proposed as we better understand the function and capabilities of immune cells 
and the effector molecules they express.
Anusaksathien and Dolby (1991) give a review of reports yielding evidence of 
autoimmunity in periodontal disease. A pertinent feature of many of these 
studies is the detection of ‘autoantibodies’, that is, antibodies that have been 
found to be reactive with self antigens. For example, autoimmunity to collagen 
has long been held as a pathogenic reaction that may be fundamental to 
periodontal disease. In a study by Hirsch et al (1988) autoantibodies to 
denatured collagen were detected and implicated in periodontal disease. As 
was previously mentioned though, the detection of autoantibodies is not 
sufficient to proclaim that autoimmune disease is occurring. It is possible that 
the autoantibodies detected play a benign, if not beneficial, role to the host in 
the disease process.
For some considerable time the idea of ‘molecular mimicry’ has been popularly 
cited as a likely cause of autoimmune reactions. Briefly, this theory holds that a 
bacterial antigen acts as the autoimmune trigger via cross-reactivity with self 
antigens. Antibodies raised against the exogenous protein are thus able to bind 
to the cross-reactive endogenous protein, and self-attack is initiated.
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Various antigens have been mooted as bacterial molecular mimics of self 
proteins, including the hsp60s of bacteria. Hsp60s fulfil many criteria that deem 
them fit as archetypal molecular mimics, although they are less mimics than 
they are true homologues of a human protein.
Heat shock reponse of periodontopathogenic bacteria
The production of heat shock proteins is a crucial response to stress that 
protects cells exposed to any of a variety of insults, including exposure to 
elevated temperatures. The proteins allow cells to survive in unfavourable 
conditions, but have also been shown to be elemental for cell survival in normal 
conditions (Craig et al, 1993) and aid survival of bacterial pathogens when 
invading a mammalian host during infection (Buchmeier and Heffron, 1990). 
Several periodontopathogenic bacteria have been shown to respond to stress 
by eliciting a heat shock response. Generally cells were incubated at 37°C, and 
then subjected to ‘heat shock’ at 42°C for up to 20 minutes. SDS-PAGE 
analysis of the heat induced proteins revealed increased synthesis of a range of 
proteins from which hsp 60 homologues can be identified by Western 
immunoblotting.
The heat shock response has been illustrated for a number of known 
periodontopathogenic bacteria. These include strains of Porphyromonas 
gingivalis (Lu and McBride, 1994), Actinobacillus actinomycetemcomitans (Koga 
etal, 1993), Treponema denticola (Stamm et al, 1991), Bacteroides forsythus, 
Prevotella oralis, Fusobacterium nucleatum, Porphyromonas endodontalis, 
Prevotella nigrescens, Prevotella melaninogenica, Treponema socranskii and
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Prevotella intermedia (Ando et al, 1995; Vayssier et al, 1994).
Environmental conditions in the periodontai pocket
Thermal shock, pH decrease, increase in oxygen concentration and mechanical 
stress have all been shown to induce the synthesis of hsp60 in oral bacteria 
(Vayssier et al, 1994; Yoshiyuki etal, 1999). The environmental conditions in 
the infected periodontal pocket are such that bacteria could be exposed to 
these stresses. The subgingival temperature is increased at diseased sites as 
compared to healthy ones (Fedi and Killoy, 1992; Kung et al, 1990), the pH of 
diseased sites decreases as periodontal pocket depth increases (Bickel and 
Cimasoni, 1985) and bacterial hsp60 levels increase after exposure to oxygen 
metabolites of phagocytes (Buchmeier and Heffron, 1990).
Cross-reactive hsp60 antibodies present in periodontitis
The hsp60 of several periodontopathic Gram negative bacteria have been 
identified as cross-reactive antigens. This has been suggested by sequencing 
the hsp60 genes and aligning the data with other hsp60 sequences (Maeda et 
al, 1994; Nakano et al, 1995; Reid and Riggio, 1998) to display the high level of 
sequence conservation shared amongst the proteins of different species, and 
verified by demonstrating that heat induced 60kDa proteins of periodontopathic 
bacteria can be detected by cross-reactive hsp60 antibodies (Ando etal, 1995; 
Hinode et al, 1998; Vayssier et al, 1994).
Heat shock proteins and the stress response of numerous prokaryotic and 
eukaryotic organisms have been widely studied as previously mentioned.
39
However, only a few research groups have focused on the heat shock proteins 
and stress responses of oral bacteria associated with periodontal disease.
To date, the DNA sequences of the hsp60 genes from three periodontopathic 
bacteria have been published: Actinobacillus actinomycetemcomitans (Nakano 
et al, 1995), Porphyromonas gingivalis (Maeda et al, 1994), and Bacteroides 
forsythus (Reid and Riggio, 1998). The sequences share up to 85% sequence 
conservation throughout the entirety of the gene. Aligning these sequences with 
the hsp60 DNA sequences of other species shows that the oral pathogens have 
a level of homology of about 50-80% with other prokaryotic micro-organisms, 
and approximately 48% homology with the human hsp60 homologue, 
mitochondrial protein P1. Particular regions of the hsp60 DNA sequence appear 
to be extremely well conserved, and it could be that antibodies raised against 
these omnipresent epitopes would be highly cross-reactive, theoretically 
possessing the ability to react with virtually any other hsp60.
That hsp60 antibodies can cross-react with oral pathogenic micro-organisms 
has been established in several immunoblot analyses (Ando et al, 1995; Hinode 
etal, 1996; Hinode etal, 1998; Koga etal, 1993; Maeda et al, 1994; Nakano et 
al, 1995; Reid and Riggio, 1998). Typically, Western blots are probed with 
monoclonal antibodies raised against hsp60 of a non-periodontopathic 
organism (e.g. against hsp60 of Yersinia enterocolitica in Ando et al, 1995; 
Mycobacterium leprae in Nakano etal, 1995; E. coli in Reid and Riggio, 1998).
More significant are the Western blots that use monoclonal antibodies raised 
against periodontopathic bacterial hsp60 as a probe to detect hsp60 in other
40
periodontopathic bacteria though, as the high antibody titres at periodontally 
diseased sites will be composed of antibodies against the periodontopathogens, 
and not antibodies against a species that is not implicated in the disease. Thus, 
if an immunoblot can evidence that antibodies raised against an oral pathogen 
can cross-react with other oral pathogens, presumably this situation could be 
mirrored in vivo and could be of importance in the pathology of the disease.
Interestingly, monoclonal antibodies against fragments of the hsp60 protein of
A. actinomycetemcomitans were shown to cross-react with several bacteria, 
but there was no reaction evidenced against the known periodontopathogens 
Porphyromonas gingivalis, Prevotella intermedia or Fusobacterium nucleatum 
(Nakano et al, 1995). Hinode et a /(1998) raised polyclonal antibodies to the 
hsp60 proteins of A  actinomycetemcomitans and P. gingivalis. These 
antibodies cross-reacted with other hsp60 proteins, including those of B. 
forsythus, but notably not with human hsp60 protein. In direct contradiction to 
Nakano’s study, Hinode’s group showed that A. actinomycetemcomitans hsp60 
antibodies did cross-react with P. gingivalis hsp60. This discrepancy in results 
may be due to Nakano using monoclonal antibodies to portions of the A. 
actinomycetemcomitans hsp60 as his immunoblot probe. Whilst monoclonal 
antibodies have an indisputable importance in research, in this study they were 
limiting in that they may have been raised to non-conserved epitopes, and 
would not be a true reflection of what may be occurring in the natural polyclonal 
respones of a patient.
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Presence of hsp60 reactive antibodies in sera from periodontai disease 
groups and heaithy controls
Having established that antigens raised against hsp60 are cross-reactive and 
have sufficient avidity to recognise hsp60 from other unrelated species, this 
work would take on further import should it be demonstrated that the hsp60 
cross-reactive antibodies can be detected at higher levels in serum samples 
from periodontitis patients as compared to healthy controls.
Koga et al (1993) obtained serum samples from 21 patients with localized 
juvenile periodontitis or rapidly progressive periodontitis. Of these, 9 samples 
reacted with the 64kDa protein of A  actinomycetemcomitans (serotype b), as 
analysed by Western blotting. In the same study, sera taken from 10 
periodontally healthy subjects showed no reaction.
Ando et al (1995) demonstrated the presence of antibodies that reacted with 
bacterial hsp60s of A. actinomycetemcomitans, Fusobacterium nucleatum and 
Prevotella nigrescens in one serum sample from a periodontitis patient. Further 
work was done to detect the immune response to hsp60 occurring in gingival 
tissue sections from 4 patients with adult periodontitis. Of the 4 tissue sections, 
3 reacted with monoclonal antibodies against human hsp60 but did not react 
with bacterial hsp60. The same results arose when homogenised gingival 
samples were utilised. The group suggests that the discrepancy between the 
results from serum and tissue samples could be due to the periodontopathic 
bacterial hsp60 antigens forming large immunocomplexes with their relevant 
antibodies in situ. The formation of antigen-antibody aggregates would preclude 
the binding of any further hsp60 antibodies that would be necessary for a 
positive result in an immunoassay. These immunocomplexes would activate the
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complement system and cause inflammation of the gingival tissue which, in 
turn, would cause an increased production of human hsp60 in host cells (as 
was detected in the gingival tissue).
A further study of hsp60 antibodies present in human periodontitis patient 
serum was performed when recombinant P. gingivalis hsp60 was purified and 
contested with sera from ten periodontitis patients with antibody titres elevated 
to P. gingivalis. Eight of the test group sera reacted to the P. gingivalis hsp60. 
Three out of nine healthy patient samples showed a positive reaction as well 
(Maeda et al, 1994).
This study possesses the advantage over the other serum studies referred to of 
utilising purified recombinant protein. The gene expressing P. gingivalis hsp60 
had been cloned into an expression vector prior to purification of recombinant 
protein. This allowed the gene to be sequenced and conclusively proven to be 
the gene encoding hsp60. This level of certainty cannot be achieved by other 
groups that identify hsp60s, prior to purification, with immunoblot assays using 
antibodies to other hsp60s as a detective probe. Hsp60 antibodies are 
frequently shown in the relevant literature to possess the ability to bind to a 
number of proteins of varying size. These proteins may be hsp60 breakdown 
products, but the possibility remains that they could be unrelated proteins 
hybridizing to the hsp60 probes. Should this be the case, proteins could be 
purified and incorrectly identified as hsp60.
More recently, Tabeta et al (1999) synthesised recombinant P. gingivalis hsp60 
to analyse the presence of reactive antibodies in serum and gingival tissue 
extracts from ten periodontitis patients and ten healthy controls. Most of the
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diseased serum samples carried hsp60 antibodies, as did half of the tissue 
samples.
Overview of hsp 60 in periodontal disease
In conclusion, a number of separate studies have shown that:
1. The area of inflammation at a periodontally diseased site provides an 
environment that induces increased synthesis of human hsp60.
2. Periodontopathogenic bacteria typically produce increased amounts of hsp 
60 following cellular stress.
3. Antibodies to bacterial periodontal pathogens and human hsp60 are cross­
reactive.
4. Antibodies to bacterial and human hsp60 have variably been demonstrated to 
be present in gingival tissue sections and serum samples from patients with 
periodontal disease.
Antibodies to hsp60 have elicited cross-reactive responses in multitudinous 
studies, and it is not surprising that the same case was upheld for antibodies 
raised against hsp60 from periodontopathogenic bacteria. Progressions from 
these studies should lead to the identification of precise epitopes that yield 
either specific or cross-reactive antibodies.
More directly implicating a role for hsp60 and the antibodies it can potentially 
raise in periodontitis are the studies that substantiate evidence for the presence 
of hsp60 antibodies in periodontal diseased tissue and serum taken from 
afflicted patients. Only small numbers of patient/healthy subject samples have
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been studied so far, with results based on groups of 1-21 patients. Hsp60 
antibodies have been detected in healthy controls as well as in periodontitis 
patient serum, although at a lower prevalence (Ando et al, 1995; Maeda et al, 
1994; Schett et al, 1997; Tabeta et al, 1999). The significance of these results is 
difficult to determine though as statistical interpretation of the data is 
problematic due to the small sample numbers used. Also, no two studies use 
identical antibodies for their studies. Replication of results has not yet been 
demonstrated between groups, and the differing studies cannot be analysed en 
masse due to differences in study design and materials used.
It is essential that these factors be addressed before a consensus on the work 
done by the various groups can be considered.
From the available data, it appears that cross-reactive antibodies to hsp60 can 
be found in healthy as well as periodontally diseased subjects ( Maeda et al, 
1994; Nakano et al, 1995; Tabeta et al, 1999) although some reports do not 
detect hsp60 reactive antibodies in healthy samples (Ando et al, 1995; Koga et 
al, 1993). The conflict in these studies may be resolved if larger numbers of 
subjects are studied. Another factor contributing to the apparent discrepancy 
may be patient age (Faulds et al, 1995). Levels of antibodies to hsps have been 
shown (in mice) to increase with age, however, none of the mentioned reports 
note the age of the patients from which serum samples or gingival tissue have 
been extracted.
As discussed previously, in the case of many other diseases in which hsp60 is 
thought to be involved in the pathogenesis, hsp60 antibodies have been found
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in healthy controls also (Handley et al, 1995; Munk et al, 1988; Munk et al, 
1989). Thus one could presume that the same situation will be described when 
more data is available to compare healthy subjects with periodontitis samples. 
This finding would not completely rule out hsp60 antibodies as factors involved 
in periodontal disease pathogenesis however. An explanation for the seemingly 
ubiquitous human response to hsp60 of human and bacterial origin has been 
postulated by Cohen (1992). Briefly, he suggests that a pre-programmed 
immune response to hsp60 is instilled within us all. Hsp60, he suggests, is a 
universal marker that permits a) recognition of damaged, infected or stressed 
human cells and their subsequent removal, and b) a rapid ready-prepared 
response to invading organisms. To modulate and keep homeostatic control of 
the immune response to hsps it is necessary that there are control elements of 
the immune system dedicated to down regulating the immune response to hsp 
60. When there is a failure of this regulation there may be a pathogenic 
autoimmune response to self-hsp60 molecules. The pathogenic autoimmune 
response may lead to initiation or perpetuation of autoimmune disease. To 
cause disease, the effector mechanisms active against exogenous hsp60 which 
facilitate the obliteration of invading micro-organisms could, if not sufficiently 
controlled, turn their potent actions against an organ specific self antigen. This 
self-antigen could be self hsp60 expressed at high levels on stressed localised 
tissue. An intriguing finding is that periodontal ligament fibroblasts have DNA 
sequences homologous to hsp60 (Gemmell and Seymour, 1995). As an 
antigen, this is specific to the periodontium and is perfectly localised to fulfil an 
explanation of the organ specific nature of periodontal disease. Should these 
cells be the target of an autoimmune attack, increasing numbers of host cells
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would be exposed to stress that would induce a further increase in hsp60 
synthesis, and mark further numbers of host cells for recognition by hsp60 
specific T-lymphocytes and antibodies. Chronic stimulation of this calamitous 
cycle would inevitably result in the destruction of tissue and bone which is 
characteristic of periodontitis.
A review of the cellular immune response in periodontitis lends some support to 
this idea. Information on cells removed from periodontal lesions suggests that 
there is an upset in local immunoregulation (Seymour et al, 1996). Also, early 
indications are that Th2 cells may be dominant in periodontitis lesions (Genco 
and Slots, 1984; Seymour et al, 1996). A crucial function of Th2 cells is to 
provide help to B cells secreting antibodies, which would implicate chronic 
antibody production in the pathogenesis of this affliction.
Bacterial hsp60 homologues may have a role other than one as immunogens in 
the pathogenisis of periodontitis. A report has presented data, based on 
sequence analysis and electron microscopic analysis of protein preparations, 
that an hsp60 homologue isolated from A. actinomycetemcomitans interacts 
directly with bone cells and induces bone resorption (Kirby et al, 1995). The 
hsp60 homologue was present in the surface associated material of the 
bacterium, and was isolated by a saline extraction procedure. Sequencing of 
the NH2 terminal of the protein revealed 36 out of 38 residues to be identical to 
the E. coli hsp60, and approximately 60% conservation shared with the human 
hsp60 homologue, mitochondrial protein P1. A preparation of the protein was 
also examined by electron microscopy, and a double ring structure
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characteristic of hsp60 was observed. The protein possessed extremely 
efficacious osteolytic activity, demonstrating resorbing activity at ~1pM molar 
concentration.
In conclusion, current literature suggests that bacterial hsp60s and antibodies to 
these proteins may be involved in the pathogenic processes of a wide range of 
infectious diseases and autoimmune conditions. The involvement of hsp60 in 
periodontal disease is currently being investigated as a number of findings have 
shown that hsp60 antigens from periodontopathogenic bacteria can a raise a 
cross-reactive immune response in the host which may be significant in disease 
progression. This study aimed to further work in this field by studying the hsp60 
of the periodontal pathogen B. forsythus. It was aimed that this should be done 
by ascertaining the molecular identity of the gene encoding the protein, which 
would indicate the level of genetic homology shared between this species and 
others, and would also allow an analysis of the predicted amino acid sequence 
of the protein. Following this, it was planned that an initial characterisation of the 
immune response to this protein could be facilitated by production of 
recombinant B. forsythus hsp60 and by using this recombinant to screen serum 
samples from healthy individuals and from patients with periodontitis to 
measure antibody responses.
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CHAPTER 2
General Materials and Methods
MATERIALS
This chapter describes materials and methods used throughout the studies 
presented in this thesis. Methods that specifically apply to work covered in 
individual chapters are detailed in the relevant section of each chapter.
Materials 
Bacterial strains
Escherichia coli strains TOP10 and TOP10F’: Invitrogen BV, 9704 CH 
Groningen, The Netherlands.
Bacteroides forsythus strain ATCC 43037.
Prevotella intermedia strain ATCC 25611.
Plasmids
Plasmid pUC18: Amersham Pharmacia Biotech, St. Albans, UK.
Plasmid pCR2.1®-TOPO: Invitrogen BV, 9704 CH Groningen, The Netherlands. 
Plasmid pBAD®-TOPO: Invitrogen BV, 9704 CH Groningen, The Netherlands.
Enzymes
Restriction endonucleases: Promega, Southampton, UK and Gibco BRL, Life 
Technologies Ltd., Paisley, UK.
Taq polymerase: Promega, Southampton, UK.
T4 DNA ligase: Gibco BRL, Life Technologies Ltd., Paisley, UK.
Klenow: Amersham Pharmacia Biotech, St. Albans, UK.
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Chemicals
Tris base, boric acid, ethidium bromide, sodium chloride, mineral oil, Triton X- 
100, spermidine, phenol, ampicillin, IPTG, X-gal, glycerol: Sigma-Aldrich, Poole, 
UK.
Ethanol, bromophenol blue, sodium acetate, magnesium chloride, sodium 
hydroxide, ethylene diamine tetraacetic acid (EDTA), sodium dodecyl sulphate 
(SDS): BDH Ltd, Poole, UK.
Formamide, agarose, tryptone, yeast extract: Gibco BRL, Life Technologies Ltd, 
Paisley, UK.
Tetramethylethylenediamine (TEMED), acrylamide, methylene bis-acrylamide, 
ammonium persulphate, Bind-Silane, Repel-Silane, urea, Rapid Gel XL: 
Amersham Pharmacia Biotech, St. Albans, UK.
Ready Red Chloroform Isoamylalcohol: Appligene Oncor Lifescreen, Watford, 
UK.
Arabinose: Invitrogen BV, 9704 CH Groningen, The Netherlands.
Lysozyme: Boehringer Mannheim 
Radioisotopes
[a- 35S] dATP: Amersham Pharmacia Biotech, St. Albans, UK.
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Other items
Kodak X-ray film: HA West, Clydebank, UK.
Whatman 3MM paper: Whatman International Ltd, Maidstone, UK.
Nylon membrane, positively charged: Boehringer Mannheim, Lewes, UK.
Kits
QIAEX II Gel Extraction Kit: Qiagen, Crawley, UK.
Qiagen Plasmid Kit: Qiagen, Crawley, UK.
Qiafilter Plasmid Maxi Kit: Qiagen, Crawley, UK.
Wizard Plus Minipreps: Promega, Southampton, UK.
Puregene Bacteria and Yeast DNA Isolation Kit: Flowgen, Lichfield, UK. 
Thermo Sequenase fluorescent labelled primer cycle sequencing kit with 7- 
deaza-dGTP: Amersham Pharmacia Biotech, St. Albans, UK.
DIG DNA Labelling and Detection Kit: Boerhinger Mannheim, Lewes, UK. 
TOPO TA Cloning, Invitrogen BV, 9704 CH Groningen, The Netherlands.
Equipment
PerkinElmer DNA Thermal Cycler: Perkin Elmer Applied Biosystems, 
Warrington, UK.
EasyjecT Basic electroporator: Flowgen, Lichfield, UK.
Hybaid Midi Dual 14 oven: Hybaid, Teddington, UK.
LI-COR Gene ReadIR 4200 automated sequencer: MWG Biotech, Milton 
Keynes, UK.
ImageMaster VDS with Fujifilm thermal imaging system: Amersham Pharmacia 
Biotech, St. Albans, UK.
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Template Tamer: Appligene Oncor Lifescreen, Watford, UK. 
Hybaid Omnigene thermal cycler: Hybaid, Teddington, UK.
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METHODS 
Bacterial culture conditions
Bacteroides forsythus ATCC strain 43037 and Prevotella intermedia ATCC 
strain 25611 were both incubated anaerobically (85% nitrogen, 10% hydrogen 
and 5% carbon dioxide) on Columbia Blood agar supplemented with 7.5% 
defibrinated horse blood. In addition to this, the B. forsythus medium contained 
N-acetylmuramic acid and the P. intermedia medium contained 0.5pg/ml 
vitamin K and 5pg/ml haemin. B. forsythus culture could typically be seen after 
7 days incubation, and P. intermedia after 5 days.
Isolation of bacterial DNA
Bacterial DNA was isolated using the Puregene DNA Isolation Kit, following the 
procedure for Gram negative bacteria. All solutions were provided in the kit. 
Bacterial cells were harvested by scraping the surface of the agar plates upon 
which they had grown. The cells were then gently agitated in 600pl cell lysis 
solution until the cells were evenly suspended, and incubated at 80°C for 5 min 
to lyse the cells. The sample was then cooled to room temperature. 
Contaminating RNA was removed by adding 3|il RNase A solution to the lysate 
and mixing the sample by inverting the tube 25 times. The sample containing 
the RNA-digesting enzyme was incubated at 37°C for 60 min and then cooled 
to room temperature. Contaminating cytoplasmic and nuclear proteins were 
then removed by salt precipitation. 200jul protein precipitation solution was 
added to the RNase treated sample and vortex mixed for 20 sec. The sample 
was then centrifuged at 14,000g for 3 min. Precipitated proteins formed a pellet, 
allowing the supernatant containing the DNA to be removed to a clean 1.5ml
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tube. Genomic DNA was finally isolated by precipitation with alcohol. 600jnl 
100% isopropanol was added to the protein-free supernatant and the tube 
inverted 50 times to gently mix. Centrifugation at 14,000g for 1 min then caused 
the DNA to form a small white pellet in the bottom of the tube. The supernatant 
was removed, and the DNA pellet washed by inverting the tube upon addition 
of 600pl 70% ethanol. The tube was then centrifuged as previously. The 
ethanol was poured off and the DNA pellet left to air dry for 20 min. The dried 
pellet was re-hydrated overnight in 10Opil dh^O, and the DNA was stored at 4°C.
Production of plasmids
All plasmids used carried an ampicillin resistance (AmpR) gene.
Transformed E. coli (strain varied depending on procedure) was inoculated into 
5ml L-broth containing 100pg/ml (final concentration) ampicillin. The bacteria 
were then cultured by incubating overnight in an orbital shaker, 200 rev/min, at 
37°C. Glycerol stocks of the bacteria were made by taking 0.5ml of culture 
and adding to it 0.5ml 50% glycerol. These stocks were maintained at -80°C 
until required.
For large scale isolation of plasmid DNA, 1ml of the overnight culture was 
inoculated into 500ml L-broth containing 100pg/ml ampicillin. This was 
incubated as previously. The following day, bacterial cells were harvested by 
centrifugation in a Sorvall SLA-1500 rotor at 10,000 rpm for 30 min at 4°C.
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Isolation of plasmid DNA 
Large scale
Plasmid DNA was isolated on a large scale to replenish parental plasmid 
stocks, and also was the method of choice to isolate plasmids carrying gene 
fragments prior to manual sequencing of the gene.
For large-scale preparations, the Qiagen Plasmid Purification kit was used, 
following the QIAfilter Maxi protocol. This protocol did not require centrifugation 
of bacterial lysates, using QIAfilter cartridges (supplied in the kit) instead. The 
procedure is therefore quicker than conventional ones. QIAGEN-tip 500s and 
all solutions were also supplied in the kit.
After the bacterial culture had been pelleted the pellet was resuspended in 
10ml Buffer P1 containing RNase A. Once the cells were evenly resuspended, 
10ml Buffer P2 was added and the sample mixed by inverting 5 times. The 
sample was then incubated at room temp for 5 min to allow lysis to occur. 10ml 
chilled Buffer P3 was added to the lysate, gently mixed by inverting, and 
immediately transferred into the barrel of a QIAfilter Cartridge (with outlet 
nozzle attached). Without inserting the cartridge plunger, the sample was left at 
room temp for 10 min. Meanwhile, a QIAGEN-tip 500 was equilibrated by 
application of 10ml Buffer QBT which was allowed to drip through the column 
by gravity flow. The plunger was inserted into the QIA filter cartridge and the 
filtered cell lysate dripped into the equilibrated QIAGEN-tip. The lysate was left 
to enter the resin by gravity flow.
The QIAGEN-tip was then washed by passing 2X30ml Buffer QC through the 
resin. Following the washes, DNA was eluted with 15ml Buffer QF and the 
eluate collected. DNA had then to be precipitated by addition of 0.7 volume
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isopropanol. The sample was quickly mixed and centrifuged in a Sorvall SS-34 
rotor for 30 min at 10,000g, 4°C. The supernatant was removed and the 
remaining pellet washed with 70% ethanol. The sample was centrifuged again 
for 10 min, supernatant removed, and the pellet air-dried for 15 min. Lastly, the 
DNA was resuspended in 200pl dh^O.
Wizard Plus Mini-Prep
Plasmid DNA to be sequenced was isolated from overnight cultures of bacteria 
using a Wizard® Plus Minipreps DNA purification system (Promega). Following 
the manufacturer’s instructions, 3ml of bacterial culture was centrifuged for 2 
min at 14,000 rpm. The resulting pellet was resuspended in 200pl cell 
resuspension solution (50mM Tris-HCI, pH 7.5; 10mM EDTA; 100pg/ml Rnase 
A) and the solution inverted 4 times to mix. The suspension of cells was then 
lysed with 200pl cell lysis solution (0.2M NaOH and 1%SDS) and the sample 
again inverted to mix. 200pl neutralisation solution (1.32M potassium acetate) 
was then added, and the mixture could be seen to have cleared instantly. 
Samples were then centrifuged at 14,000 rpm for 5 min. The cleared 
supernatant was added to 2ml Wizard® Minipreps DNA purification resin in a 
syringe column, and the slurry slowly pushed through an attached Luer-Lok® 
minicolumn. The minicolumn was then washed by passing 2ml column wash 
solution (80mM potassium acetate; 8.3mM Tris-HCI, pH 7.5; 40pM EDTA; 55% 
ethanol) through the column. The column was completely dried after washing by 
placing the detached minicolumn in a clean tube, and centrifuging at 14,000 
rpm for 2 min. To elute DNA from the column, 30pl dH20 was applied to the 
column for 1 min prior to centrifuging in another clean tube for 20 sec.
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dh^O to bring the mixture to the correct working concentration. Spermidine 
(1mM final concentration) was added to reactions containing Life Technologies- 
supplied enzymes, and bovine serum albumin (0.1 mg/ml final concentration) 
added to reactions containing Promega-supplied enzymes.
Digestion reactions were thoroughly mixed and incubated at 37°C for no less 
than 3 hours. Digests could then be stored at -20°C until required.
Agarose gel electrophoresis
Agarose was dissolved in 1XTBE buffer (Table 1.1) to a final concentration of 
0.8% or 2%, by heating in a microwave. Ethidium bromide (1fig/ml) was added 
to the molten gel. The agarose solution was poured into the electrophoresis gel 
box, the well-forming comb inserted and the gel left to solidify. When solid, the 
comb was removed and 1XTBE electrophoresis buffer poured into the gel box 
to cover the gel.
0.1 volume sample loading dye was added to each of the samples before they 
were loaded into the wells. Electrophoresis was typically performed by applying 
a voltage of 65V for 30 min-1 hour.
DNA was visualised on an lmageMaster®VDS (Amersham Pharmacia Biotech) 
and photographed with the Fujifilm thermal imaging system.
DNA purification from agarose gels
DNA was purified from agarose gels following electrophoresis to either a) 
isolate a discrete fragment of a specific size or b) to purify the DNA and remove 
contaminating enzymes and buffers. Two methods were routinely used:
i) Spin-X filter tubes
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DNA was excised from the agarose gel using a sterile scalpel and the gel slices 
put into Spin-X filter centrifuge tubes. The tubes were frozen at -20°C for 20 
min and then centrifuged at 14,000 rpm in a benchtop microcentrifuge. The 
eluate collected in the bottom of the tubes was transferred to a clean 1.5ml tube 
and the DNA extracted with an equal volume of phenol (1M Tris-HCI, pH 8.0 
equilibrated)/chloroform (1:1), then 1 volume chloroform. Precipitation of DNA 
was performed by adding 2 volumes filter-sterilised 100% ethanol and 0.1 
volume 3M sodium acetate, pH 6.0, and stored at -70°C for 30 min. The tubes 
were then centrifuged at 14,000rpm for 10 min, and the DNA pellet washed in 
70% ethanol. The washed pellet was lyophilised and finally resuspended in 20- 
30pl dH20. This was stored at -20°C until required.
ii) QIAEX II Gel Extraction Kit
The manufacturer’s protocol for DNA extraction from agarose gels was 
followed. All components were contained within the kit.
As previously, DNA was excised from an agarose electrophoresis gel using a 
scalpel. The gel slice was weighed, and the appropriate amount of Buffer QX1 
added to the tube. The amount of Buffer QZ1 to be added was also dependent 
on the size of the DNA fragment, and could be determined according to the 
following table:
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DNA fragments <100bp Add 6 volumes Buffer QX1 
e.g: 600pl buffer per 100mg gel
DNA fragments 100bp-4kb Add 3 volumes Buffer QX1
DNA fragments >4kb Add 3 volumes Buffer QX1 
plus 2 volumes H2O
QIAEX II was resuspended by vortexing for 30 sec. QIAEX II contains silica gel 
particles that adsorb nucleic acids, and was added to the sample as below:
< 2pg DNA Add 10pl QIAEX II
2-1 Opg DNA Add 30pl QIAEX II
Each additional 10pg DNA Add 30pl QIAEX II
The agarose was solubilised by incubating the tube at 50°C. The sample was 
vortexed every 2 min to keep the QIAEX II particles in suspension. At the end 
of the incubation, the sample was centrifuged at 14,000rpm for 30 sec and the 
pellet washed once with 500pl Buffer QE. The washed pellet was air-dried and 
the DNA eluted with 20pl H2O as below:
DNA fragments <4kb Incubate at room temp for 5 min
DNA fragments 4-10 kb Incubate at 50°C for 5 min
DNA fragments >10 kb Incubate at 50°C for 10 min
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This was centrifuged for 30 sec, and the supernatant containing the DNA was 
transferred to a clean tube. The elution was repeated with another 20pl dhhO to 
increase the yield of DNA, and the pooled eluates stored at -20°C.
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Table 1.1. General Stock Solutions and Buffers 
Luria Bertani (LB) broth
Tryptone 10g
Yeast extract 5g
NaCI 10g
Make volume up to 1 litre with dh^O. Sterilise by autoclaving. 
10x TBE
Trisbase 108g 
Boric acid 55g 
0.5MEDTA 40ml
Make volume up to 1 litre with dh^O. Sterilise by autoclaving.
Ethidium bromide (3mg/ml)
Ethidium bromide 30mg 
dhhO to 10ml
Store away from light and use at a final concentration of 1pg/ml.
Bromophenol blue loading dye
Bromophenol blue 0.05% w/v 
Glycerol 50%
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1M Tris-HCl (pH 8.0)
Tris base 121 g
dH20  900ml
Adjust to pH 8.0 with HCI. Make up to 1 litre with dH20. Sterilise by autoclaving.
STET buffer
NaCI 0.12g
1M Tris-HCl 0.2ml
Triton-X 100 1.0ml
0.2M EDTA 10.0ml
Make up volume to 20ml with
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CHAPTER 3
Identification and cloning of the B. forsythus hsp60 gene
INTRODUCTION
At the onset of the studies presented in this thesis the hsp60 gene of B. 
forsythus had not been cloned or sequenced. Data presented in this chapter 
confirms the presence of a hsp60 gene in B. forsythus, and details the isolation 
and cloning of this gene into a plasmid vector.
The hsp60 protein was chosen for study for several reasons. As discussed in 
Chapter 1 of this thesis, numerous studies of hsp60s have illustrated a role for 
hsp60 in bacterial immunogenicity, and a possible involvement in the 
pathogenicity of autoimmune diseases (Kaufmann, 1991, 1993, 1994; Kiessling 
etal, 1991; Shinnick, 1991; Winfield and Jarjour, 1991; Coates, 1996). It has 
been demonstrated that the protein can confer protective immunity (Bloemendal 
et al, 1997), and it has been mooted as a candidate for potential vaccine 
development (Young etal, 1987; Lussow etal, 1991; Jindal, 1996). There is a 
growing realisation that a comprehension of hsp60 antigens is not only 
important for our understanding of the immunopathology of bacterial infections, 
but may also expand our appreciation of immune surveillance and 
autoimmunity.
Of the periodontal pathogens, those most widely studied with regards to the 
hsp60 they express are A. actinomycetemcomitans and P. glngivalis. The gene 
expressing the hsp60 protein of A. actinomycetemcomitans was amplified by 
PCR, and this product cloned into a vector for subsequent DNA sequence 
analysis (Nakano et al, 1995). Chromosomal DNA of P. gingivalis was digested 
with restriction endonucleases and a fragment harbouring the hsp60 gene 
identified by Southern blot analysis using a labelled E. coli hsp60 gene probe. 
This fragment was then cloned into a plasmid vector prior to sequence analysis
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(Maeda e ta l, 1994).
B. forsythus is a Gram negative, strictly anaerobic bacillus that has recently 
been strongly associated with periodontitis and may be a risk factor for 
particular forms of the disease. Studies on S. forsythus are more limited than 
those carried out on other periodontal pathogens, such as P. gingivalis and A. 
actinomycetemcomitans, which is probably due to the difficulties encountered in 
culturing this fastidious organism in the laboratory.
A 32-base pair fragment of the N-terminus of the hsp60 gene of B. forsythus 
has been characterised previously (Hinode et al, 1998), but there are no current 
reports of successful cloning or sequencing of the entire gene from this species. 
This chapter describes how the hsp60 gene of B. forsythus was identified, 
isolated and cloned into a plasmid vector. Cloning the gene circumvents the 
need to purify B. forsythus hsp60 by conventional methods that require large 
culture volumes (Hinode et al, 1996). The hsp60 gene was isolated by PCR, 
using degenerate oligonucleotide primers derived from the consensus of an 
alignment of hsp60 DNA sequences from other species. The identity of the 
resulting PCR product was confirmed by Southern blot analysis using a labelled 
E. coli hsp60 probe. Cloning of the gene was a crucial development that would 
allow further characterisation of the B. forsythus hsp60 gene and the protein it 
encodes.
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MATERIALS AND METHODS 
PCR amplification ofhspGO genes from various species
i) Primer selection
Primers were synthesised by Cruachem Ltd, Glasgow, and supplied as 
lyophilised pellets. Primers were resuspended in molecular biology grade water 
at a concentration of l^g/pl. For amplification of the B. forsythus hsp60 gene, 
consensus primers were derived by alignment of known sequences of the 
groEL genes of several other species. The sequence of the consensus primer 
C1 is taken from Nakano et al (1995). The sequences of the consensus primers 
used were:
5’-ATTATGGCAAAAGAAATCAAATTCG-3’ (PgN1) 
and
5-TTACATCATGCCGCCCA-3’ (C1)
Primer PgN1 is a region of the P. gingivalis groEL gene that corresponds to 
nucleotides 45-70 of the E. coli hsp60 sequence. Primer C1 represents the 3’ 
terminus of the groEL gene.
ii) Template DNA
B. forsythus strain ATCC 43037 genomic DNA was used as the template for 
PCR. The primers were also used on genomic DNA extracted from Prevotella 
intermedia, Prevotella nigrescens, Treponema denticola and Streptococcus 
mutans to attempt the amplification of their groEL genes by PCR. Bacteria were 
cultured and genomic DNA purified as previously described.
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iii) PCR
All solutions were handled in a designated PCR laboratory in a UV-sterilised 
microbiological safety cabinet, using filter pipette tips to prevent contamination 
of the samples. Template DNA was added using positive displacement pipettes 
in a sterile Template Tamer cabinet (Oncor Appligene, Watford, UK) as a further 
anti-contamination step, to prevent exposing the laboratory to aerosolised 
genomic DNA.
Lower and upper reaction master mixes were prepared separately on ice before 
aliquoting to prevent primer annealing and polymerisation occurring before the 
optimum designated temperature was attained in the thermal cycler. For the 
upper reaction mix, primers were at a final concentration of 0.2pM. The 
composition of the reaction mixes is shown in Table 3.1. The upper and lower 
reaction mixes were thoroughly mixed by vortexing and 50|il of the lower mix 
was aliquoted into each 0.5ml reaction tube. 50pl molten wax was pipetted on 
top of the lower mix and allowed to solidify, and then 49jnl upper mix added to 
each tube. The wax separated the lower mix from the upper mix until a high 
temperature was reached in the thermal cycling reactions, and prevented any 
reactions from occurring before this temperature was attained. This ‘hot start’ 
PCR ensured that increased sensitivity and specificity of the reactions was 
obtained. Finally, 1pl (100ng) template DNA was added per tube. A negative 
control reaction was always used. This contained the same lower and upper 
mixes and wax as the reaction tubes, but contained 1pl molecular biology grade 
water in place of template DNA.
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iv) Thermal cycling
Thermal cycling was carried out in a Hybaid Omnigene thermal cycler (Hybaid, 
Teddington, UK). Cycling conditions were as follows:
(94°C, 1 min) 1 cycle
(94°C, 1 min; 55°C, 1 min; 72°C, 1.5 min) 30 cycles 
(72°C, 10 min) 1 cycle
PCR products were either analysed immediately or stored at -20°C until 
required.
Southern Blot analysis of PCR products
i) Southern transfer
PCR products were electrophoresed on a 0.8% agarose gel as previously 
described, and visualised on a UV transilluminator.
Unused areas of the gel were cut away with a scalpel and the top left corner of 
the gel nicked to allow the gel to be easily orientated. The gel was placed in a 
glass dish and washed as described below. A description of the required 
solutions is given in Table 3.2.
1- 2x10 min washes with 250ml 0.25M HCI.
2- 2x15 min washes with 250ml Denaturation solution (to separate double 
stranded DNA).
3- 2 brief washes with 250ml dh^O to remove traces of Denaturation solution.
4- 2x15 min washes with 250ml Neutralisation solution (to prevent DNA 
reannealing).
All washes were performed at room temp with gentle shaking.
The gel was placed DNA side down on the permanent wick of the transfer unit.
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The transfer unit consists of a shallow bench-top bath bridged by a porous 
material that is the wick. The bath holds 2xSSC solution which passes through 
the permanent wick, causing the transfer of DNA from the agaorse gel to a 
nylon membrane. To ensure efficient DNA transfer, air bubbles trapped 
between the gel and the wick were removed by rolling a 10ml pipette gently 
over the gel surface.
Handling with sterile tweezers, a piece of nylon membrane was cut to the same 
size as the gel, soaked in 2xSSC and rolled on top of the gel and trapped air 
bubbles removed. Six pieces of 3MM Whatman paper were also cut to the 
same dimensions, soaked in 2XSSC and layered on top of the membrane, 
sandwiching the transfer membrane between the gel and the Whatman paper.
A (3-inch) stack of folded paper towels was placed on top of the gel sandwich, 
the lid of the transfer unit put in place and a light weight applied to the top of the 
lid to ensure good contact between the gel and the membrane. 2xSSC was 
poured into the unit until level with the bottom edge of the permanent wick, and 
the unit left overnight. Following transfer, the unit was dismantled and the 
membrane carefully peeled off the gel using tweezers. The membrane (now the 
“blot”) was then washed twice in 2xSSC to remove traces of agarose, blotted 
dry on Whatman paper and left to air dry for 10 min. The DNA was then 
immobilised on the membrane by crosslinking in a UV crosslinker (UVC-508; 
Anachem, Luton, UK). The blot was either used immediately for hybridisation to 
labelled DNA probe or kept in a sealed bag at 4°C until required.
ii) DNA probe preparation
An E. coli hsp60 probe was prepared using the Random Primed DNA Labelling
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method, with Digoxigenin-11-dUTP as a label. Components for the labelling 
reaction were contained in the DIG DNA Labelling and Detection kit (Boehringer 
Mannheim, Lewes, UK) and are listed in Table 3.3. The E. coli hsp60 gene 
amplified by PCR was used as the DNA template in the labelling procedure. 1 pg 
of DNA template was heat-denatured in a boiling water bath for 10 min and 
immediately chilled on ice. The template was then mixed with 2pl 
hexanucleotide mixture, 2pl dNTP labelling mixture, 1pl Klenow enzyme and 
sufficient molecular biology grade H2O to bring the volume to 20pl. The reaction 
was incubated at 37°C for 18 hours and then terminated by adding 2pl 0.2M 
EDTA. Labelled DNA was precipitated by adding 0.1 volume 4M LiCI and 3 
volumes chilled 100% ethanol, mixing, freezing the reaction at -70°C for 30 min 
and centrifuging at 13,000 rpm for 15 min in a microcentrifuge. The pellet was 
isolated and washed with 100pl chilled 70% ethanol. After centrifugation at 
13,000 rpm for 5 min, the supernatant was removed and the pellet lyophilised. 
The labelled DNA was resuspended in 50pl molecular biology grade H20  and 
stored at -20°C. From the starting amount of 1pg DNA template, 750ng of 
labelled DNA was normally generated.
Hi) PCR amplification of E. coli hsp60 gene probe
The hsp60 gene of E. coli was generated by PCR to use as a probe in Southern 
blots. E. coli hsp60 primers N1 and C1 were used. These primers had been 
utilised previously by another group to successfully amplify the groEL genes of 
E. coli and A. actinomycetemcomitans (Nakano et al, 1995). The primer 
sequences were as follows:
5’-AATGGCAGCTAAAGACGT-3’ (N1)
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and
5’-TTACATCATGCCGCCCA-3’ (C1)
Primer N1 corresponds to nucleotides 45-62 at the 5’ end of the E. coli gene, 
and C1 corresponds to a region at the 3’ terminus (nucleotides 1676-1692).
PCR was carried out using the same reaction conditions as described 
previously in this chapter. E. coli genomic DNA was used as the template for 
PCR. The bacteria were cultured and DNA isolated as described in Chapter 2.
iv) Hybridisation of labelled DNA probe to membranes
The dried, cross-linked blot was sandwiched between 2 pieces of nylon mesh 
that had been cut to the size of the blot. This sandwich was submerged in 
2xSSC, rolled up tightly and placed in a glass Hybaid rolling tube with 10ml 
2xSSC. The bottle was rotated manually such that the blot unwound and 
covered the interior surface of the glass tube. The SSC was discarded and 20ml 
standard prehybridisation solution applied. The tube was placed in a Hybaid 
hybridisation oven (Hybaid, Teddington, UK) and rotated. Prehybridisation was 
allowed to proceed at 68°C for 3 hours.
The prehybridisation solution was discarded after this time and the labelled 
DNA probe applied. Immediately prior to use, 15pl labelled DNA probe 
(approximately 250ng DNA) was heat-denatured in a boiling water bath for 10 
min and chilled on ice. The chilled probe was diluted in 10ml fresh standard 
hybridisation buffer (Table 3.2) before incubating with the membrane. The probe 
was left to hybridise to membrane-bound DNA at 68°C for 16-20 hours. After 
hybridisation, the probe was retained and stored at -20°C. The diluted probe 
could be re-used in 5 subsequent Southern blots. For re-use, the probe was
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thawed and denatured by boiling as 10 min and used directly.
Unbound probe was removed from the membrane by washing the blot for 2x5 
min in 2x wash solution at room temp. The blot was then washed for 2x15 min 
in 2xSSC/0.1%SDS with shaking at 68°C and processed directly for colorimetric 
detection of hybridised probe.
v) Detection of hybridised probe
During the probe detection procedure, all washes were performed at room temp 
with shaking, using clean containers. The composition of buffers used is shown 
in Table 3.4. Firstly, the membrane was equilibrated in Buffer 1 for 1 min. The 
membrane was then placed in another dish and blocked in Buffer 2 for 30 min. 
During this time, the antibody solution was prepared by diluting the anti-DIG- 
alkaline phosphatase (anti-DIG-AP) to 1:10,000 in Buffer 2 (i.e. 3pl Anti-DIG-AP 
in 30ml Buffer 2). Buffer 2 was poured off after blocking the blot, and the 
membrane incubated in the antibody solution for 30 min. The membrane was 
removed to another clean dish and washed for 2x15 min in Buffer 1. The 
membrane was then equilibrated in 20ml Buffer 3 for 2 min.
10 ml of colour substrate solution was freshly prepared by mixing 45pl NBT 
solution and 35pl X-phosphate in 10 ml Buffer 3. After the membrane had 
equilibrated in Buffer 3 for 1 min, the buffer was poured off and the colour 
substrate solution applied. Development was allowed to proceed in the dark. 
Generally, the colour precipitate formed 15-20 min after application of the colour 
substrate solution, although detection could occur over a much longer period if 
necessary. After development was complete, the membrane was rinsed with 
water to prevent further reaction that could lead to a highly coloured background
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on the membrane, and the dried membrane sealed in a plastic bag.
Cloning of B. forsythus and P. intermedia hsp60 genes (PCR products)
PCR products were cloned into the plasmid vector pCR@2.1-TOPO. The 
plasmid was contained in the TOPO TA Cloning® kit (Invitrogen) which provides 
a one-step cloning procedure for the insertion of PCR products into the plasmid. 
The technique is very efficient and extremely rapid as no post-PCR procedures 
are required. The only stipulation is that the PCR products are generated with 
Taq polymerase. Taq polymerase causes the products to be synthesised with a 
single deoxyadenosine (A) overhang at the 3’ end of the product, which allows 
efficient ligation to the overhanging 3’ deoxythymidine (T) residues present on 
the linearised vector.
The kit supplied the plasmid, chemically competent cells (One Shot™ 
Competent Cells, which are E. coli strain TOP10F’ SOC medium and p- 
mercaptoethanol required for transformation. These and other components 
used are listed in Table 3.5.
i) Ligation of PCR products to vector
For the correct insert:vector ratio required for successful cloning, 4^ 1 of the B. 
forsythus and P. intermedia PgN1 C1 PCR products were used (products are 
approximately 1.6kb in size, and at a concentration of 10ng/pl as determined by 
visual comparison to standards on agarose gels). The products were added to 
1pl pCR®-TOPO vector, gently mixed and left to incubate at room temp for 5 
minutes. The reaction was briefly centrifuged, the tube placed on ice, and the 
transformation reaction carried out immediately.
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ii) Transformation of competent E. coli cells
A vial of 50jil of OneShot TOP10 competent cells was thawed on ice, and 2pl 
0.5M p-mercaptoethanol gently stirred into the cells. 2pl of each cloning reaction 
(see above) was then mixed into the cells, and the sample incubated on ice for 
30 min. The cells were then exposed to heat shock at 42°C for 30 seconds, and 
then immediately transferred back onto ice, and incubated for a further 2 min. 
250pl SOC medium was subsequently added to the reaction tube, and the cells 
incubated at 37°C for 30 min. Following this, 10Opil samples of the cells were 
evenly spread onto L-agar plates containing 100pg/ml ampicillin, 100mM IPTG 
and 40pg/ml X-gal. The plates were incubated overnight at 37°C, resulting in 
the growth of thousands of colonies, from which 10 white colonies were 
selected for analysis.
iii) Screening of recombinant clones
Selected recombinant clones (white colonies) were subjected to small-scale 
plasmid isolation by the boiling method, as described in Chapter 2. The plasmid 
preps were then analysed by digesting 10pil of mini-prep DNA with EcoRI in a 
total reaction volume of 20pl, as described in Chapter 2. This caused the insert 
to be excised from the plasmid vector, and the sizes of the inserts determined. 
This was most easily done by a comparative analysis of the size of the inserts 
when electrophoresed with the B. forsythus hsp60 gene PCR product. 10pl of 
each digestion reaction was electrophoresed on a 0.8% agarose gel and the 
insert sizes compared, with the B. forsythus hsp60 gene PCR product used as 
an insert size marker.
Identification of correct hsp60 gene inserts was further verified by Southern blot
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analysis. The same electrophoresis gel used to illustrate the sizes of the 
released vector inserts was transferred onto positively charged membrane and 
the membrane hybridised to an E. coli hsp60-labelled DNA probe as described 
previously in this chapter. Colorimetric detection of the hybridised probe 
identified recombinant clones carrying the B. forsythus hsp60 gene.
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Table 3.1: PCR buffers and reaction mixes
10X reaction buffer 
500mm KCI
100mM Tris-HCl (pH 9.0)
1% Triton X-100 
15mM MgCb
Lower reaction mix
10X reaction buffer 10pl
dNTPs (10m M stock) 1pl
Taq polymerase (5U/pl stock) 1pl
Molecular biology grade water 38pl
Upper reaction mix
Primer PgN1 (1pg/jul stock) 0.2pl
Primer C1 (1pg/pl stock) 0.2pl
Molecular biology grade water 48.6jnl
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Table 3.2: Hybridisation stock solutions and buffers
HCI
Denaturation solution 
Neutralisation solution 
20X SSC buffer 
Standard prehybridisation 
buffer
2X wash solution 
Blocking reagent 
SDS
250mM hydrochloric acid
0.5 M NaOH, 1.5 M NaCI
0.5 M Tris-HCl, pH 7.5; 3M NaCI
3M NaCI, 300mM sodium citrate; pH 7.0
5X SSC, 1.0% (w/v) Blocking reagent, 0.1%
N-lauroylsarcosine, 0.02% sodium dodecyl
sulphate (SDS)
2X SSC containing 0.1% SDS
10% (w/v) filtered through a 0.2- 0.45pm 
membrane
Table 3.3: Random primed DNA labelling solutions
10X Hexanucleotide mix 62.5 A260 units/ml random hexanucleotides, 500mM
Tris-HCl, 100mM MgC^, 1mM Dithioerythritol (DTE), 
2mg/ml BSA; pH 7.2 
10X dNTP mix 1 mM dATP, 1 mM dCTP, 1 mM dGTP, 0.65 mM
dTTP, 0.35mM DIG-11-dUTP; pH 7.5 
Klenow enzyme 2 units/pl DNA polymerase I (Klenow enzyme, large
fragment),labelling grade, from E. coli.
EDTA 200mM EDTA, pH8.0
LiCI 4M lithium chloride solution
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Table 3.4: Stock solutions and buffers for colorimetric detection
Anti-digoxigenin-AP, Fab Anti-digoxigenin [Fab] conjugated to alkaline
fragments phosphatase
NBT solution 75mg/ml nitroblue tetrazolium salt in 70%
(v/v) DMF
X-Phosphate solution 50mg/ml 5-bromo-4-chloro-3- idolyly
phosphate
(X-phosphate) toluidinium salt in 100% DMF 
Buffer 1 100mM maleic acid, 150mM NaCI; pH 7.5
Buffer 2 1% (w/v) Blocking reagent dissolved in Buffer
1
Buffer 3 10OmM Tris-HCl, pH 9.5; 10OmM NaCI,
50mM MgCb
Table 3.5: TOPO TA cloning and
SOC medium
p-mercaptoethanol
ampicillin
IPTG
X-gal
transformation solutions
100mg/ml solution, filter sterilised 
1M solution in water 
50mg/ml solution in 
dimethylformamide (DMF)
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RESULTS
Derivation of hsp60-specific PCR oligonucleotide primers
Degenerate oligonucleotide primers for PCR amplification of the hsp60 gene of 
S. forsythus were designed by means of aligning the published DNA sequences 
of several hsp60 genes and their immediate flanking regions of other bacterial 
species. From the alignment, a consensus sequence was derived which aided 
the design of the primers
The sequences of the consensus primers selected were:
5’ ATTATGGCAAAAGAAATCAAATTCG 3’ (PgN1) and 
5’ TTACATCATGCCGCCCA 3’ (C1).
These primers amplify the entire coding region of the groEL component of the 
hsp60 gene of B. forsythus and P. intermedia, but were not specific for T. 
denticola, P. nigrescens or S. mutans. Primer PgN1 annealed at the start site of 
the open reading frame (ORF) of the hsp60 gene (the second triplet of the 
primer, ATG, annealing to the start codon of the gene). Primer C1 annealed at 
the end of the ORF (the first triplet of this primer, TTA, annealing to the stop 
codon, AAT, of the gene).
Analysis of hsp60 PCR products
i) Size analysis
PCR of B. forsythus and P. intermedia chromosomal DNA with the consensus 
primers yielded a discrete band of approximately 1.8-kb (Fig 3.1 and Fig 3.2) 
which was of the expected size. No products of similar size were generated 
using genomic DNA from P. nigrescens, T. denticola or S. mutans (Fig 3.2).
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ii) Southern blot analysis
To unequivocally identify the PCR product as the hsp60 gene of 8. forsythus, 
the product was subjected to Southern blot analysis. The product was blotted 
with a probe derived from the hsp60 protein of E. coli. The probe clearly 
hybridised to the PCR product (Fig 3.3) under relaxed washing conditions 
(2xSSC/0.1% SDS at 68°C).
Analysis of recombinant clones
i) Restriction endonuclease digestion of mini prep DNA
The hsp60 PCR products of B. forsythus and P. intermedia were cloned into the 
plasmid vector pCR 2.1-TOPO, which has been designed with 3’ T overhangs 
that complement the A overhangs present on PCR products synthesised by Taq 
DNA polymerase. These complementary sequences allow for a simple and 
quick cloning protocol. A plasmid map of vector pCR2.1-TOPO is shown in Fig 
3.4. E. coli strain TOP10F’ was transformed with the ligated vector, and 
recombinant clones identified by their white colour.
EcoRI cleavage sites flanking the insertion site of the vector allow restriction 
endonuclease analysis of selected clones. Digestion of the plasmid with EcoRI 
releases the DNA fragment that has been inserted into the cloning site of the 
vector.
For all 8 . forsythus clones analysed, a 1.8-kb insert was released, which 
confirmed successful cloning of the 8. forsythus groEL gene (Fig 3.5). A lower 
rate of recombination success was achieved for the P. intermedia hsp60 gene 
with three clones out of 12 analysed apparently carrying the gene (Fig 3.6).
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ii) Southern blot analysis
To verify the identity of the 1.8-kb insert carried by the transformants, 8. 
forsythus fragments released by digestion with EcoRI were Southern blotted 
using a DIG-labelled E. coli hsp60 probe. As can be seen in Fig 3.7, the 8. 
forsythus inserts all hybridised to the probe, thus confirming that the 
successfully cloned insert was the hsp60 gene of 8. forsythus.
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DISCUSSION
The groEL portion of the hsp60 gene of B. forsythus has been successfully 
identified and isolated via PCR, using consensus primers. The PCR product, a 
1.8-kb fragment encoding the groEL gene, was cloned into pCR2.1-TOPO, 
which is a plasmid vector specifically designed for simple and rapid cloning of 
PCR products. E. coli strain TOP10F’ was then transformed with the ligated 
plasmid. The hsp60 gene of P. intermedia was similarly identified and cloned 
into pCR2.1-TOPO to facilitate later DNA sequencing of the gene.
This approach to the detection and cloning of homologous genes in other 
species has been frequently utilised previously. Nakano et al (1995) used E. 
co//-derived primers to amplify a portion of the groEL gene of the major 
periodontal pathogen, A. actinomycetemcomitans. These primers amplified a 
fragment which was then labelled with digoxigenin-dUTP and used to probe 
Southern blots of restriction endonuclease digests of A. actinomycetemcomitans 
chromosomal DNA. The probe detected 3-kb fragments which, upon analysis, 
were found to contain the entire groESL operon of A. actinomycetemcomitans 
(Maeda et al, 1994). The hsp60 gene of Chlamydia trachomatis serovar E was 
amplified by PCR using primers derived from the DNA sequence of serovar A of 
the same species. The product was gel-purified and digested with Sma\ prior to 
being ligated into a plasmid vector digested to provide blunt-ends (Horner et al, 
1996). A similar system was employed to isolate the hsp60 genes of various 
Neisseria species (Pannekoek et al, 1995). Whilst this methodology produced 
the desired results, there are several intervening procedures between PCR and 
eventual cloning. The pCR2.1-TOPO vector used in this chapter for cloning of 
the B. forsythus and P. intermedia groEL genes possesses the distinct
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advantage of being able to ligate PCR products directly, unmodified and 
uncleaned. As an alternative method for identifying hsp60 genes, another 
commonly employed technique is to digest the chromosomal DNA of the 
species in question with various endonucleases to produce a range of DNA 
fragments of different sizes. These fragments are then hybridised to a hsp60 
probe using the Southern blot method. A fragment to which the probe hybridises 
can then be gel purified, digested and ligated into a suitably prepared vector. 
This technique has led to the successful identification and cloning of the hsp60 
genes of Bacillus subtilis (Schmidt et al, 1992), Clostridium acetobutylicum 
(Naberhaus and Bahl, 1992) and the periodontal pathogen P. gingivalis (Maeda 
etal, 1994).
Another popular approach for identifying desired genes involves the 
construction of a chromosomal gene library in plasmid or bacteriophage 
vectors. The chromosomal gene library is formed by partially digesting the 
bacterial chromosomal DNA with Sau3A, and cloning the fragments into a 
vector such as pUC18. The cloned fragments are then screened by blotting with 
a genomic or protein probe specific for hsp60, and reactive clones isolated from 
the library. This method has been well applied to enable the cloning of the 
hsp60 genes of Chlamydia psittaci (Morrison et al, 1989) and B. subtilis (Li and 
Wong, 1992).
In summary, this chapter describes the design of degenerate oligonucleotide 
primers for the PCR amplification of the groEL fragment of the hsp60 gene of 
bacterial species. The primers successfully amplified the hsp60 genes of B. 
forsythus and P. intermedia, but were found not to amplify the corresponding 
gene from T. denticola, P. nigrescens or S. mutans. The amplified hsp60 genes
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were cloned into the vector pCR®2.1-TOPO, and the cloned genes then 
subjected to DNA sequence analysis as described in Chapter 4.
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FIGURE 3.1
PCR amplification of the B. forsythus hsp60 gene using degenerate
primers
2.32kb — t  
2.01 kb
Single PCR 
—  product;
approx. 1.8kb
Figure 3.1 PCR amplification of the B. forsythus hsp60 gene using degenerate 
primers PgN1 and C1. Hind\\\ digested X DNA fragments were used as size 
markers (23.1, 9.42, 6.56, 4.36, 2.32, 2.01 kb) (lane 1), negative control (lane
2), B. forsythus samples (lanes 3-5).
FIGURE 3.2. PCR amplification of hsp60 genes from various periodontal
micro-organisms.
Figure 3.2. Degenerate oligonucleotide primers PgN1 and C1 were used to 
amplify the hsp60 genes from various periodontal micro-organisms. A negative 
PCR control was electrophoresed (lane 1), along with products generated from 
B. forsythus (lane 2), P. gingivalis (lane 3), P. intermedia (lane 4), T. denticola 
(lanes 5 and 6), P. nigrescens (lanes 7 and 8), S. oralis (lane 9) and S. mitis 
(lane 10). A product of the same size as the positive controls in lanes 2 and 3 
was generated using P. intermedia template DNA (arrow), and was further 
investigated to characterise the hsp60 of this organism. PCR products were 
also generated from P. nigrescens and Streptococci templates (lanes 7-10) but 
were too small to carry the entire hsp60 gene. These products were not studied 
further, although they may have been carrying fractions of the gene.
FIGURE 3.3. Southern blot analysis of B. forsythus hsp60 PCR products
using an E. coli hsp60 probe.
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Figure 3.3. Southern blot analysis of P. gingivalis and B. forsythus hsp60 PCR 
products. PCR products generated using primers PgN1 and C1 were 
electrophoresed and transferred to hybridisation membranes. Transferred DNA 
was probed with DIG labelled E. coli hsp60 DNA (whole groEL gene) previously 
amplified with primers N1 and C1. Lane 1= P. gingivalis PCR product, a positive 
control for the PCR reactions. Lanes 2-4 are B. forsythus PCR products, which 
appear to have a higher affinity for the E. coli probe than the P. gingivalis 
product had. Primers PgN1 and C1 were known to amplify the entire hsp60 
gene of P. gingivalis, indicating that the B. forsythus product was the correct 
size to be carrying the hsp60 gene.
FIGURE 3.4. Physical map and cloning site of plasmid pCR®2.1-TOPO.
M 13 Reverse Primer Hind III Kpn I S a c \ B arrH \ Spe I
CAG GAA ACA GCT ATG ACC ATG ATT ACG CCA AGC TTG GTA CCG AGC TOG GAT CCA CTA 
GTC CTT TGT CGA TAC TGG TAC TAA TGC GGT TCG AAC CAT GGC TCG AGC CTA GGT GAT
GsfX I EcoR I EcoR I
CAT TGC CGG CGG TCA C?AC GAC CTT AAG CGG C .A 9 A |A IA M M i|T T C  CCG CTT AAC, ACG
EcoR V BsIX I Not I Xho I Nsi I Xba  I Apa I ^
AGA TA T CCA TCA CAC TGG CGG CCG CTC GAG CAT CCA TCT AGA GGG CCG AAT TCG CCC TAT
TCT AT A GGT AGT GTG ACC GCC GGC GAG CTC GTA CGT AGA TCT CCC GGG TTA AGC GGC. AT A
T7 Promoter M 13 Forward (-20) Primer M 13 Forward (-40) Primer
AGT GAG TCG TAT TAC AAT TCA CTC GCC GTC GTT TTA“”c!AA QGT CGT CAC TGG GAA AAC
TCA CTC AGC ATA ATG TTA AGT GAC CGG CAG CAA AAT GTT CJCA GCA CTG ACC CTT TTG
Figure 3.4. Physical map and cloning site of the plasmid pCR®2.1-TOPO. The 
map shows features of pCR®2.1-TOPO and the sequence surrounding the 
cloning site. The insertion and ligation point for Taq polymerase amplified PCR 
products is indicated, as are primer recognition sites.
Plasmid map Copyright 1997 Invitrogen Corporation, Carlsbad, CA, USA. All 
rights reserved. Used by permission.
FIGURE 3.5. Mini-prep analysis of plasmid constructs pBf1.8.
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Figure 3.5. Mini-prep analysis of plasmid pBf1.8. Eight recombinant clones 
were randomly selected and plasmid purified using the small scale boiling 
method. Plasmid DNA was digested with EcoRI (lanes 3-10). Hind\\\ digested X 
DNA fragments were used as size markers (23.1, 9.42kb bands apparent, lane 
1). Lane 2 is the B. forsythus hsp60 PCR product (1.8kb, yellow arrow), which 
indicates that the digest-released cloning fragments are of the correct size
FIGURE 3.6. Mini-prep analysis of plasmid constructs pPi1.6.
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Figure 3.6. Mini-prep analysis of plasmid pPi1.6. 12 recombinant clones were 
randomly selected and plasmid purified using the small scale boiling method. 
Plasmid DNA was digested with EcoRI and released DNA inserts 
electrophoresed. H/ndlll digested X DNA fragments were used as size markers 
(lane 1, sizes in kb) and digested plasmid loaded in lanes 3-14. Recombinant 
clones carrying a DNA insert of the correct estimated size of the P. intermedia 
hsp60 gene are indicated in lanes 4, 6 and 9 (black arrows). The pCR2.1 TOPO 
plasmid is 3.9kb, seen in lanes 3-14.
FIGURE 3.7. Southern blot analysis of plasmid pBf1.8 mini-preps.
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Figure 3.7. Southern blot analysis of pBf1.8 mini-preps (gel shown in Fig 3.5). 
DNA inserts in plasmid pBf1.8 released by endonuclease digestion were 
transferred to hybridisation membrane and probed with DIG labelled E. coli 
hsp60 DNA (lanes 2-9). Lane 1 is a PCR positive control.
CHAPTER 4
Determination of the DNA sequence of the B. forsythus hsp60 
gene and analysis of the predicted amino acid sequence, and 
partial sequence of the P. intermedia hsp60 gene
INTRODUCTION
The hsp60s have become the focus of intense research since the realisation 
that hsp60 is a ‘common antigen’ expressed by a wide variety of bacterial 
species, many of which are human pathogens (Thole et al, 1985; Young et al, 
1987; Shinnick, 1991; Jones et al, 1993). Not only is hsp60 common to bacteria, 
but highly conserved homologues have been identified in yeasts and higher 
eukaryotic cells, including a human counterpart, mitochondrial matrix protein P1 
(Dudani and Gupta, 1989; Jindal etal, 1989). More distantly related 
homologues, which still maintain functional and sequence similarity, are the 
Tcp-1 (t-complex polypeptide 1) family of proteins found in archaebacteria and 
eukaryotic cell cytosol (Gupta, 1995).
The burgeoning interest in hsp60 has lead to numerous groups sequencing 
hsp60 genes from across the entire spectrum of prokaryotic and eukaryotic 
species (reviewed in Shinnick, 1991; Zeilstra-Ryalls, 1991; Gupta, 1995). These 
studies have revealed that the functional conservation of hsp60s is reflected at 
the genomic level. The level of sequence homology maintained between all 
species is remarkable and virtually unprecedented in the living kingdom. 
Measuring sequence similarity as the number of positions at which identical 
amino acid residues can be found in a pairwise alignment, the level of homology 
between different genera ranges from the lowest level at approximately 45% to 
over 80%. Even between organisms as distantly related as humans and E. coli, 
the level of hsp60 sequence conservation is 50%. Of the amino acids that are 
not identical, up to 20% of the substitutions are conservative replacements 
(Gupta, 1995). Such conservation indicates that these proteins express a 
universally important function.
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Hsp60 genes continue to be isolated and sequenced. Whilst this may appear 
superfluous considering the well documented high level of genomic homology 
between species, the need to further characterise hsp60 genes of more species 
is a very real one, which will allow an accurate awareness of their functional and 
immunogenic importance to be founded.
Recent publications have brought to light the fact that some disparate proteins 
have been found to have genetic homology with hsp60. These include a protein 
of A. actinomycetemcomitans that possesses potent osteolytic activity, 
demonstrating bone resorbing activity at ~1pM molar concentrations. The 
structure of this protein was also examined by electron microscopy and was 
found to form the double ring structure characteristic of hsp60 homologues 
(Kirby et al, 1995). These findings suggest that there are aspects of hsp60s that 
have yet to be examined, and a better understanding of the protein will only 
result from further studies of hsp60, be it at a molecular, structural or functional 
level.
As mentioned previously, hsp60 of bacterial origin has been demonstrated to 
elicit a cross-reactive immune response (Young et al, 1987; Thole et al, 1988; 
Winfield, 1991; Kaufmann and Schoel, 1994; Handley etal, 1995; Krenn etal, 
1996; Hinode et al, 1998), that may provoke an autoimmune reaction in 
humans. Those who expound this theory as applied to periodontal disease have 
sequenced the hsp60 genes of the major periodontal pathogens A. 
actinomycetemcomitans and P. gingivalis to allow further immunologic studies 
of the protein (Maeda etal, 1994; Nakano etal, 1995; Hinode etal, 1998). An 
understanding of the DNA and amino acid sequence of the proteins is essential 
to determine the level of sequence homology shared between species, and thus
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their potential to raise a cross-reactive immune response. Elucidating the entire 
DNA and amino acid sequence of a protein is an important first step towards 
characterising individual epitopes and designating them as unique species- 
specific epitopes or as well-conserved ones that may result in cross-reactive 
antibodies, and can also allow identification of immunodominant epitopes.
This chapter presents the DNA and predicted amino acid sequence of the 
hsp60 gene of B. forsythus, and sequence data for the 3’ region of the hsp60 
gene of Prevotella intermedia. This is the first report of the nucleotide sequence 
of the B. forsythus hsp60 gene. Alignments of these gene sequences with the 
published sequences derived from other species shows that the genes are 
characteristically well conserved.
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MATERIALS AND METHODS 
DNA sequencing: manual method
Double-stranded DNA was sequenced using the dideoxy chain termination 
method. Single stranded DNA templates were produced from plasmid DNA by 
alkaline denaturation. DNA to be sequenced was cloned into pCR2.1-TOPO™ 
as previously described. The gene was completely sequenced on both strands 
using a genome walking method to generate sequence data.
i) Sequencing primers
Commercially available primers (M13 and Reverse) and custom-made hsp60 
specific primers (Cruachem) were diluted to 5ng/pl and stored at -20°C until 
required.
ii) Primer design
As a general rule the primer sequence contained:
1. no inverted repeats
2. no direct repetition
3. a G/C content of 40-60%
4. no primer-dimer formations
5. a G/C 3’ tail, of no more than 3 G or C residues.
The absence of inverted repeats ensures that the primer is less able to form 
hair-pin structures by self-annealing. Direct repeats may cause the primer to 
anneal in the wrong position to the template DNA. The correct proportion of GC 
residues increases the primer-template binding strength, and a GC domain at
the 3’ tail ensures a strong bond of the primer to the template at the crucial end 
of the primer, from whence elongation will proceed.
Hi) Radioactive label
The radioactive label used for manual sequencing was deoxyadenosine 5-[<x- 
35S] thiotriphosphate triethylammonium salt (dATP, Sp isomer) (Amersham).
The label had a specific activity of >1200 Ci/mmol and a concentration of 
10mCi/ml.
iv) Denaturation reaction
Generally, for every 3 kb of plasmid, 2pg of DNA was used as template. DNA 
was denatured with NaOH at 0.4M, and H20  added to a final reaction volume of 
1 OjlxI. The sample was mixed by pipetting and incubated at room temp for 10 
min. The reaction was then neutralised by addition of 3pl 3M NaOAC (pH 5.3), 
and dH20  added to a final volume of 20pl. DNA was precipitated with 3 volumes 
100% ethanol and incubation at -70°C for 30 min prior to centrifugation at 
14,000 rpm for 10 min. The isolated DNA pellet was washed with 70% ethanol 
and centrifuged again, and the resulting pellet lyophilised before being 
resuspended in 1 OjlxI dH20.
v) Annealing reaction
To 10pl of denatured DNA, 2pl annealing buffer (Table 4.1) and 2pl sequencing 
primers at 5ng/pl was added. The reaction was thoroughly mixed and incubated 
at 37°C for 20 min, and then at room temp for 10min.
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vi) Labelling reaction
An enzyme pre-mix containing the following was formed on ice: 1 pi dhhO, 3pl 
labelling mix, 2pl T7 DNA polymerase diluted 1:4 in dilution buffer, and 1pl 35S- 
dATP. This was briefly centrifuged to mix, and 6pl of the premix added to the 
DNA sample with primers annealed (i.e. the product of the annealing reaction). 
The sample was thoroughly mixed and incubated at room temp for 5 min.
2.5pl of A, C, G and T mixes (Table 4.1) was added to appropriately labelled 
tubes and warmed at 37°C for 2 min. The concentration of dNTPs and ddNTPS 
in the reaction mixes (supplied in the kit) are balanced such that there is an 
equal chance of a ddNTP being incorporated at each position within the length 
of the sequence, terminating the extension of that fragment. 4.5pl of the 
DNA/label/enzyme mix was added to each A, C, G and T tube and mixed by 
brief centrifugation. The tubes were incubated at room temp for 5 min, and 
reactions then terminated by adding 5pl stop solution (Table 4.1) per tube. The 
reactions were stored at -70°C until required. Immediately prior to loading on 
the sequencing gel, the samples were heated at 80°C for 3 min. Half of each A, 
C, G and T sample was loaded for a “long run” sequence read, and the other 
half of each mix loaded approximately 3 hours later for a short run read.
vii) Denaturing polyacrylamide sequencing gel
A 6% acrylamide gel was prepared using the solutions listed in Table 4.2, and 
wedge shaped gels poured. The Macrophor gel sequencing system 
(Pharmacia) was used according to manufacturer’s instructions. Prior to pouring 
the gel, the notched glass plate was treated with Bind-Silane solution (Table 
4.2) to adhere the gel to this plate. The upper thermostatic plate was polished
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twice with Repel-Silane to ensure that the gel bonded to the notched glass plate 
separated easily from the upper plate following electrophoresis.
Gels were cast on a gradient for ease of gel pouring, using a platform placed at 
an angle to support the glass plate sandwich. The glass plates were clamped 
together at the bottom end away from the upper notch to give a wedge-shaped 
gel. The well-forming comb was inserted, the gel placed horizontally and left to 
polymerise for at least 1 hour.
Prior to loading samples, gels were pre-electrophoresed at 2000V and 60°C for 
30 min to remove charged contaminants from the gel. Before the samples were 
loaded, the wells were flushed out with buffer to remove air bubbles and any 
urea deposits or debris in the wells. 6pl of sample was loaded per well, and 
electrophoresis performed at 2000V. When the bromophenol blue dye front 
reached the bottom of the gel (after ~3 hours) the remaining half of the samples 
were loaded and electrophoresis proceeded until this dye front also reached the 
bottom of the gel. This resulted in a “long run” and a “short run” which yielded a 
maximum amount of sequence data. After completion of electrophoresis, the 
upper thermostatic plate was prised apart from the gel and the gel, still bonded 
to the notched glass plate, soaked in 10% acetic acid for 15 min to remove 
urea. The gel was then dried with a hair drier and wrapped in cling film.
The gel was exposed to X-ray film in a light-proof box overnight, prior to 
development.
viii) DNA sequence data analysis
Sequence data was obtained from developed autoradiograms. Data was initially 
compiled using the University of Wisconsin’s GCG package of programs, and
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the collated sequence ultimately submitted to EMBL (accession number 
AJ006516).
DNA sequencing: automated method
Genes inserted into the plasmid vectors pCR2.1-TOPO™ were sequenced on 
an automated DNA sequencer (LI-COR DNA sequencer 4200 series), using a 
cycle sequencing method. The Amersham Thermo Sequenase labelled primer 
cycle sequencing kit with 7-deaza-dGTP was used.
i) Sequencing primers
Fluorescently labelled primers were synthesised by MWG-Biotech. 
Commercially available primers M13 Forward and M13 Reverse were used, 
which target the plasmid sequence flanking the insertion site of the vector. 
Custom synthesised hsp60-specific primers were also designed, following the 
same guidelines as for the manual sequencing primers. 2pmol of primer was 
used per reaction.
ii) Piasmid DNA template preparation
Plasmid DNA to be sequenced was isolated from overnight cultures of bacteria 
using the Wizard® Plus Minipreps DNA purification system (Promega), as 
described in Chapter 2. The concentration of the purified DNA was crucial for 
good sequencing reactions to occur. For optimal results, 130ng/kb plasmid DNA 
was required per reaction, and ideally this should be in a volume not greater 
than 5pl to decrease the chance of introducing contaminants into the reaction.
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iii) Cycle sequencing reactions
Pre-labelled primers were purchased from MWG Biotech and used to generate
amplification products via cycles of thermal denaturation, annealing and
extension/termination using Thermo Sequenase heat stable DNA polymerase.
The reaction mixes were performed on ice before being transferred to a thermal
cycler. A DNA/primer pre-mix was first formed as below:
plasmid template <5jj.I, using 130ng DNA per kb template
labelled primer, 2pmol <5jj.I
DMSO 0.7pl
dH20  to 21 jil
1.5pl aliquots of the A, C, G and T reagents, contained within the kit, were each 
transferred into 1.5ml centrifuge tubes. 4.5pil of the DNA/primer pre mix was 
aliquoted into each tube, and overlayed with 1 drop of Chill-out 14™ liquid wax 
(MWG Biotech; the liquid wax solidifies below 10°C and can be pierced with a 
micro-pipette tip to remove the aqueous phase of chilled samples). Cycling 
reactions were then performed in a Perkin Elmer 420 thermal cycler as follows: 
95°C, 30 sec (1 cycle): 95°C 10 sec; Ta°C 30 sec; 70°C 30 sec (20 cycles): 
95°C 10 sec; 70°C 30 sec (15 cycles).
On completion of the cycling reactions, 6pl of stop solution was added to each 
tube. 1.5|ul of each reaction was loaded onto a denaturing polyacrylamide gel.
iv) Preparation of denaturing polyacrylamide sequencing gels.
Gels were formed by pouring liquid acrylamide solution between 2 glass plates 
(41 cm), and then allowing this solution to polymerise prior to electrophoresis.
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Both glass plates were thoroughly cleaned before use by subsequent washings 
with 0.1M HCI, 0.1M NaOH, distilled water and finally 100% ethanol, using lint- 
free tissue. The gel sandwich was formed by assembling spacers between the 
glass plates, with the glass plates placed with the bevelled edges together for 
ease of separation later. The plates were fixed together with rail clamps. 
Subsequently, the gel solution was prepared as described in Table 4.3. Prior to 
the addition of the polymerising agents TEMED and APS, the gel solution was 
de-gassed for 20 min using a vacuum pump.
The glass plate sandwich was laid horizontally, and the top end lifted 1 inch to 
give a gradient for ease of casting. The prepared gel mix was applied with a 
50ml syringe to the well at the top end of the plate sandwich. The surface of the 
plates was firmly tapped whilst the gel was being applied to prevent air bubbles 
from being trapped within the gel. Once the gel had been poured, the gel 
sandwich was laid flat and the well-forming spacer inserted between the top 
edges of the two plates. The gel was left to polymerise for at least one hour.
v) Pre-electrophoresis
The polymerised gel was installed in the LI-COR sequencer according to 
manufacturer’s instructions, and the upper and lower buffer tanks filled with 1x 
long run TBE. To remove contaminants from the gel and to allow focusing of the 
laser, the gel was pre-electrophoresed at 1500V and 50°C for 30 min, and the 
system prepared for scanning as according to the manufacturer.
vi) Loading and running the gel
Following electrophoresis, the well-forming spacer was carefully removed from
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the gel and the well flushed out with a syringe to remove acrylamide debris and 
excess urea. After the well had been cleared, a 64-lane sharkstooth comb was 
inserted such that the tip of the teeth touched the top edge of the gel. Sample 
wells were formed by the spaces that existed between the comb teeth.
The gel was run at 1500V and 50°C until such time that the reactions had run to 
completion and could no longer be read. This was after approximately 8 hours.
vii) Analysis of sequence data
Sequence data was automatically read by BaselmagIR™ Software (for LI-COR 
DNA sequencers). Generally, up to 800 bases could be read per reaction. The 
software package stopped reading data after this time, when the number of 
ambiguities or unreadable regions of sequence increased.
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Table 4.1: Manual DNA sequencing reaction buffers and solutions
10X Annealing buffer 
100mM Tris HCI (pH 8.0)
50mM MgCb
ddG Termination mix
80pM dGTP, 80pM dATP, 80^M dCTP, 80pM dTTP, 8pM ddGTP, 50mM NaCI 
ddA Termination mix
80pM dGTP, 80pM dATP, 80pM dCTP, 80pM dTTP, 8pM ddATP, 50mM NaCI 
ddT Termination mix
80pM dGTP, 80pM dATP, 80^iM dCTP, 80jliM dTTP, 8pM ddTTP, 50mM NaCI 
ddC Termination mix
80pM dGTP, 80pM dATP, 80pM dCTP, 80pM dTTP, 8pM ddCTP, 50mM NaCI
Stop solution 
95% formamide 
20mM EDTA 
0.05% Bromophenol blue 
0.05% Xylene Cyanol FF
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Table 4.2: Manual DNA sequencing and gel mixes and solutions
Bind-Silane solution
100% ethanol 20ml
10% (v/v) acetic acid 5ml
Bind-Silane 75pl
Gel mix using LONG RANGER
urea 31.5g
50% stock LONG RANGER (Flowgen) 9.0ml
10X TBE 7.5ml
dH20 To 75 ml
Prior to use add 0.6 ml 10% APS and 56pl TEMED.
10% ammonium persulphate (APS) 
ammonium persulphate 0.1g
dH20  1ml
97
Table 4.3: Automated DNA sequencing stock solutions and gel mixes
6% Sequencing gel mix
Rapid gel XL solution, 40% stock 
(Amersham)
7.5ml
Urea 21g
10xTBE long run 5ml
H20 28ml
DMSO 500pJ
TEMED 50pl
10% APS, freshly prepared 350pl
APS was made as required, by dissolving 0.1g APS in 1ml MB grade H2O. 
The reagents minus TEMED and APS were stirred together until the urea 
dissolved. The mixture was then de-gassed for 20 min using a vacuum pump, 
prior to the addition of the polymerising agents TEMED and APS. The solution 
was kept on ice to slow down the polymerisation process whilst the gel was 
being poured.
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Table 4.3 (continued)
10x TBE Long Run Buffer
Tris base 162g
Boric acid 27.5g
EDTA 9.3g
Molecular biology grade H2O To 1 litre
The dry ingredients were weighed out and placed in a flask. 900ml MB grade 
water was added, and the solution stirred on a heated plate until all the 
components had dissolved. The pH of the solution was measured and adjusted 
to pH 8.5 with NaOH. The volume was then made up to 1 litre with MB grade 
water.
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RESULTS
Molecular cloning of the B. forsythus hsp60 gene
A 1.8-kb PCR product was inserted into the cloning site of the plasmid vector 
pCR2.1-TOPO as described in Chapter 3. The resulting recombinant plasmid 
was designated pBfl .8.
Determination of the DNA sequence of the B. forsythus hsp60 gene
To initiate sequencing of the DNA insert of pBf1.8 commercially available 
primers M13 Forward and M13 Reverse were used. Thereafter, B. forsythus 
hsp60-specific custom-made oligonucleotide primers were used to rapidly 
generate sequence data using a genome walking method. The cloned PCR 
product was completely sequenced on both strands, so that each nucleotide 
was sequenced at least twice. An autoradiograph obtained from a typical 
manual sequencing gel is shown in Fig 4.1. A sample of data resulting from 
BaselmagIR® sequence analysis of an automated sequencing reaction is shown 
in Fig 4.2.
DNA sequence alignment of the hsp60 genes of B. forsythus and P. 
gingivalis
The DNA sequence obtained from the hsp60 gene (groELunit) of B. forsythus 
represents 1635 nucleotides and is shown in Fig 4.3. An alignment of this 
nucleotide sequence with the sequence from the corresponding gene of the 
closely related species P. gingivalis is shown in Fig 4.4. The B. forsythus hsp60 
nucleotide sequence shares 73% identity with the P. gingivalis hsp60 sequence 
(identical at 1192 out of 1635 residues).
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Analysis of the predicted amino acid sequence of B. forsythus hsp60
Translation of the DNA sequence of the hsp60 gene (groEL unit) from 8. 
forsythus in all six reading frames identified only one open reading frame of 
sufficient length to code for a protein of the size expected for hsp60. The DNA 
sequence of the gene and the predicted amino acid sequence of the B. 
forsythus hsp60 protein are shown in Fig 4.3. The B. forsythus groEL gene has 
an ATG initiation codon at position 1, and a chain termination codon at position 
544 of the amino acid sequence. The predicted translation product is a 544 
amino acid, 58-kDa protein. This compares with a 545 amino acid (58.4-kDa) 
groEL protein from P. gingivalis and a 547 amino acid (57-kDa predicted 
molecular weight) predicted gene product from the hsp60 gene of A. 
actinomycetemcomitans.
Comparison of the predicted B. forsythus hsp60 amino acid sequence 
with those from other species
An alignment of the B. forsythus hsp60 amino acid sequence and the hsp60 
amino acid sequences from A. actinomycetemcomitans, P. gingivalis, E. coli 
and human mitochondrial protein P1 is shown in Fig 4.5. The genes possess a 
notably high degree of homology, which is characteristic of the hsp60 family of 
proteins. The highest level of sequence identity is shared between the hsp60 
genes of 8. forsythus and P. gingivalis, which is predictable as both organisms 
belong to the same Bacteroides taxonomic group.
From the alignment, it can be calculated that the 8. forsythus groEL amino acid 
sequence shares 81% sequence identity with the hsp60 gene of P. gingivalis,
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63% identity with A. actinomycetemcomitans, 62% identity with E. coli and 50% 
identity with the human homologue, mitochondrial protein P1. Regions of amino 
acid sequence which were common to all species are identified in the 
consensus sequence shown in Figure 4.4.
Predicted secondary structures and features of the B. forsythus hsp60 
amino acid sequence
From the amino acid sequence derived for B. forsythus hsp60, a prediction of 
some of the protein’s secondary structures could be made via use of the 
PEPPLOT and PEPTIDESTRUCTURE functions of the Genetics Computer 
Group Wisconsin package (Devereux et a!, 1984) (Fig 4.6). These programmes 
illustrate various measures of protein secondary structure on parallel lanes of 
one co-ordinated plot i.e. the amino acid sequence. The structural predictions 
are based on the average, sum or product of features of a specific residue 
contained within a 7-residue window. Thus some residue properties are 
dependent on other residues within an immediate proximity.
The plot measures the propensity for any residue to form a helices and p sheets 
(according to parameters defined by Chou and Fasman, 1978; and Gamier et 
ai, 1978), displayed diagrammatically in lanes (e) and (f). a helices appear to 
be the dominant secondary structure of the protein examined, with p sheets 
likely to form only occasionally throughout the length of the sequence. The 
protein does not display any regions of marked hydrophobicity or hydrophilicity. 
The antigenic index (lane d) illustrates that 8. forsythus hsp60 is predicted to be 
highly antigenic virtually throughout the length of the sequence. Some of these 
regions of predicted antigenicity correspond to regions of the amino acid
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sequence likely to be expressed on the surface of the protein (lane b) which 
further implies their antigenic potential.
3’ DNA sequence of the hsp60 gene of P. intermedia
A 1.6-kb PCR product containing the hsp60 gene of P. intermedia was 
generated using the same oligonucleotide primers and under the same PCR 
conditions as described previously when the hsp60 gene of B. forsythus was 
isolated. The PCR product was inserted into the plasmid vector pCR2.1-TOPO 
as described for the B. forsythus hsp60 gene in Chapter 3.
The DNA insert was sequenced using an automated sequencer and the 
commercially available primers M13 Forward and M13 Reverse. Sequencing 
data was analysed using the BaselmagIR® software package which collected 
sequence data from the automated sequencer and provided a program for 
reading the bases. The DNA sequence was converted into FASTA format 
(compatible with BLAST searches) and on-line DNA sequence databases were 
searched for matches to identify the DNA sequence that the recombinant clone 
carried. DNA sequence databases were searched using the Institute for 
Genomic Research web-site at http://www.tigr.org.
The DNA sequence representing 653 nucleotides of the 3’ terminal sequence of 
the hsp60 gene of P. intermedia is shown in Figure 4.6.
Predicted amino acid sequence of the hsp60 protein of P. intermedia
Translation of the sequenced portion of the 3’ terminus of the groEL gene from 
P. intermedia revealed a single open reading frame of 217 amino acids. The 
predicted amino acid sequence is shown in Figure 4.6.
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Comparison of the predicted P. intermedia hsp60 amino acid sequence 
with those from other species
The predicted amino acid sequence of the 3’ terminus of the hsp60 gene from 
P. intermedia, representing 40% of the total hsp60 sequence, was aligned with 
the corresponding sequence of the hsp60 proteins of B. forsythus, P. gingivalis,
A. actinomycetemcomitans, E. coli and human mitochondrial protein P1. This 
alignment is presented in Figure 4.7. For the portion of the gene shown, the P. 
intermedia sequence shares 71% amino acid homology with B. forsythus 
hsp60, 70% homology with P. gingivalis, 55% homology with E. coli, 54% 
homology with A. actinomycetemcomitans and 42% homology with the human 
homologue P1.
Construction of a molecular phylogenetic tree
A molecular phylogenetic tree was deduced from analysis of existing nucleotide 
sequences of hsp60 from a range of organisms along with that of B. forsythus. 
Phylogenetic analyses were performed using the PUZZLE (version 4.0.2) 
program in PHYLIP (version 3.5c). This program constructs trees from 
molecular sequence data by maximum likelihood, all sequence analysis used 
1000 puzzling steps. The program tests whether the base composition of each 
sequence is identical to the average base composition of the whole alignment, 
and also computes the average distance between all pairs of sequences. The 
average distances can be viewed as a rough measure of the overall sequence 
divergence. Branches showing support values from 90 to 100% can be 
considered very strongly supported. The tree indicates a close evolutionary 
relationship between B. forsythus and P. gingivalis, confirming previous 
phylogenies.
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DISCUSSION
This chapter describes the DNA sequence of the hsp60 gene which codes for 
the groEL monomer of the hsp60 protein of B. forsythus. The nucleotide 
sequence representing the entire coding region of this gene was determined on 
both strands using overlapping oligonucleotide primers, and is described here 
for the first time. The DNA sequence of B. forsythus hsp60 was translated into a 
predicted protein sequence, and the derived amino acid sequence used to 
search for homologous proteins in on-line databanks using BLAST searches 
made available by the Institute of Genomic Research. As expected, virtually all 
members of the hsp60 family of chaperonins share an extremely high level of 
homology with B. forsythus hsp60.
The amino acid identity ranged from 81% with P. gingivalis, to 62% with E. coli 
and 50% with the gene product of human mitochondrial protein P1. The B. 
forsythus DNA sequence shares 73% identity with the nucleotide sequence of 
P. gingivalis hsp60, with some of the nucleotide differences occurring in the 
third or ‘wobble’ base of codons causing the higher level of amino acid 
homology. High levels of conserved amino acid residue changes have been 
described when the hsp60 peptide sequence of Salmonella typhi was compared 
to that of E. coli (Lindler and Hayes, 1994) and when the hsp60 sequences of 
various Neisseria species were analysed (Pannekoek et al, 1995). A broader 
study indicated that the minimum level of sequence identity between any two 
hsp60 sequences is 40%, beyond which a further 20% of the amino acid 
changes can be predicted to be conservative (Gupta, 1995).
Several well-conserved motifs and signature sequences have been identified
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within the nucleotide and amino acid sequences of groEL. One motif consists of 
a Gly-Gly-Met repeat at the extreme terminal end of the sequence, with the 
number of repeats varying between species (Gupta, 1995; Pannekoek et al,
1995; Schmidt et al, 1992). This sequence is repeated twice in the B. forsythus 
hsp60 sequence, three times in the P. gingivalis sequence and four times in the 
E. coli sequence. Similar GGM motifs have also been observed in eukaryotic 
hsp60 homlogues. Deletions at the C terminus of yeast hsp60 suggest that the 
presence of at least three glycine and methionine residues is essential for cell 
viability (Shu et al, 1991). A truncated version (minus GGM) of E. coli hsp60 has 
been constructed and hydrolyses ATP 1.5 times more slowly than wild type, and 
fails to suppress certain temperature-sensitive mutations (McLennan et al,
1991). Another motif, identified using the MOTIF programme of the Wisconsin 
Computer Group Package, is a conserved region of 12 amino acids located in 
the last third of the groEL sequence. The consensus pattern A-[A/S]-X-[E/Q]-E- 
X(4)-G-G-[G/A] has been found to exist in virtually all hsp60 sequences 
currently characterised, with the exception of mitochondrial Plasmodium 
falciparum groEL. The motif is located in the B. forsythus hsp60 sequence at 
residues 404-415 and is represented by the amino acid sequence 
AAIEEGTVPGGG. A signature that differentiates between sequences derived 
from Gram positive and Gram negative species has been located at residue 153 
of E. coli hsp60 (which corresponds to residue 153 of B. forsythus hsp60 
sequence). In Gram positive species, this residue is missing and a gap is 
created in the amino acid sequence as compared to Gram negative-derived 
sequences (Gupta, 1995).
As a result of their ubiquitous presence in prokaryotes and eukaryotic
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organelles, universal conservation and considerable size, hsp60 sequences are 
ideal ‘molecular clocks’ that can be used to track evolutionary relationships 
between organisms, and to estimate at which period in the evolutionary time 
scale any sequence changes occurred. Due to their omnipresence and high 
level of sequence identity, it is apparent that all hsp60 sequences are derived 
from the sequence of an ancient common ancestor. Changes that have 
occurred in the sequence since then, for example the Gram positive ‘missing’ 
amino acid residue 153, can yield information on inter-bacterial relationships, 
allowing the construction of phylogenetic trees which plot their common 
ancestry. A phylogenetic tree constructed by Gupta (1995), rooted using a 
distant homologue of hsp60 from the archaebacterium Sulfolobus shibatae, 
arranges the hsp60 homologues in groups (Fig 4.8). These groups, and their 
order of branching in the evolutionary tree from the most ancient to the most 
recent group, provide a pattern that is consistent with observations made by 
other groups who have formed evolutionary trees using sequences from other 
genes in a similar manner. The hsp60 evolutionary tree indicates that the Gram 
positive bacteria, due to their deepest branching within the tree, represent the 
most ancient group studied. This ancient group includes examples of 
extremophiles and the mycobacteria. Midway through the evolutionary tree, a 
group diversifies that contains the spirochaetes and chlamydiae, and P. 
gingivalis. A molecular phylogenetic tree deduced from analysis of the 
nucleotide sequences of representatives from each different group and B. 
forsythus hsp60 sequence strongly supports the placement of B. forsythus in 
the same evolutionary group as P. gingivalis (Fig 4.9). More recently diversified 
than B. forsythus hsp60 is the group of mitochondrial hsp60 homologues.
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Interestingly, the hsp60 phylogenetic tree supports the hypothesis described for 
the formation of eukaryotic organelles (mitochondria and chloroplasts), which 
are thought to have evolved following an endosymbiotic ‘consumption’ of 
particular groups of bacteria by an ancestral eukaryotic cell (Margulis, 1970). 
The high degree of amino acid identity conserved within a species may reflect 
evolutionary relatedness as Gupta implies, but it may also indicate that only 
minor sequence changes can be tolerated by a species. Perhaps each species’ 
hsp60 is structurally adapted to best handle the proteins and polypeptides of 
that species, indicated by the relatively ineffective functional interchange of 
chaperonins between species.
The predicted a helical structure of 8. forsythus hsp60 (Fig 4.5) is in 
accordance with the predicted secondary structure of the hsp60 protein of 
mycobacteria (Young et al, 1987). Similar to the structural analysis of 8. 
forsythus hsp60, the mycobacterial homologue displayed no strikingly 
hydrophobic regions, which contradicts data presented in a study of Neisserial 
hsp60 proteins (Pannekoek et al, 1985). This apparent difference may reflect 
the cellular localisation of hsp60 in different species. The lack of hydrophobic 
domains in the 8. forsythus and mycobacterial sequences would make an 
association between these proteins and the lipid-rich cell wall of the species 
unlikely. However, the hydrophobic regions noted in the Neisserial sequence 
would permit such an interaction, and may indicate that Neisserial hsp60 could 
act to transport cellular proteins to the cell wall, or may chaperone proteins prior 
to secretion to maintain them in a conformation conducive to transport.
Notably hydrophilic regions of the M. leprae hsp65 predicted protein sequence 
have been shown to be major antibody-binding epitopes of the linear sequence
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of the mycobacterial homologue to B. forsythus hsp60 (Anderson et al, 1988). 
Whilst hydrophilic domains do not feature in the B. forsythus hsp60 analysis, 
several of the antigenic regions identified match areas of the sequence which 
have been predicted to be expressed on the surface of the protein. Some of 
these areas of the protein, notably around residues 80, 360 and 390, are also 
amongst the best-conserved stretches of the B. forsythus hsp60 sequence. It is 
therefore possible that these are highly antigenic linear epitopes, or parts of 
discontinuous epitopes, that represent domains that may be important epitopes 
for inducing immune responses either as cross-reactive antibody binding sites 
or as epitopes recognised by T-lymphocytes.
Studies on the antigenic sites of hsp60 proteins of Neisseria species 
(Pannekoek et al, 1987) and mycobacteria (Young et al, 1987) support this 
postulation, with an area of the protein capable of binding a cross-reactive 
monoclonal antibody identified around residue 360. Interestingly, amino acid 
361 was found to be a crucial determinant of the epitope with regards to 
Neisseria species binding the monoclonal antibody. N. flavescens was the only 
species in this study which did not bind the cross-reactive monoclonal antibody. 
Upon analysis, the N. flavescens sequence at the 360 region was found to differ 
in only one residue, at position 361. Thus it must be borne in mind that whilst 
well conserved domains may be identified and tagged as potentially cross­
reactive epitopes, the alteration of a single amino acid within the conserved 
domain can deem a seemingly cross-reactive epitope to be species-specific.
The high level of sequence identity that hsp60 homologues share has been well 
documented (Shinnick, 1991; Young etal, 1987) and B. forsythus shares this 
characteristically high level of homology, as seen in the alignment of hsp60
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sequences from various species in Fig 4.4. Not only do these hsp60 
homologues share sequence identity, but their genomic conservation reflects a 
conserved structure (a double ring ‘doughnut’ shape exhibiting 7-fold rotational 
symmetry) and function (‘molecular chaperones’) that all hsp60 chaperonins 
share.
Increasingly though, hsp60 proteins are being found to share a high level of 
sequence identity with a diverse array of apparently unrelated proteins. Dudani 
and Gupta (1989) initially observed this phenomenon after they had 
characterised the human hsp60 homologue, protein P1. Sequence alignments 
of the human hsp60 homologue revealed statistically significant alignments 
occurred with sequences coding for a number of seemingly unrelated proteins 
from pathogenic bacteria and viruses, including the pol polyprotein of 
immunodeficiency viruses, the p chain of cholera enterotoxin and the penicillin 
binding protein of N. gonorrhoeae. Jones et al (1993) sought to substantiate the 
implication that hsp60, due to its high level of sequence conservation, may be 
involved in autoimmune diseases. This they achieved by aligning the human 
hsp60 amino acid sequence, divided into 25-amino acid lengths that covered 
the entire gene, with the sequences of proteins which were ‘known’ 
autoantigens involved in a range of autoimmune diseases. Regions of the 
hsp60 sequence predicted to be potentially highly antigenic demonstrated 
sequence homology with 19 known autoantigens. Of these, the highest 
similarity scores were attributed to cytokeratin (associated with the autoimmune 
disease rheumatoid arthritis), neurofilament triplet M protein (multiple sclerosis), 
cardiac myosin heavy chain (coxsackie myocarditis) and cytochrome P450 
(chronic active hepatitis). The human hsp60 protein also shared sequence
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homology with proteins not currently identified as autoantigens, although the 
authors postulate that a role for these less-characterised proteins in 
autoimmune diseases may be proven in time.
More recently, hsp60 shared sequences have been found in tissues and 
bacterial cells that have a degree of periodontal tissue specificity. The NH2 
terminus of a component of the surface-associated material (SAM) of A. 
actinomycetemcomitans shares >95% homology with the corresponding 38 
residues from the NH2 terminus of E. coli hsp60 (Kirby et al, 1995). As this 
protein has an apparent molecular weight of 62-kDa, and binds a monoclonal 
antibody that recognises E. coli and mycobacterial hsp60, it may be that this is 
less of a discovery of a new protein sharing hsp60 homology, but is more likely 
to be a further characterisation of a function that some hsp60 proteins may 
share, and also indicates the outer membrane localisation of hsp60 in A. 
actinomycetemcomitans.
Gemmell and Seymour (1995) refer to unpublished data which demonstrates 
that hsp60 proteins possess DNA sequence homologous to periodontal 
ligament fibroblast DNA. The periodontium-specific nature of these cells invites 
interesting speculation as to their involvement in autoimmune processes of 
periodontitis. Future work shall perhaps better characterise the protein from the 
ligament fibroblasts, and determine its antigenicity and potential for binding 
cross-reactive hsp60 antibodies.
In summary, this chapter presents the first report of the DNA sequence and 
predicted protein sequence of the hsp60 gene of B. forsythus, as well as a 
partial characterisation of the hsp60 DNA sequence of P. intermedia. Predicting 
some of the B. forsythus hsp60 secondary structures using the PEPPLOT and
in
PEPTIDESTRUCTURE functions of the Genetics Computer Group Wisconsin 
programs, regions of the peptide that are likely to be immunogenic have been 
identified. By expressing the recombinant protein and assessing its reactivity 
with various antibody and serum preparations in Chapters 5 and 6, the 
assumption that B. forsythus hsp60 is an immunogenic protein bearing cross­
reactive hsp60 antibody binding sites can be tested.
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FIGURE 4.1. Autoradiograph of a typical sequencing gel obtained in 
determining the DNA sequence of the B. forsythus hsp60 gene.
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Figure 4.1. Autoradiograph of a typical sequencing gel obtained in determining 
the DNA sequence of the B. forsythus hsp60 gene. Forward and reverse 
orientated custom-made primers were annealed to single-strand DNA 
generated from plasmid pBf1.6 and sequencing reactions then performed so 
that DNA was sequenced entirely in both directions. The samples shown on the 
gel are as follows:
Forward primer (long run)- A track (lane 1), C track (lane 2), G track (lane 3), T 
track (lane 4); reverse primers (long run)- A track (lane 5), C track (lane 6), G 
track (lane 7 ), T track ( lane 8); forward primer (short run)- A track (lane 9), C 
track (lane 10), G track (lane 11), T track (lane 12); reverse primer (short run)- A 
track (lane 13), C track (lane 14), G track (lane 15), T track (lane 16).
Thus, the first forward reaction (long run, lanes 1-4) begins reading at 
nucleotide position 78 of the sequence: ACGGTAAGCT....
The second forward reaction (short run, lanes 9-12) begins reading in this 
image at nucleotide position 367: GTATCGAAAG...
FIGURE 4.2. Example of sequence data derived from automatic DNA 
sequencing using LICOR 4200 system.
Figure 4.2. Example of sequence data obtained from automated DNA 
sequencing using the LICOR 4200 system. Commercially available and custom- 
made fluorescently labelled primers were annealed to denatured plasmid DNA, 
and cycle sequencing reactions performed. DNA was sequenced entirely in 
both directions. This image displays plus-strand DNA data.
FIGURE 4.3. DNA sequence and predicted amino acid sequence of the
B. forsythus hsp60 gene.
ATGGCAAAAGAAATCAAATTCGACATGAATGCCCGCGACCTTTTGAAGAAAGGTGTGGAT 6 0
M A K E  I  K F D M N A R D L L K K G V D  2 0
GAATTGGCAAATGCCGTTAAGGTAACATTAGGTCCGAAAGGTCGCAATGTGATCCTCGAA 1 2 0
E L A N A V K V T L G P K G R N V I L E  4 0
AAGAAATTCGGTGCTCCGCAAATCACCAAAGACGGTGTAACGGTGGCGAAAGAAATAGAG 1 8 0
K K F G A P Q I T K D G V T V A K E I E  6 0
CTCGCTTGTCCGTACGAGAACATGGGGGCGCAGCTTGTGAAGGAAGTCGCTTCGAAGACG 2 4 0
L A C P Y E N M G A Q L V K E V A S K T  80
AACGACAAAGCCGGCGACGGTACGACAACTGCTACCGTTTTGGCGCAAGCCATCATTGGC 3 00
N D K A G D G T T T A T V L A Q A I  I G  1 0 0
GTAGGATTGAAGAACGTAACGGCCGGGGCTAATCCAATGGACTTGAAACGCGGTATCGAC 3 6 0
V G L K N V T A G A N P M D L K R G I D  1 2 0
AAGGCCGTATCGAAAGTGGTAGAAAGCATCGCATCGCAGTCCGAAGCGGTAGGTACGAAC 4 2 0
K A V S K V V E S  I A S Q S E A V G T N  1 4 0
ATGGACCGTATCGAGCATGTGGCTAAAATCTCGGCAAACGGCGATGAGGGTATCGGTAAG 4 80
M D R I E H V A K I  S A N G D E G I G K  1 6 0
CTGATTGCCGAAGCGATGCAGAAGGTGAAGAAAGAAGGCGTCATCACGGTAGAAGAAGCC 5 4 0
L I A E A M Q K V K K E G V I T V E E A  1 8 0
AAGGGAACGGAAACGACCGTGGAGGTTGTGGAAGGTATGCAGTTCGATCGCGGTTATATC 6 0 0
K G T E T T V E V V E G M Q F D R G Y I  2 0 0
TCCGCTTATTTCGTGACCGATACGGAAAAGATGGAAACACAGTTCGAAAATCCGTACATT 6 6 0
S A Y F V T D T E K M E T Q F E N P Y I  2 2 0
CTGATCTACGATAAAAAGATTTCAGTGCTGAAAGACCTGCTTCCCATCCTGGAGCAAATG 7 2 0
L I Y D K K I S V L K D L L P I L E Q M  2 4 0
GTTCAGTCGGGTCGTGCTTTGCTGATCATTGCCGAAGACATCGACAGCGAAGCGTTGGCT 7 8 0
V Q S G R A L L I  I A E D I D S E A L A  2 6 0
ACGCTTGTGGTGAACCGTCTGCGCGGTGGTTTGAAAGTGTGCGCCGTGAAGGCTCCGGGC 84  0
T L V V N R L R G G L K V  C A V K A P G  2 8 0
TTCGGCGACCGTCGTAAGGCTATGCTCGAAGATATTGCCATCTTGACAGGTGGAACGGTG 9 0 0
F G D R R K A M L E D I A I L T G G T V  3 0 0
ATTACCGAAGAAAAAGGCATGAAACTGGAAGATGCCAAGATGGATATGCTCGGGTCGGCC 9 6 0
I  T E E K G M K L E D A K M D M L G S A  3 2 0
GACAAGGTCACGGTGAACAAAGACAATACGACGATCGTGAAAGGGAACGGCGACAAGGCT 1 0 2  0
D K V T V N K D N T T I V K G N G D K A  3 4 0
GCTATTGAGTCTCGTATCGGCCAGATCAAGGCACAGATCGAAACAACGACATCGGACTAC 1 0 8 0
A I E S R I G Q I K A Q I E T T T S D Y 360
GACAAGGAGAAGTTGCAGGAACGTTTGGCGAAGTTGGCCGGCGGAGTCGCCGTGCTCTAC 1 1 4 0  
D K E K L Q E R L A K L A G G V A V L Y  3 8 0
GTCGGCGCTCCTTCGGAAGTGGAAATGAAAGAGAAGAAAGACCGTGTAGACGACGCCTTA 12  00  
V G A P S E V E M K E K K D R V D D A L  4 0 0
CATGCTACCCGCGCCGCGATCGAAGAAGGTACGGTGCCCGGCGGTGGAGTCGCTTATCTT 1 2 6 0
H A T R A A  I  E E G T V P G G G V A Y L  4 2 0
CGCGCGATCCCGGCACTCGAAGGCCTCAAGGGGGAGAACGAAGACGAAACGACGGGTATC 1 3 2 0
R A I  P A L E G L K G E N E D E T T G I  4 4 0
GAGATTGTGAAACGCGCCATCGAAGAGCCGTTGCGTCAGATCGTGAACAACGCCGGTAAG 1 3 8 0
E I V K R A I E E P L R Q I V N N A G K  4 6 0
GAAGGTGCGGTAGTGGTGCAGAAAGTGAAAGAAGGCACAGGTGCTTTCGGATACAACGCT 1 4 4 0
E G A V V V Q K V K E G T G A F G Y N A  4 8 0
CGTACCGATGTGTACGAAGACCTCTCTGAGGCCGGAGTCGTTGACCCTGCCAAAGTGACA 1 5 0 0
R T D V Y E D L S E A G V V D P A K V T  5 0 0
CGTATCGCCCTTGAGAATGCCGCATCGATTGCCGGCATGTTCCTGACCACCGAATGCGTC 1 5 6 0
R I A L E N A A S  I A G M F L T T E C V  5 2 0
GTAGCCGATAAGAAGGAAGAGGCACCGGCCCCCCCGATGAACCCGGGCATGGGTGGCATG 1 6 2 0
V A D K K E E A P A P P M N P G M G G M  5 4 0
GGCGGCATGATGTAA 1 6 3  5
G G M M * 5 4 4
FIGURE 4.3. DNA sequence and predicted amino acid sequence of the coding 
region of the B. forsythus hsp60 gene. The predicted amino acid sequence is 
shown below the nucleotide sequence. The amino acid sequence constitutes a 
single open reading frame of 544 amino acids.
FIGURE 4.4. Alignment of the B. forsythus and P. gingivalis 
hsp60 DNA sequences.
B.  f .  h s p 6 0  ATGGCAAAAGAAATCAAATTCGACATGAATGCCCGCG 3 7
l l l l l l l l l l l l l l l l l l l l l l l  I I I  I I I N I
P .  g .  h s p 6 0  ATGGCAAAAGAAATCAAATTCGATATGGAATCTCGCG 3 7
ACCTTTTGAAGAAAGGTGTGGATGAATTGGCAAATGCCGTTAAGGTAACA 8 7
M i l l  l l l l l l l  I I  I I  I N I  I I I  l l l l l l l l l l l l l  I I  I I
ACCTTCTGAAGAAGGGCGTAGATGCACTGCCAAATGCCGTTAAAGTTACC 8 7
TTAGGTCCGAAAGGTCGCAATGTGATCCTCGAAAAGAAATTCGGTGCTCC 1 3  7
I I I  l l l l l l l  I I I  I I  I I  M i l l  1111 I I I I  M i l l
CTCGGGCCGAAAGTTCGTAACGTTATCCTTAGCAAGACGTACGGAGCTCC 1 3 7
GCAAATCACCAAAGACGGTGTAACGGTGGCGAAAGAAATAGAGCTCGCTT 1 8 7
I I I  I I  M i l l  M I N I M  I I I  11111111 M i l l  I I I
GCACATTACCAAGGACGGTGTGAGCGTAGCGAAAGAGATAGAATTGGAGT 1 8 7
GTCCGTACGAGAACATGGGGGCGCAGCTTGTGAAGGAAGTCGCTTCGAAG 23  7
I 1111 111111 111111  I I  I I I  I M i l l  M i l l  I I  I I  I I I
GCCCGTTCGAGAACATGGGTGCCCAGTTGGTGAAAGAAGTAGCCTCCAAG 2 3 7
ACGAACGACAAAGCCGGCGACGGTACGACAACTGCTACCGTTTTGGCGCA 2 87
I I  I I  I I I  I M i l l  I I I 1 1 1 1 1 1 1 1  I I  M i l l  I I I I  I I
ACCAATGACGATGCCGGTGACGGTACGACTACGGCTACGATCCTCGCCCA 2 87
AGCCATCATTGGCGTAGGATTGAAGAACGTAACGGCCGGGGCTAATCCAA 3 3 7
I I I  I I  M i l l  I I  1111111111  M i l l  I I  I I  M i l l  I
GAGCATTATCGGCGTGGGTCTGAAGAACGTTACGGCAGGAGCCAATCCGA 3 3 7
TGGACTTGAAACGTGGTATCGACAAGGCCGTATCGAAAGTGGTAGAAAGC 3 87
1111 M i l l  111111 111111111 I I I I  I l l l l l l  I
TGGATTTGAACCGTGGTATCGACAAGTCTGTAAAGTCTGTGGTAACTCAC 3 87
ATCGCATCGCAGTCCGAAGCGGTAGGTACGAACATGGACCGTATCGAGCA 4 3 7
M i n i  m  m  i i  i i  i i  i i  i i i i i i m i
ATCGCAGGTATGGCTAAGGAAGTGGGCGCCGACTTCCAGAAGATCGAGCA 4 3  7
TGTGGCTAAAATCTCGGCAAACGGCGATGAGGGTATCGGTAAGCTGATTG 4 8 7
I I  I I  I I  M i l l  I I  M i l l  I I  I I  l l l l l l l  I I  1111
CGTAGCCAAGATCTCTGCCAACGGAGACGAAAACATCGGTAGCCTCATTG 4 87
CCGAAGCGATGCAGAAGGTGAAGAAAGAAGGGGTCATCACGGTAGAAGAA 5 3 7
l l l l l l l  1111 M i l l  11111111111  I I  1 1 I I 1 1 1 1 1 1 1 1 1 1 1
CCGAAGCCATGCGCAAGGTAAAGAAAGAAGGCGTTATCACGGTAGAAGAA 5 3 7
GCCAAGGGAACGGAAACGACCGTGGAGGTTGTGGAAGGTATGCAGTTCGA 5 8 7
I I I I I II I I I I II II II II II II I I I I I I I I I I I I I I I I I I I I
GCCAAGGGAACCGACACTACGGTAGAAGTGGTGGAAGGTATGCAGTTCGA 5 8 7
TCGCGGTTATATCTCCGCTTATTTCGTGACCGATACGGAAAAGATGGAAA 6 3 7
h i m  i i  h i m  i i i  11111111 i i i i m i  i i i i i m
CCGCGGCTACATCTCTCCCTACTTCGTGACGAATACGGATAAGATGGAGG 6 3 7
CACAGTTCGAAAATCCGTACATTCTGATCTACGATAAAAAGATTTCAGTG 6 8  7
I I  l l l l l l l  I I I I  I I  l l l l l l l l  I I  I I  I I  I I  I I I
TCCAAATGGAAAATCCTTTCATCCTCATCTACGACAAGAAAATATCCGTG 6 8 7
CTGAAAGACCTGCTTCCCATCCTGGAGCAAATGGTTCAGTCGGGTCGTGC 7 3 7
M I N I M  1111  I I  M i l l  I I  1111 l l l l l l l  1111 I
CTGAAAGAGATGCTCCCGATCCTCGAACAAACGGTTCAGACGGGCAAGCC 73 7 
TTTGCTGATCATTGCCGAAGACATCGACAGCGAAGCGTTGGCTACGCTTG 7 8 7
I I I  1 1 1 1 1 1 1 1  l l l l l l l  1 1 1 1 1 1 1 1 1 1 1 1  I 1111  I I
CCTCCTCATCATTGCAGAAGACAACGACAGCGAAGCACTCCCTACCTTGG 7 8 7  
TGGTGAACCGTCTGCGCGGTGGTTTGAAAGTGTGCGCCGTGAAGGCTCCG 8 3 7
I I I  I I I I I I I I I I I I I I I I I I  I I I  I I  I I I I I I I I I I  I I
TTGTAAACCGTCTGCGCGGCAGCCTCAAGATCTGTGCAGTGAAGGCTCCC 8 3 7  
GGCTTCGGCGACCGTCGTAAGGCTATGCTCGAAGATATTGCCATCTTGAC 8 8 7
I I  1 1 1 1 1 1 1 1  M i l l  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  M i l l  I I I  1111
GGATTCGGCGATCGTCGCAAGGCTATGCTCGAAGACATTGCTATCCTGAC 8 8 7  
AGGTGGAACGGTGATTACCGAAGAAAAAGGCATGAAACTGGAAGATGCCA 9 3 7
I I  I I I  1111  I I  I l l l l l l  I I I  M i l  I I  I I I  I I  I
GGGCGGAGCGGTTATCAGCGAAGAGACCGGTCTGAACCTCGAAAATACTA 9 3 7  
AGATGGATATGCTCGGGTCGGCCGACAAGGTCACGGTGAACAAAGACAAT 9 8 7
I I I I I I I I I I I I I I I I I I  I I  I I  I I  I I I I  I I I I I I I I I I
CGATGGATATGCTCGGTACAGCTGAGAAAGTAAGGGTTGATAAAGACAAT 9 8 7  
ACGACGATCGTGAAAGGGAACGGCGACAAGGCTGCTATTGAGTCTCGTAT 1 0 3  7
I I  I I  M i l l  I I  I I  I I I  1111  I I  I I  I I  M i l l
ACTACTATCGTTAACGGAGCCGGAAACAAAGAAGGCATCGCTTCACGTAT 1 0 3  7 
CGGCCAGATCAAGGCACAGATCGAAACAACGACATCGGACTACGACAAGG 1 0 8 7
I 1 1 1 1 1 1 1 1  I I  l l l l l l l l  I M i l l  1 1 1 1 1 1 1 1 1  I
CACGCAGATCAAAGCTCAGATCGAGAATACGACCAGCGACTACGACCGCG 1 0 8 7  
AGAAGTTGCAGGAACGTTTGGCGAAGTTGGCCGGCGGAGTCGCCGTGCTC 1 1 3  7
I I I I  1111  1 1 1 1 1 1 1 1 1 1 1  I I I  I l l l l l l l l  I I  I I  I I  I I
AAAAGCTGCAAGAACGTTTGGCCAAGCTCGCCGGCGGTGTAGCTGTTCTT 1 1 3 7  
TACGTCGGCGCTCCTTCGGAAGTGGAAATGAAAGAGAAGAAAGACCGTGT 1 1 8  7
M i l l  I I  I I I  I 1 1 1 1 1 1 1 1 1 1 I I 1 1  I I  M i l l  I I  I I  I I
TACGTGGGTGCTGCCAGCGAAGTGGAAATGAAGGAAAAGAAGGATCGCGT 1 1 8 7  
AGACGACGCCTTACATGCTACCCGCGCCGCGATCGAAGAAGGTACGGTGC 12  3 7
I I I  I I  1111  I I I I  I I  I I l l l l l l l l  M i l l  I I  I
AGAAGATCCCTTGAGTCCAACGCGTCCTCCAATCGAAGAGGGTACAGTAC 1 2 3 7  
CCGGCGGTGGAGTCGCTTATCTTCGCGCGATCCCGGCACTCGAAGGCCTC 1 2 8 7
1111 I I  I I  I I  1111 I I  I I  I I I  I M i l l  I I I
CCGGTGGCGGTACGACATACATTCGTGCCATAGCTGCTTTGGAAGGTCTC 12  8 7 
AAGGGAGAGAACGAAGACGAAACGACGGGTATCGAGATTGTGAAACGCGC 1 3 3 7
M i l l  I I I I I I I I I I 1 1 1 1 1 1 1  I I  I I I 1 1 1 1 1 I I I  1 1 1 1 1 1 1 I I I I
AAGGGTGAGAACGAAGACGAAACCACAGGTATCGAGATCGTGAAACGCGC 1 3 3  7 
CATCGAAGAGCCGTTGCGTCAGATCGTGAACAACGCCGGTAAGGAAGGTG 1 3 8 7
l l l l l l  l l l l l l  I 1 1 1 1 1 1 1 I I 1 1  1 1 1 1 1 1 1 1 1 1 1  I I  1111
CATCGAGGAGCCGCTTCGTCAGATCGTAGCGAACGCCGGTAAAGAGGGTG 13  87
CGGTAGTGGTGCAGAAAGTGAAAGAAGGCACAGGTGCTTTCGGATACAAC 1 4 3 7
I I I  I N I  M i l l  1 1 1 1 1 I I 1 1 1 1 1 1  I I M i l l  M i l l
CCGTTATGGTACAGAAGGTGAAAGAAGGCAAGGACGACTTCGGCTACAAT 1 4 3 7
GCTCGTACCGATGTGTACGAAGACCTCTCTGAGGCCGGAGTCGTTGACCC 14  87
I I  M i l l  M i l l  I 1111  l l l l l l  1111  I I  I M i l l
GCCCGTACGGATGTTTTCGAAAACCTCTACACCACCGGTGTTATCGACCC 14  87
TGCCAAAGTGACACGTATCGCCCTTGAGAATGCCGCATCGATTGCCGGCA 1 5 3 7
l l l l l l l l  l l l l l l  I I I  I I I  M i l l  I I  I I  I I  I I  I I  I
AGCCAAAGTAACACGTGTTGCATTGGAAAATGCAGCGTCTATCGCAGGTA 1 5 3 7
TGTTCCTGACCACCGAATGCGTCGTAGCCGATAAGGAGGAAGAGGCACCG 1 5 8  7
1 1 1 1 1 1 1 1 1 1  I I  I I  M i l l  I I I  I I  I I I  I M i l l  I I
TGTTCCTGACTACGGAGTGCGTTATCGCTGACAAGAAAGAAGATAATCCT 1 5 8 7
GCCCCCCCG ATGAACCCGGGCATGGGTGGCATGGGCGGCATGATGTA 1 6 3 4
I I I  I I I I  I I I  I I I  M i l l  I I  1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
GCCGCACCGGCCATGCCCGGAGGTATGGGAGGAATGGGCGGCATGATGTA 1 6 3 7
A ------------------------------------------------------------------------------------------------------------  1 6 3 5
I
AACATCGATGCGAACAGGATGCGTTTTTGATTCCTTTCGAAAAAAATATC 1 6 8 7
CTGTAGGACATTCATATCACATTACAAGCCGAAGGCTGTGCAGAGGGTTC 1 9 3  7
TCCCTCACTGCACAGGCTTCATTTTGGACTT 1 9 6 8
Figure 4.4. Alignment of the B. forsythus (upper sequence) and P. 
gingivalis (lower sequence) hsp60 DNA sequences. Identical 
residues are indicated with a vertical bar, and dashes denote spaces 
introduced to maximise homology between the two species.
FIGURE 4.5. Alignment of the B. forsythus hsp60 amino acid sequence 
with hsp60 sequences from other species.
B f ----------------------------------------------------------- MAKEIKFDMNARDLLKKGVDELA 2 3
A a ---------------------------------------------------------MAAKDVKFGNDARVKMLNGVNILA 2 4
E c ---------------------------------------------------------MAAKDVKFGNDARVKMLRGVNVLA 24
p g ----------------------------------------------------------- MAKEIKFDMESRDLLKKGVDALP 23
P I
C on
- - MLRL PTVFRQMRPVS RVLAPHLTRAYAKDVKFGADARALMLQGVDLLA 
------------------------------------------------------------- A K --K F --------R ---------- G V --L -
4 8
B f NAVKVTLGPKGRNVILEKKFGAPQITKDGVTVAKEIELACPYENMGAQLV 73
A a DAVKVTLGPKGRNWLDKSFGAPTITKDGVSVAREIELEDKFENMGAQMV 74
E c DAVKVTLGPKGRNWLDKS FGAPTITKDGVS VAREIELEDKFENMGAQMV 74
p g NAVKVTLGPKVRNVILSKTYGAPHITKDGVSVAKEIELECPFENMGAQLV 73
P I
C on
DAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLV 
-A V -V T -G P K -R -V ------------ G - P -  -  TKDGV-VA- - I - L ---------- N -G A --V
98
B f KEVASKTNDKAGDGTTTATVLAQAIIGVGLKNVTAGANPMDLKRGIDKAV 1 2 3
A a KEVAS KANDAAGDGTTTATVLAQAIVNEGLKAVAAGMNPMDLKRGIDKAV 1 2 4
E c KEVAS KANDAAGDGTTTATVLAQAIITEGLKAVAAGMNPMDLKRGIDKAV 1 2 4
P g KEVAS KTNDDAGDGTTTATILAQS11GVGLKNVTAGANPMDLNRGIDKSV 1 2 3
P I
C on
QDVANNTNEEAGDGTTTATVLARSIAKEGFEKIS KGANPVEIRRGVMLAV 
-  -V A ----- N - -AGDGTTTAT-LA- - 1 ------G-------------G -N P -------- RG-------- V
1 4 8
B f S K W E SIA SQ S EAVGTNMDRIEHVAKIS ANGDEGIGKLIAEAMQKVKKEG 1 7 3
Aa NSWAELKNLSKPC-ETSKEIEQVGTISANSDSIVGQLIAQAMEKVGKEG 1 7 3
E c TAAVEELKALSVPC-SDSKAIAQVGTISANSDETVGKLIAEAMDKVGKEG 1 7 3
p g KSWTHIAGMAKEVGADFQKIEHVAKISANGDENIGSLIAEAMRKVKKEG 1 7 3
P I
C on
DAVIAELKKQS KPV- TTPEEIAQVATISANGDKEIGNIISDAMKKVGRKG 
------------------------------------------- I  -  -  V —  IS A N -D ------ G - - I - -A M - K V ------G
1 9 7
B f VITVEEAKGTETTVEWEGMQFDRGYISAYFVTDTEKMETQFENPYILIY 2 2 3
Aa VITVEDGTGLEDELDWEGMQFDRGYLSPYFINKPETATVELDNPFILLV 2 2 3
E c VITVEDGTGLQDELDWEGMQFDRGYLSPYFINKPETGAVELESPFILLA 2 2 3
pg VITVEEAKGTDTTVEWEGMQFDRGYIS PYFVTNTDKMEVQMENPFILIY 2 2 3
P I
C on
VITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLS 
V I TV----------------------------EG M -FD R G Y -S-Y F----------------------------------- L - -
2 4 7
B f DKKISVLKDLLPILEQMVQSGRALLIIAEDIDSEALATLWNRLRGGLKV 2 7 3
Aa DKKISNIRELLPVLEGVAKAGKPLLIIAEDVEGEALATLWNTMRGIVKV 2 7 3
E c DKKISNIREMLPVLEAVAKAGKPLLIIAEDVEGEALATAWNTIRGIVKV 2 7 3
pg DKKISVLKEMLPILEQTVQTGKPLLIIAEDNDSEALPTLWNRLRGSLKI 2 7 3
P I
C on
EKKIS SIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQV  
-K K IS ------------ P -L E ----------------- L -I I A E D ------E A L -T -V -N -----------------
2 9 7
B f CAVKAPGFGDRRKAMLEDIAlLTGGTVITEE- KGMKLEDAKMDMLGSADK 3 2 2
Aa AAVKAPGFGDRRKAMLQDIAILTAGTVISEE- IGMELEKATLEDLGQAKR 3 2 2
E c AAVKAPGFGDRRKAMLQDIATLTGGTVISEE-IGMELEKATLEDLGQAKR 3 2 2
Pg CAVKAPGFGDRRKAMLEDIAILTGGAVISEE- TGLNLENTTMDMLGTAEK 3 2 2
P I
C on
VAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGE 
-AVKAPGFGD-RK- - L - D - A -  -T - G - V -  -E E ----------L E -------------LG--------
3 4 7
B f VTVNKDNTTIVKGNGDKAAIESRIGQIKAQIETTTSDYDKEKLQERLAKL 3 7 2
A a IVINKDNTT11DGIGDEAQIQGRVAQIRQQIEES TSDYDKEKLQERVAKL 3 7 2
EC WINKDTTTIIDGVGEEAAIQGRVAQIRQQIEEATSDYDREKLQERVAKL 3 7 2
pg VRVDKDNTTIVNGAGNKEGIASRITQIKAQIENTTSDYDREKLQERLAKL 3 7 2
p i VIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKL 3 9 7
C on --------KD-------------G -G -------- I - - R ------ I - - Q -------- T S -Y -  -E K L -E R -A K L
B f AGGVAVLYVGAPSEVEMKEKKDRVDDALHATRAAIEEGTVPGGGVAYLRA 4 2 2
A a AGGVAVIKVGAATEVEMKEKKARVEDALHATRAAVEEGIVAGGGVALIRA 4 2 2
E c AGGVAVIKVGAATE VEMKE KKARVEDALHATRAAVE EGWAGGGVALIR V 4 2 2
pg AGGVAVLYVGAASEVEMKEKKDRVEDPLSPTRPPIEEGTVPGGGTTYIRA 4 2 2
p i SDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRC 4 4 7
C on -  -GVAV- -V G ------- V E - -E K K -R V -D -L - -T R ------EEG -V-GG G-------- R -
B f IPALEGLKGENEDETTGIEIVKRAIEEPLRQIVNNAGKEGAVWQKVKEG 4 7 2
A a AGRWGLQGENEEQNVGIKLALRAMEAPLRQIVANAGEEASVIASAVKNG 4 7 2
E c AS KLADLRGQNEDQNVGIKVALRAMEAPLRQIVLNCGEEPSWANTVKGG 4 7 2
pg IAALEGLKGENEDETTGIEIVKRAIEEPLRQIVANAGKEGAVMVQKVKEG 4 7 2
P I IPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQS 4 9 7
C on ------------ L ------ N E-------- G I -------- R -------- P ------I - - N - G - E ------------------------
B f TGAFGYNARTDVYEDLSEAGWDPAKVTRIALENAASIAGMFLTTECWA 5 2 2
A a EGNFGYNAGTEQYGDMIAMGILDPTKVTRSALQFAASVAGLMITTECMVT 5 2 2
E c DGNY GYNAATEEYGNMIDMGILDPTKVTRSALQYAASVAGLMITTECMVT 5 2 2
pg KDDFGYNARTDVFENLYTTGVIDPAKVTRVALENAASIAGMFLTTECVIA 5 2 2
P I SSEVGYDAMAGDFVNMVEKGIIDPTKWRTALLDAAGVASLLTTAEVWT 5 4 7
C on --------G Y -A ------------------------G - -D P -K V -R -A L - -  A A - -  A -------- T - E --------
B f DKKEEAPAPPMNP- GMGGMGGMM 5 4 4
A a ELPKDDKADLGAA-GMGGMGGMGGMM 5 4 7
E c DLPKNDAADLGAAGGMGGMGGMGGMM 5 4 8
pg DKKEDNPAAPAMPGGMGGMGGMM 5 4 5
p i EIPKEEKDP- - GMGAMGGMGGGMGGGMF 5 7 3
C on -------------------------------- MGGMGG---------------
FIGURE 4.5. Alignment of the amino acid sequences of the hsp60 proteins of 
Bacteroides forsythus (Bf), Actinobacillus actinomycetemcomitans (Aa), 
Escherichia coli (Ec), Porphyromonas gingivalis (Pg) and human mitochondrial 
protein P1 (P1). Dashes denote spaces introduced to maximise homology 
between the sequences. The consensus sequence (Con) denotes residues that 
are identical in all five proteins.
•Q
d
0
0
>»
TO
O
X I
0
E
0
XI-4—'
XO
•0
0
C
E
0
0
"o
0
o
"a.
o
TO
Q_
O
TO
>4
X
'aT
o
CD
CL
tn
JZ
co
13
5
£
OQ
M—o
0
13-t—<
o 
0 L_ -4—'
CO
0
*0
co
o
0
0
•0
0 •4—>
o
0
4—•P o 
la co« -4—'
O CL 
0
I ' g
3 £0 0 
*4”o c  
0  -*—* —1
O J?CL O 
^ ' O
e  cn . 0  
>4 Q_
o 0 
*ox: 0 a. xz o
±= >4
XI "0
0 g
co —
2 §
§ £
0 0
© ^  
S t
0  .-9
*4-  *o _0
0 *- c  c
.9  ’0co x: 
a o
*- M—
C °0 j2
0  O
2 q I
C L^
0 g
0 •
.E uo
— 00 M_
m CD O
'oroI
13 S
i ->  j —-4-J.P 0 
XO 0
0  j -
o '52 3  
Q_ CO
0  2
£  3^  -4—<
^  0 o ZJ
0  - t  i- 0
3  .  0 CT
3 - 3
m °  0 O
0  0  •— 0
x P0 o
■0 CO
.E 0
cn
c
5  CO 
O h- 
XI CD 
0 t —
LL
O
0
O
d
0>
0
0
O 0  
p  0
no ©
■ B e
. *xr- x:
g -2>
CD 0
±= *0
§  0
^  0 TO 0  
C M_0 o 
c  co o
0  X3 
0 0
E  E  
0
CO 
h- .
CO c
ZZ> 0 
c O
1 * 5
0  TO 
0  O  
LL -£=
TOII
a  t
■ s - §
TO > 4  
£ 0 
£  C 
0  0
E 0 
0 0 
£  O
>4 2
■° 0
• -  ^  0  p >4 TO
TO
XI
DO
*0
0
0-4-^
0
c
o"-4—> 
_0 
>4 
0 
O 
O
.>4
DO
0
C
0 -4—<o
CL
'oo
— n  0
O
0
Co
o
0
CO
0 : =
E
0
0
0x:
0
o
0
TO 
O
£  >4
0  XI
tn
0 0 
X I 
_  0
0 0 
CO -g
aT-0— " TO 
^  C >» 0
00
_C0
0
: 0 xo
TO■ c  0
<D
0)u.0
CO
0  -F 
X I  £=
-|-J LU
0  V4_
«  O
0 iE p  0
■I E
a. 0
. XI^  H—' 
C\i >4
CO xo
2  -0 zz 0
0) =
£  E
o 0  
o 0
D  TO
TO0 «*—»
03
- 10
TO Q
S.sa
i ?
0 0 
* 0  O 
TO c
X  0
0  DO= 1— 0
.9  0 
c •“  
0  c
D0.O 
p  DO
E 00 i—
.-9 :— 
_0 w
c  J
’0  © 
X I -C- 
O  03 
TO -<= 
C 
0  0; 
>4 -
00
M  c  0 .9  
J~ 0
p  0.9 - o 0 0
0 O
E >4
3  S
0o*-4—• 0 C 
0 
CD
0coo
0
o
>4■4~>
tn
0
>
c
X
0x:-4—»
Eo
LU
a
Z ) 
i—
o
ZD 
CL 
I— 
CO 
I—o
TO
C
0
LU
DC
ZD
I—  •
CD Tf 
ZD co CL cd 
I— T_*
LU ,ca
g  0
I— X  
CL 3  
LU 0  
Q_ 0
0
Q0 -
0 0
9 o
XO 0 0 c XO p
CL TO
0 &  o g
0 xj 
a 2
0  CL
DO 0
I  S9  0
« 2
^ -4  CL
CL 0  
O i—
0P 0
o E
TO E 
.9  2
t  DO 0 O
°  C l
2  CL 0 13
5  2 
0  CD 0 T_w q3 -*—» 0 ^  C ©-0 E =  o
<  o
FI
GU
RE
 
4.6
. 
Pr
ed
ict
ed
 
se
co
nd
ar
y 
st
ru
ct
ur
es
 
of 
the
 
B.
 f
or
sy
th
us
 
hs
p6
0 
am
ino
 
ac
id 
se
qu
en
ce
.
FIGURE 4.7. DNA sequence and predicted amino acid sequence of the C 
terminal fragment of the P. intermedia hsp60 gene.
GGTGTTGTTATCXGCGAAGATAAGGGTTTGACACTCGACAAGGCAACACTC 5 0
G V V I X E D K G L T L D K A T L
GAAATGTTGGGTTCAGCTAAAAAGGTTACCGTTTCTAAGGATTTCACCAAC 1 0 0  
E M L G S A K K V T V S K D F T N
ATCGTAGACGGTGCAGGCTCTAAGGAAAGCATTGCAGAGCGTGTGAATGCT 1 5 0  
I V D G A G S K E S  I A E R V N A
ATCAAGAGCGAAATTGCGAACACAAAGAGCCAGTACGATAAAGAGAAACTA 2 00
I K S E I A N T K S Q Y D K E K L
CAAGAGCGTTTGGCAAAACTTGCTGGTGGCGTTGCAGTGCTTTACGTGGGT 2 5 0  
Q E R L A K L A G G V A V L Y V G
GCCAACTCTGAAGTAGAGATGAAAGAGAAGAAAGACCGTGTAGACGATGCA 3 0 0  
A N S E V E M K E K K D R V D D A
CTCTGTGCGACTCGTGCAGCAACCGAAGAAGGTGTTGTTGTAGGTGGCGGT 3 5 0  
L C A T R A A T E E G V V V G G G
ACTACTTATATCCGTGCTCAAGAGGTTTTGAAAGTCCTTACAGGCGAAAAT 4 0  0
T T Y I R A Q E V L K V L T G E N
CCTGACGAACAGACAGGTATCAATATTGTTTGCCGTGCCATTGAAGAACCA 4 5 0  
P D E Q T G I N I V C R A I E E P
CTTCGCCAGATTGTTTATAACGCTGGTGGCGAGGGTGCAGTAGTTGTCAAT 5 0 0  
L R Q  I V Y N A G G E G A V V V N
AAGGTACGCGAAGGCAAGGGCGACTTCGGTTACTACGCGCGTCGCGACCAG 5 5 0
K V R E G K G D F G Y Y A R R D Q
TACGAAGACTTGCGTGCAGCAGGTGTTATCGACCCCGCAAAGGTTTCTCGT 6 0 0  
Y E D L R A A G V I D P A K V S R
GTAGCTTTGGAAAATGCAGCTTCAATCGCTGGTATGTTC 6 3 8
V A L E N A A S  I A G M F
Figure 4.7. DNA sequence and predicted amino acid alignment of the C 
terminal portion of the P. intermedia hsp60 gene. The predicted amino acid 
sequence is shown below the nucleotide sequence.
Figure 4.8. Alignment of P. intermedia hsp60 amino acid sequence (Pi) with 
amino acid sequences of the hsp60 proteins of A. actinomycetemcomitans 
(Aa), E. coii (Ec), B. forsythus (Bf), P. gingivalis (Pg) and human mitochondrial 
protein (P1). Dashes denote spaces introduced to maximise homology between 
the sequences. The consensus sequence (Con) denotes residues that are 
identical in at least four of the six proteins.
FIGURE 4.8. Alignment of the P. intermedia hsp60 amino acid sequence 
with hsp60 sequences from other species.
A a AAVKAPGFGDRRKAMLQDIAILTAGTVISEE-IGMELEKATLEDLGQAKR
E c AAVKAPGFGDRRKAMLQDIATLTGGTVISEE-IGMELEKATLEDLGQAKR
B f  CAVKAPGFGDRRKAMLEDIAILTGGTVITEE-KGMKLEDAKMDMLGSADK
P g CAVKAPGFGDRRKAMLEDIAILTGGAVISEE- TGLNLENTTMDMLGTAEK
pi ------------------------ GWIXED - KGLTLDKATLEMLGSAKK
P I  VAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGE
C on  ---------------------------------------------------- G -V I -E E -G  L E -A T  L G -A --
A a IVINKDNTTIIDGIGDEAQIQGRVAQIRQQIEESTSDYDKEKLQERVAKL
E c WINKDTTTIIDGVGEEAAIQGRVAQIRQQIEEATSDYDREKLQERVAKL
B f  VTVNKDNTTIVKGNGDKAAIESRIGQIKAQIETTTSDYDKEKLQERLAKL
P g  VRVDKDNTTIVNGAGNKEGIASRITQIKAQIENTTSDYDREKLQERLAKL
P i  VTVSKDFTNIVDGAGSKESIAERVNAIKSEIANTKSQYDKEKLQERLAKL
P I  VIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKL
C on  V -V -K D -T T I— G -G -K A -I— R— Q I— Q IE - TTSDYDKEKLQERLAKL
A a AGGVAVIKVGAATEVEMKEKKARVEDALHATRAAVEEGIVAGGGVALIRA
E c  AGGVAVIKVGAATEVEMKEKKARVEDALHATRAAVEEGWAGGGVALIRV
B f  AGGVAVLYVGAPS EVEMKEKKDRVDDALHATRAAIEEGTVPGGGVAYLRA
P g  AGGVAVLYVGAASEVEMKEKKDRVEDPLSPTRPPIEEGTVPGGGTTYIRA
P i  AGGVAVLYVGANSEVEMKEKKDRVDDALCATRAATEEGVWGGGTTYIRA
P I  SDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRC
C on  AGGVAVL-VGA-SEVEM KEKKDRV-DAL-ATRAA-EEG-V-GGG-A-IRA
A a AGRWGLQGENEEQNVGIKLALRAMEAPLRQIVANAGEEASVIASAVKNG
EC AS KLADLRGQNEDQNVGIKVALRAMEAPLRQIVLNCGEE P SWANTVKGG
B f  IPALEGLKGENEDETTGIEIVKRAIEEPLRQIVNNAGKEGAVWQKVKEG
P g  IAALEGLKGENEDETTGIEIVKRAIEEPLRQIVANAGKEGAVMVQKVKEG
P i  QEVLKVLTGENPDEQTGINIVCRAIEEPLRQIVYNAGGEGAVWNKVREG
P I IPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQS
C on  L— L-GENED G I - I — R A -E -P L R Q IV -N A G -E G -V -V -K V K -G
A a EGNFGYNAGTEQYGDMIAMGILDPTKVTRSALQFAASVAGLMITTECMVT
E C DGNYGYNAATEEYGNMIDMGILDPTKVTRSALQYAASVAGLMITTECMVT
B f  TGAFGYNARTDVYEDLS EAGVVD PAKVTRIALENAASIAGMFLTTECWA
P g KDD FGYNARTDVFENLYTTGVIDPAKVTRVALENAASIAGMFLTTECVIA
P i  KGD FGYYARRDQYEDLRAAGVIDPAKVS RVALENAASIAGMF------------------
PI SSEVGYDAMAGDFVNMVEKGIIDPTKWRTALLDAAGVASLLTTAEVWT
Con -G-FGYNA-T— Y------ G— DP-KVTR-AL— AAS-AG-- TTEC-V-
A a ELPKDDKADLGAA-GMGGMGGMGGMM
E c DLPKNDAADLGAAGGMGGMGGMGGMM
B f  DKEEEAPAPPMNP- GMGGMGGMM
P g DKKEDNPAAPAMPGGMGGMGGMM
pi -----------------------
P I  E IP K E E K D P-- GMGAMGGMGGGMGGGMF
C on ---------------A ------------ GMGGMGGM------------
FIGURE 4.9. Evolutionary' tree based on hsp60 sequences
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Figure 4.9. Evolutionary tree based on hsp60 sequences (Gupta, 1995). The 
tree was rooted using the Tcp-1 protein (hsp60 homologue) from Sulfolobus 
shibatae. The numbers 1 to 6 identify different groups of sequences 
corresponding to p- and y-purple bacteria (1), a :purple bacteria (2), 
mitochondrial homologues (3), spirochaetes, chlamydia and P: gingivalis (4), 
chloroplasts and cyanobacteria (5) and Gram-positive bacteria (6).
FIGURE 4.10. Hsp60 phylogenetic tree incorporating B. forsythus
sequence.
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Figure 4.10. Molecular phylogenetic tree deduced from analysis of the 
nucleotide sequences of hsp60 sequences from 9 different species; Escherichia 
coli, Actinobacillus actinomycetemcomitans, Pseudomonas aeruginosa, 
Mycobacterium paratuberculosis, Bacteroides forsythus, Porphyromonas 
gingivalis, Leptospira interrogans, Helicobacter pylori and human mitochondrial 
protein P1 (hsp60 homologue). The tree was built by maximum likelihood 
criteria with the programs Puzzle (Version 4.0.2) and the Tree.View (1.5). The 
numbers give the quartet puzzling reliability (support values) for the internal 
branches. The length of the horizontal branches is proportional to the numbers 
of nucleotide substitutions.
Representative species from different bacterial groups identified by Gupta (Fig. 
4.9) were chosen for comparison to B. forsythus hsp60. As seen here, the 
newly identified hsp60 gene is most closely related to the periodontal organism 
P. gingivalis in this tree.
CHAPTER 5
Expression of B . f o r s y t h u s  hsp60 in a prokaryotic vector 
system and purification of recombinant protein
INTRODUCTION
The hsp60s are widely held to be efficacious stimulators of immune reactions, 
as evidenced by the accumulating literature that documents hsp60-reactive T 
and B lymphocytes from patients with a wide range of different diseases and 
infections (Haregewoin et a/; 1989; Tsoulfa et al, 1989; De Graeff-Meeder et 
al, 1990, 1991; Kaufmann, 1990; Kaufmann etal, 1991; Fu etal, 1993; 
Astarloa e ta l; 1996; Coates, 1996; Gruber etal, 1996; Krenn etal, 1996; 
Peeling et al, 1997; Portig etal, 1997; Rudolphi etal, 1997; Warr etal, 1997 
Lemos et al, 1998). Some workers have also found that apparently healthy 
subjects can also carry hsp60-reactive immune components (Munk et al,
1988, 1989; Handley et al, 1996) but it may be that these antibodies have 
persisted from a response to a previous infection and are still circulating in 
detectable amounts. Either way, the human immune potential against hsp60 
has yet to be fully determined, as has the significance of this immune 
response and its possible role in pathogenicity.
Recently, several workers have measured antibody titres to hsp60 in an 
attempt to define patient sub-populations in large disease groups such as 
arteriosclerosis and cardiomyopathy. As smaller sub-populations are better 
characterised, so too can therapy be better targeted, with increased specificity 
improving efficacy (Gruber etal, 1996; Prakken etal, 1996; Portig etal, 1997). 
Notably, Schett et al (1997) suggested that salivary anti-hsp60 could be used 
as a diagnostic marker for gingivitis. Testing periodontitis and gingivitis patient 
groups along with healthy controls, they found that all the groups carried anti- 
hsp60 antibodies in their sera, but that high concentrations of antibodies 
against a cross-reactive hsp60 epitope were found only in the sera from
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gingivitis patients. As B. forsythus has been implicated in particular forms of 
periodontitis, including recurrent periodontitis (Lai e ta l, 1987; Gersdof etal, 
1993; Gu et al, 1997), it may be that antibodies specific for B. forsythus hsp60 
could be used diagnostically to predict which patients may be more likely to 
suffer from recurrent disease. Similar to this idea, Prakken et al (1996) have 
shown that antibodies to hsp60 in the serum of patients with oligoarticular 
juvenile rheumatoid arthritis predicted disease remission.
Some data exists which indicates that particular strains of B. forsythus have 
developed a level of antibiotic resistance (van Winkelhoff et al, 1997). As 
antibiotic resistance has become an unavoidable evolutionary consequence, 
albeit one forced by man, it is now accepted that as the use of current 
antibiotics will inevitably decline, antibacterial drugs will take the form of highly 
targeted vaccines and other modulators of our own immune response. The 
hsp60 proteins offer themselves as an attractive candidate target for such 
developments. Their immunogenicity is well recognised, and their ubiquity and 
conservation proffers the advantage of mass characterisation which will allow 
the rapid identity of species-specific epitopes from virtually any infectious 
bacterial species. A vaccine against such a peptide fraction could be 
accurately targeted to specific bacterial agents, could produce a rapid and 
strong immune response and could eliminate a protein known to be essential 
for cell viability. Alternatively, it has been suggested that a dampening down of 
our immune responses to hsp60s in localised sites of autoimmune disease 
may be sufficient to break a cycle of spiralling hsp60 production by human 
cells and hsp60 antibody attack that results in tissue destruction common to 
autoimmune diseases (Cohen and Young, 1991). The dampening effect would
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be best achieved by modulating the regulators of anti-hsp immune responses. 
Such regulators could be anti-idiotypic T cells that recognise the antibodies 
that bind commonly conserved hsp60 epitopes. As anti-idiotypic T cells are 
already thought to be part of the regulatory process we possess to control anti- 
hsp reponses and prevent them from escalating into systemic autoimmune 
processes (Cohen and Young, 1991), there would be limited harm in 
introducing a population of these cells at a localised site of autoimmune 
disease, and their effect would only be consequential where levels of hsp60 
antibody populations were highest.
With this wealth of potential follow-on work, it was a necessary first step to 
synthesise working amounts of the B. forsythus hsp60 to allow preliminary 
characterisation of the protein. The production of purified B. forsythus hsp60 
protein may be used to raise antibodies, and to determine regions of the 
protein homologous to other hsps previously characterised.
There are two main techniques which could be utilised to produce purified B. 
forsythus hsp60 protein. The first technique involves isolating the protein from 
pure cultures of B. forsythus naturally expressing hsp60. Hinode et al (1996) 
detailed a procedure specifically for isolating hsps from periodontopathogenic 
bacteria. Their technique is based on previous work which has purified hsps 
via use of their ability to bind substrates such as adenosine 5’-triphosphate 
(ATP) (Khandekar et al, 1993). Hinode’s method isolated proteins under 
denaturing conditions by binding hsp60 from heat-stressed cell cultures to ATP 
agarose columns and then eluting the protein with low concentration ATP. 
Other workers who have used this ATP-binding affinity of hsp60 proteins to 
allow purification used high performance liquid chromatography (HPLC)
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systems (Khandekar et al, 1993; Jindal et al, 1994). This confers the 
advantage of purifying protein in its native form, but incurs the disadvantage of 
the high cost of HPLC systems. Hinode succeeded in producing purified hsp60 
proteins from A. actinomycetemcomitans, P. gingivalis and B. forsythus 
without using HPLC, although the yield of B. forsythus hsp60 was low. Nakano 
et al (1995) purified the hsp60 protein of A. actinomycetemcomitans from a 
liquid culture of the bacterium using DEAE-sepharose and hydroxyapatite 
chromatography.
The second method, chosen for this study, is to clone the gene encoding the 
protein to be expressed into a vector expression system, and then transform 
this into host cells capable of expressing the protein. Thus eukaryotic cells, for 
example yeasts, should be used to synthesise protein from the coding 
sequence of eukaryotic genes, whilst bacterial species such as E. coli and B. 
subtitlis can be utilised to produce exogenous prokaryotic proteins. Typically, 
these systems have been engineered such that an element of inducer control 
is present to switch on production of the foreign gene. The expression vector 
carries a suitable antibiotic resistance gene to allow the selection of 
recombinant transformants, and the gene insertion site on the plasmid is 
proximal to a tag that is co-expressed with the protein to allow purification. 
Various systems are currently available for the affinity purification of such 
recombinant proteins. Most rely on the affinity of an immobilised ligand for the 
tag on the protein of interest. For example, some systems use immobilised 
antibody ligands or proteinaceous affinity tags such as (3-galactosidase 
(Horner, 1996) to bind and purify recombinant protein from the sample. The 
disadvantages of having a large proteinaceous tag are that the tag is only
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functional in its native form, which stipulates that the protein of interest must 
be isolated under native conditions. This purifies a protein that retains its 
correct structure and functional properties, but can be limiting in that over­
expressed protein in prokaryotic vector systems often have to be purified 
under denaturing conditions to increase their solubility. Also, the protein affinity 
tags can be highly antigenic and can interfere with measures of the purified 
protein’s biological activity. Thus, the tags have to be removed and the protein 
re-purified before the antigenicity of the protein can be validated.
As an alternative to this, 6x histidine (His) affinity tags have been developed. 
These protein tags are small, uncharged and non-antigenic, and therefore do 
not interfere with the activity of the recombinant protein. The 6x His tag can 
also be used to purify proteins under denaturing conditions. The 6x His system 
has been used before to isolate hsp60 protein from human mitochondria 
(Handley et al, 1996).
This chapter describes the cloning of B. forsythus groEL into an expression 
vector, and over-expression of the protein product in E. coli. The recombinant 
protein was purified by use of immobilised metal affinity chromatography to a 
nickel ion resin. Although the yield of purified protein was low, the protein 
isolated reacted with anti-hsp60 monoclonal antibodies.
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MATERIALS AND METHODS 
Construction of recombinant plasmid
The B. forsythus hsp60 gene previously generated by PCR (Chapter 3) was 
cloned into pBAD-TOPO (Invitrogen), a prokaryotic vector system for the 
expression of PCR products. Expression of this vector in E. coli is regulated by 
arabinose, with expression from the ara BAD promoter (P b a d )  being turned on 
in the presence of arabinose. Only very low levels of transcription from P Bad  
occur in the absence of arabinose.
The cloning site of pBAD-TOPO contains a polyhistidine region which encodes 
a metal-binding domain. This allows affinity purification of recombinant fusion 
protein by immobilised metal affinity chromatography (IMAC) using a metal- 
chelating resin.
The B. forsythus hsp60 gene was amplified by PCR using Taq DNA 
polymerase. This enzyme causes the PCR product to have a 3’ A overhang, 
which enabled annealing to the corresponding 3’ T overhang on linearised 
pBAD-TOPO vector. Essentially this permits directional cloning of the PCR 
product into the vector, such that the 6x histidine tag is attached at the 3’ end 
of the gene (ie at the carboxyl terminus of the protein). The vector was 
supplied in a kit containing other components required for the reactions. These 
are the same as those listed in Chapter 3 except that this plasmid was 
provided with TOP10 One Shot™ competent cells for transformation. This 
strain allows blue/white screening without addition of IPTG to the agar 
medium.
The protocol for the cloning reactions was the same as for cloning into the 
pCR2.1-TOPO vector, as described in Chapter 3. Samples of the
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transformation reaction were spread on LB-agar plates containing ampicillin, 
as previously described.
Analysis of recombinant clones
Small-scale preps of recombinant clones were obtained using the boiling 
method. Plasmids were analysed by simultaneous digestion of 10pl of the 
resuspended plasmid prep with restriction enzymes BamHI and Sacl. This 
enabled the orientation of the insert to be determined.
Induction of fusion protein synthesis and optimisation of conditions
Clones with inserts in the correct orientation were selected. A pilot study was 
performed to optimise the arabinose concentration required for maximum 
expression of the recombinant protein. Five tubes containing 10 ml L-broth and 
100pg/ml
ampicillin were each inoculated with 0.1ml of an overnight culture of the 
selected clone. The cultures were incubated in an orbital shaker at 37°C and 
200rpm until they attained an OD6oo of 0.5.
During this time four 10-fold serial dilutions of a 20% arabinose stock solution 
(provided in the pBAD-TOPO kit) were prepared in dH20.
When the cultures had reached an OD6oo=0.5, a 1ml aliquot of sample was 
taken from each tube, pelleted by centrifugation (14,000 rpm, 30 sec), and the 
pellet stored at -20°C. These samples were the zero time points in the study. 
The series of arabinose dilutions was then added to the tubes of culture as 
follows:
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Arabinose dilution series
Tube Stock solution of 
arabinose
Vol. added (ml) to 
9ml culture
Final conc. Of 
Arabinose
1 0.002% 0.09 0.00002%
2 0.02% 0.09 0.0002%
3 0.2% 0.09 0.002%
4 2.0% 0.09 0.02%
5 20.0% 0.09 0.2%
The cultures were mixed with the inducer and incubated at 37°C with shaking 
for 4 hours, after which time 1 ml samples were taken and pelleted and stored 
as for the zero time point samples.
Preparation of samples
Prior to analysis by SDS-PAGE (see below), the zero hour and 4 hour samples 
for each arabinose concentration were prepared by resuspending each pellet 
in 100pl 1X SDS sample buffer (Table 5.1). Each sample was incubated on a 
95°C heating block for 5 min and 10pl samples loaded onto the SDS gel for 
electrophoresis. The remainder of the samples were stored at -20°C.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS- 
PAGE)
SDS-PAGE gels were composed of a 12% acrylamide separating gel and 4%
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stacking gel. Components of the gel mixes are shown in Table 5.1. SDS- 
PAGE was performed on a vertical Mini-Protean® II Dual Slab Cell (Bio-Rad) 
following the manufacturer’s instructions. The separating gel was poured to a 
level 1 cm below the bottom of the well-forming comb, and overlayed with a 
layer of 100% isopropanol to smooth the upper surface of the liquid gel. The 
gel was left to polymerise for 1 hour, and the isopropanol then rinsed off with 
distilled water. The stacking gel was poured on top of the separating gel, and 
the well forming comb put into place. This was left to polymerise for 1 hour 
before the gel was installed in the buffer chamber. Gels were electrophoresed 
at 200V in 1X running buffer for 45 min, until the dye front of the samples 
reached the bottom of the gel. On completion of electrophoresis the unit was 
dismantled and the gel stained with Coomassie Blue (Table 5.1) for 1 hour. 
The gel was then destained (Table 5.1) for 2 hours, until the background 
staining was reduced sufficiently for bands to be clearly visible.
Purification of fusion products using ProBond™ resin
The six histidine residues expressed at the carboxyl terminus of the 
recombinant protein have a high affinity for ProBond™ resin (Invitrogen). Once 
bound, the protein could be eluted from the resin by washing with an imidazole 
pH gradient under native conditions. Protein was purified following a protocol 
outlined by the resin manufacturers in “Xpress™ System Protein Purification”. 
Other buffers required for the procedure were made as detailed in Table 5.2.
i) Preparation and pre-equilibration of ProBond™ columns
The resin was fully resuspended by inverting and tapping the bottle, and 2 ml
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applied to a 5ml centrifuge tube. The resin was packed in the tube by 
centrifuging at 800Xg for 2 min in a MSE benchtop centrifuge.
The buffer was aspirated without disturbing the packed resin, and the resin 
resuspended in 7ml sterile water. Resin was packed by centrifugation as 
before. The water was aspirated and the resin washed 3 times in 7ml Native 
Binding Buffer (Table 5.2) by resuspending and centrifuging as previously 
described.
ii) Preparation of bacterial cell lysates and sample application
A 50ml culture of transformed bacteria carrying the plasmid bearing the 
recombinant protein was prepared by inoculating 50ml L-broth (containing 
100jng/ml ampicillin) with 50jul glycerol stock of bacteria. This was incubated 
overnight at 37°C whilst shaking at 200 rpm. The following day, the optical 
density of the culture was measured and adjusted to an OD6oo=0.5. The 
culture was then induced with the optimum concentration of arabinose, which 
had previously been determined as 0.02% arabinose (final concentration). The 
culture was incubated for a further four hours. The cells were then harvested 
by centrifugation at 5000rpm for 5 min in a Sorvall SS-34 rotor. The pellet was 
resuspended in 10ml Native Binding Buffer (Table 5.2), egg white lysozyme 
added to 100|ig/ml, and the sample incubated on ice for 15 min. The cells 
were lysed by sonication and rapidly freeze-thawed 3 times by alternately 
freezing the sample at -80°C and then warming at 37°C. Insoluble debris was 
removed from the lysate by centrifuging at 3000Xg for 15 min, and the clear 
supernatant maintained at -20°C until use. The protein to be purified from the 
lysate was bound to the resin by resuspending the pre-equilibrated resin with
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two 5ml aliquots of the lysate. The resin was resuspended in 5ml lysate and 
gently rocked for 10 min to prevent the resin packing. The sample was 
centrifuged at 800Xg, supernatant removed and the resin resuspended in the 
remaining 5ml lysate as previously described.
iii) Column washing and protein elution under native conditions
The resin (with bound protein) was washed three times with 4ml Native 
Binding Buffer by resuspending the resin in the buffer, rocking gently for 2 min 
and then centrifuging at 800Xg for 2 min to separate the resin from the 
supernatant. The resin was then washed three times with 4ml Native Wash 
Buffer (Table 5.2) in the same way.
To elute the bound protein, the resin was sequentially resuspended in elution 
buffers of increasing imidazole concentration. The resin/buffer mix was rocked 
for 5 min prior to centrifugation, and the supernatants stored at -20°C. Prior to 
SDS-PAGE analysis, the samples were concentrated in an Amplicon unit. 5ml 
samples were reduced to ~0.5ml.
Protein purification using TALON™ Metal Affinity Resin
TALON resin (Clontech, UK) is a cobalt-based IMAC resin for the purification 
of 6x His proteins. A protocol utilising TALONspin columns to isolate 
recombinant protein under denaturing conditions was followed.
i) Sample preparation
A 25ml culture of pBAD-TOPO carrying the B. forsythus hsp60 gene was 
established. The culture was induced with 0.02% (final concentration)
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arabinose as previously described.
Cells were harvested by centrifuging at 2000Xg for 15 min at 4°C. The isolated 
pellet was resuspended in 2ml lysis buffer (Table 5.3), stirred and sonicated 
until the viscosity of the suspension was reduced. The sample was centrifuged 
at 10,000Xg for 20 min to pellet insoluble material. The supernatant, which 
was cloudy but not opaque, was transferred to a clean tube.
ii) TALONspin column purification
A TALONspin column was held upright, and flicked until the resin settled in the 
bottom of the column. A breakaway seal at the bottom of the column was 
snapped off, and the column placed in a 1.5ml microcentrifuge tube. The clear 
top lid of the column was removed, and the tubes spun in a microcentrifuge at 
700Xg for 2 min. The column was removed from the centrifuge tube, and a 
cap placed over the nozzle at the bottom of the column. 1ml of the cell 
preparation was applied to the column, and once the resin bed was thoroughly 
wet (after 30 sec) the contents were briefly vortex-mixed to resuspend the 
resin, and gently rocked for 5 min to allow the 6x His protein to bind to the 
resin. Both caps were removed from the column, and then centrifuged as 
before. The eluate was discarded. The cap was replaced on the bottom 
nozzle, and 1ml of pH 7.0 wash buffer (Table 5.3) applied. The resin was 
soaked by the wash buffer, and resuspended and gently rocked as previously. 
Both caps were removed again, and the column centrifuged at 700Xg for 
2min. This wash was then repeated.
Once it had been ascertained that the resin was semi-dry after centrifugation, 
the bottom nozzle was capped and 500pl elution buffer containing 20mM
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PIPES applied (Table 5.3). The resin bed was soaked for 1 min in the elution 
buffer, prior to the resin being resuspended by briefly vortexing. Both column 
caps were removed, and the column placed in a clean 1.5ml microcentrifuge 
tube. This was centrifuged at 700Xg for 2 min, and the eluate retained. The 
elution step was repeated with another 500jnl of elution buffer. The resulting 
1ml of purified protein was stored at -20°C until analysed by SDS-PAGE and 
Western blotting.
Western blotting
Following SDS-PAGE of samples, six pieces of Whatman 3MM paper and a 
piece of 0.45pm nitrocellulose filter paper were cut to the same size as the gel. 
It was important that the papers and gel were all of the same size to prevent 
short-circuiting of the electro-blotting apparatus. The Whatman paper and 
nitrocellulose membrane were equilibrated in transfer buffer for 5 min at room 
temp. The top left corner of the nitrocellulose was marked with a soft lead 
pencil to allow for later orientation of the blot.
On a clean, flat surface, three pieces of the wet Whatman paper were stacked, 
and the gel carefully placed on top of this pile. It was ensured that there were 
no air-pockets between the gel and the paper. The nitrocellulose membrane 
was layered on top of the gel, and the membrane gently rolled over with a 
sterile 10ml pipette to remove air-pockets. The remaining three pieces of 
Whatman paper were put on top of the pile.
The entire ‘gel sandwich’ was place onto the graphite plate of an electro­
transfer unit. The electrode cassette was assembled by placing another 
graphite plate on top of the gel sandwich. Electro-transfer was performed at
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low voltage (1-1OV), 40mA for 90 min. After this time, the apparatus was 
disconnected and the gel sandwich carefully peeled apart. By using pre­
stained molecular weight markers, it could instantly be ascertained that 
transfer had taken place successfully when the markers could be seen on the 
nitrocellulose membrane.
Blotting procedure
All washes took place by agitating on a rocking platform at room temp. Buffers 
and solutions used throughout this procedure are listed in Table 5.4.
1. The nitrocellulose filter was placed in a clean glass dish and blocked with 
blocking buffer for 30 min.
2. The blocking buffer was poured off, and the nitrocellulose washed in 
washing solution for 10 min.
3. Primary antibody (anti-groEL, IgG raised in rabbit) was diluted as required in 
blocking buffer. Typically 15ml of antibody solution was applied. The primary 
antibody was allowed to bind for 2 hours.
4. The antibody solution was poured off. The filter was rinsed with 3x10 min 
washes of 15ml washing solution.
5. The filter was transferred to a clean dish. Secondary antibody (anti-rabbit 
IgG), diluted in 15ml blocking buffer, was applied for 2 hours.
6. Secondary antibody was poured off, and the filter washed as at step 4.
7. Bound antibody was detected using freshly made detection solution (15ml). 
The filter was left in the detection solution in a dark place for 30-45 min.
8. The reaction was stopped by washing the filter in water for 5 min. The filter 
was then blotted dry and stored in a sealed plastic bag.
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Table 5.1: SDS-PAGE stock solutions, gel mixes and buffers
1.5M Tris-HCI, pH 8.8 
Tris base 27.23g
dH20 to 150ml
Adjust to pH 8.8 with 1N HCI
0.5M Tris-HCI, pH 6.8 
Tris base 6g
dH20  to 100ml
Adjust to pH 6.8 with 1N HCI
10% sodium dodecyl sulphate (SDS)
dH20  to 100ml
12% Separating gel 
30% acrylamide/bis-acrylamide 4.0ml 
1.5M Tris-HCI pH 8.8 2.5ml
10% SDS 100pl
dH20  3.35ml
10% APS (freshly prepared) 50pl
TEMED 5|il
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Table 5.1 (continued)
4% Stacking gel
30% acrylamide/bis-acrylamide 1.3ml
0.5M Tris-HCI pH 6.8 2.5ml
10% SDS 100pl
dH20  6.1ml
10% APS (freshly prepared) 50pl
TEMED 10pl
5X Running buffer stock 
Tris base 3.75g
glycine 18.0g
SDS 1.25g
dH20  to 250ml
Sample buffer
0.5M Tris-Hcl pH 6.8 1.0ml
glycerol 0.8ml
10% SDS 1.6ml
p mercaptoethanol 0.4ml
0.05% (w/v) bromophenol blue 0.2ml
dH20  4.0ml
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Table 5.1 (continued)
Coomassie blue
Coomassie blue R-250 0.5g
methanol 200ml
acetic acid 50ml
dH20  to 500ml
Destain
methanol 200ml
glacial acetic acid 50 ml
dH20  to 500ml
Table 5.2: Pro Bond™ resin purification reagents and buffers
Stock solution A (10X)
monobasic sodium phosphate (NaH2P0 4 ) 27.6g
sodium chloride 292.2g
dH20  to 1 litre
Stock solution B (10X)
dibasic sodium phosphate 28.4g
sodium chloride 292.2g
dH20  to 1 litre
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Table 5.2 (continued)
3M Imidazole stock buffer (1 OX) 
imidazole 20.6g
stock solution A 8.77ml
stock solution B 1.23ml
dH20  to 100ml
Adjust to pH 6.0 with HCI or NaOH as necessary.
Native Binding Buffer 
1X Stock solution A 2.9ml
1X Stock solution B 47.1 ml
Adjust to pH 7.8 using 1X Stock solution A to lower and 1X Stock solution B to 
raise the pH.
Native Wash Buffer
1X Stock solution A 37ml
1X Stock solution B 13ml
Adjust to pH 6.0 using 1X Stock solution A to lower and 1X Stock solution B to 
raise the pH.
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Table 5.2 (continued)
Imidazole Elution Buffers
Four imidazole gradient elution buffers were formed by combining volumes of 
Native Wash Buffer and 3M Imidazole Stock Buffer as below:
3M Imidazole Wash Buffer
50mM 0.08ml 4.92ml
200mM 0.33ml 4.67ml
350mM 0.58ml 4.42ml
500mM 0.83ml 4.17ml
Table 5.3: TALONspin column purification buffers
Lysis buffer pH8.0
Reagent Final concentration Amount for 50ml soln.
NaH2P04 (pH 8.0) 50mM 0.35g
Tris-HCI (pH 8.0) 10mM 0.5ml
Urea 8M 24g
NaCI 100mM 0.29g
Adjust final pH to 8.0
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Table 5.3 (continued)
Wash buffer
Reagent Final concentration Amount for 50ml soln.
NaH2P04 50mM 0.35g
Urea 8M 24g
NaCI 100mM 0.29g
Adjust final pH to 7.0 
Elution buffer
Reagent Final concentration Amount for 50ml soln.
NaH2P04 50mM 0.35g
Urea 8M 24g
PIPES 20mM 0.30g
NaCI 100mM 0.29g
Adjust final pH to 6.0
Table 5.4: Western blot buffers and solutions
Transfer buffer
Reagent Final concentration Amount for 1 litre soln
Tris-HCI (pH 8.0) 25mM 3.0g
Glycine 192mM 14.4g
Methanol 20% 200ml
Adjust final pH to 8.3.
132
TNT
Table 5.4 (continued)
Reagent Final concentration Amount for 1 litre soln
Tris-HCI (pH 8.0) 10mM 10ml
NaCI 150mM 8.76g
Tween 20 0.05% 0.5ml
Blocking buffer
3% bovine serum albumin (BSA) in TNT
Washing solution 
0.1% BSA in TNT
Detection solution
66pl nitroblue tetrazolium salt (NBT) (75mg/ml stock) and 50pl 5-bromo-4- 
chloro-3-indolyl phosphate (X-phosphate, BCIP solution) (50mg/ml stock) in 
15ml 0.1 M Tris-HCI.
Antibodies
Anti-GroEL, IgG raised in rabbit (Sigma-Aldrich) (used at 1:10,000 dilution). 
Anti-rabbit IgG, raised in goat, alkaline phosphatase conjugate (Sigma-Aldrich) 
(used at 1:10,000 dilution).
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RESULTS
Construction, structure and mini-prep analysis of recombinant plasmids
The structure of the pBAD-TOPO plasmid used to express the B. forsythus 
hsp60 protein as a fusion with a 6x His tag is shown in Fig 5.1 .The resulting 
recombinant plasmid is referred to as pBADBf.
Mini-prep digestion analysis of recombinant plasmids determined the 
orientation of the hsp60 gene insert. The fragment sizes resulting from BamHI 
and Sacl digestion of a recombinant plasmid with the gene in the correct 
orientation were predicted to be 5.4-kb, 0.2-kb and 0.1-kb. As the two smaller 
fragments would be too small to be visualised on an agarose gel, the digest 
products would essentially appear as one band. A gene inserted incorrectly 
would yield digestion fragments of 4.1 kb, 1.5kb and 0.1 kb, and this would be 
seen on the gel as two distinct bands. Restriction endonuclease digestion with 
EcoRI indicated that all the clones examined carried the hsp60 gene insert in 
the correct orientation for expression of the B. forsythus hsp60 protein.
Arabinose-induced expression of the fusion protein
The fusion protein product of pBAD Bf was expected to be approximately 
60kDa, as the 6x His tag was not of sufficient size to contribute significantly to 
the molecular weight of the fusion protein.
Expression of pBADBfwas subject to regulation by the inducer arabinose. In 
the absence of arabinose, expression from the ara BAD promoter occurs at 
very low levels (illustrated in Fig 5.2). The arabinose concentration needed for 
maximum expression of the vector was determined in an optimisation study 
(Fig 5.3). Following incubation with varying concentrations of arabinose,
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pBADBf cultures were processed and analysed via SDS-PAGE and staining of 
the proteins contained in the gel. This confirmed that there was only very low 
expression of the fusion protein in the absence of arabinose. When arabinose 
concentrations were increased, synthesis of a ~60kDa protein increased 
proportionally. The optimised conditions required for maximal expression of 
the induced protein were found to be when the culture was incubated in the 
presence of 0.02% arabinose for 4 hours at 37°C (Fig 5.3). Levels of 
arabinose higher than this lead to a corresponding decrease in protein yield.
Verification of the identity of the induced protein by Western biotting
To confirm that the inducible, over-expressed protein identified in the 
expression study was the hsp60 protein, SDS-PAGE gels were repeated as 
above in duplicate. One gel was stained with Coomassie blue to verify the 
presence of the inducible protein. The other gel was Western blotted using a 
commercially available anti-GroEL (anti-hsp60) antibody as the primary 
detection antibody. As this antibody had been raised in rabbits, anti-rabbit IgG 
antibody was used as the secondary antibody that would bind to the primary 
antibody. Protein bands reactive with the anti-GroEL antibody can be seen in 
Fig 5.4, which correspond to the over-induced protein band seen on 
Coomassie blue stained gels.
A strongly labelled band was observed in the induced samples, which has an 
apparent molecular weight of 62-kDa. A much weaker band of similar size was 
also detected in the uninduced samples. It is most likely that this is the 
endogenous E. coli hsp60 which will be present in the host E. coli TOP10 
strain. The E. coli hsp60 is expressed constitutively and would undoubtedly be
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immunoreactive with the anti-GroEL antibody used in the screening process.
Purification of recombinant fusion protein using ProBond™ coiumns
Preliminary examination of protein purified using the ProBond columns 
indicated that it was necessary to concentrate the protein samples using an 
Amplicon unit before protein bands could be seen to bind anti-groEL.
However, even after the protein had been concentrated bands were still not 
very strong, as can be seen in Fig 5.5. The double banding pattern indicates 
that the hsp60 protein has either been co-purified with another, smaller 
molecular weight protein, or that the purified hsp60 has undergone some 
proteolysis resulting in the smaller fragment. The latter explanation is the likely 
cause of the secondary band, as it is also able to bind anti-groEL antibody. 
With the protein concentration so low, an alternative purification technique 
using TALONspin columns was utilised in an attempt to improve the yield.
Purification of recombinant fusion protein using TALONspin columns
B. forsythus hsp60 purified from TALONspin columns can be seen bound to 
anti-groEL in Fig 5.6. As seen in this figure, the molecular weight of the 
purified protein appears to be higher than was predicted, at approximately 
80kd. However, the ability of the purified protein to bind hsp60 specific 
antibodies and the inducibilty of this protein was taken as assurance of it’s 
identity. The optimum imidazole concentration for eluting the protein was 
200mM. However, as with the ProBond columns, the yield was still low.
136
DISCUSSION
When the whole cell lysates of induced cells expressing the recombinant B. 
forsythus hsp60 protein were blotted with anti-hsp60 antibody, it was apparent 
that the antibody was capable of binding to a range of protein bands smaller 
than the induced 62-kDa protein (Fig 5.4). Reviewing the available literature, 
similar multiple protein banding patterns have previously been observed with 
anti-hsp antibodies. Thole et al (1988) noted that the Mycobacterium bovis 65- 
kDa antigen appeared to be partially degraded to low molecular weight 
products when this protein was expressed in E. coli. This phenomenon was 
also recorded by a group working with hsp60 of Chlamydia trachomata 
(Horner, 1996), and it is possible that a similar situation arises when the hsp60 
protein of B. forsythus is expressed in E. coli. Even monoclonal antibodies 
raised against groEL homologues, which by definition are specific for only this 
antigen, have been seen to frequently cross-react with low molecular weight 
proteins or degraded protein fractions, resulting in the detection of several 
bands (Thole et al, 1988; Maeda et al, 1994; Ando et al, 1995; Nakano et al, 
1995). Young et al (1987) observed that monoclonal antibodies to the 65-kDa 
antigen of M. leprae frequently bound to bands of various molecular weights in 
Western blots. They suggested that the most likely origin of the multiple 
banding is that an original protein, ie. the 65-kDa hsp, undergoes progressive 
proteolytic digestion to produce multiple protein fragments, each possessing a 
subset of the total antibody binding sites of the intact protein. As they 
observed that antibodies against N-terminal epitopes bound the smaller weight 
fragments more readily than antibodies to C-terminal epitopes, it appears that 
the initial site of proteolytic cleavage is near the N-terminus of the hsp.
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Another factor to consider is the purity of the anti-GroEL preparation. The 
preparation used in this study was the polyclonal IgG fraction of rabbit 
antiserum which was formulated by repeated inoculation of rabbits with 
recombinant E. coli hsp60. Presumably, the rabbit’s immune system had had 
previous assaults by E. coli and would have raised antibodies to other E.coli 
antigens. These other antibodies would be present in the IgG fraction of the 
rabbit serum, and could be reacting with the endogenous E. coli antigens 
present in the cell lysates on the SDS gel. This problem may be partially 
overcome by pre-absorbing the anti-GroEL with E. coli, although this was not 
an option available in the current study as pre-absorption of the anti-groEL 
with disrupted E. coli, to reduce background binding, would simultaneously 
prevent any reactivity of the anti-hsp antibodies with B. forsythus hsp60.
The proteolysis of cellular proteins by bacteria that express digestive enzymes 
is a recognised problem with regards to the interpretation of SDS-PAGE 
analysis of whole cell proteins (Weidner et al, 1996). Proteolysis of protein 
samples prior to SDS electrophoresis can result in greatly varying banding 
patterns within species, the diversity of which cannot be attributed to 
differences in bacterial strains or growth conditions alone. If proteolysis of 
samples is extensive, high molecular weight bands can disappear and diffuse 
smears in the low molecular weight part of the gel may materialise. Proteolysis 
of cellular proteins can occur once bacterial cells are solubilised in SDS 
sample buffer. Treatment of cells with trichloroacetic acid or low pH buffer 
(pH<4) prior to SDS analysis can prevent degradation of cellular proteins. 
Alternatively, specific protease inhibitors can be used to treat cells if it is 
desired that the proteins should not be denatured. Weidner (1996) also
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suggested that the proteolytic inhibitor be used during protein purification 
procedures or cell fractionation.
Proteolysis of the expressed B. forsythus hsp60 recombinant by endogenous 
E. coli proteases may offer some explanation as to why recombinant B. 
forsythus hsp60 was only purified in small amounts. As mentioned above, 
Young et al (1987) had evidence to suggest that proteolysis of hsp60 
molecules was initiated at the N-terminal end of the molecule. An alternative 
explanation is that a cloning anomaly occurred which altered the reading frame 
of the S. forsythus hsp60 gene. However, it is unlikely that such a chance 
occurrence is the explanation for the poor protein yield seen in this study, as 
SDS-PAGE analysis of the recombinant expression products shows an 
inducible gene of the correct size (Fig 5.3).
Another potential problem may be the nature of the protein that attempts were 
made to isolate. Hsp molecules, due to their function as protein chaperones, 
naturally have a high binding affinity for a diverse range of cellular proteins.
The hsp60 of B. forsythus, once expressed in E. coli, may be of sufficient 
similarity to endogenous E. coli hsp60 to recognise and bind other E. coii 
proteins. This would increase the size, and possibly the structural formation 
and solubility of the recombinant 8. forsythus hsp60, and the protein would not 
be able to be purified using the procedures outlined in this chapter.
As it appeared that some small amount of purified protein was being purified, it 
would seem that the protein was being co-expressed in the correct reading 
frame with the 6x His tag, but that a post-transcriptional event was taking 
place which hindered isolation of higher yields. This could either be due to 
proteolysis of the recombinant protein that removed the tag, in which case the
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recombinant hsp60 would not be able to bind to the affinity chromatography 
resin, or due to it binding an endogenous E. coli protein causing the B. 
forsythus hsp60 to adopt a non-soluble format that is incompatible with the 
purification procedures used here.
As the protein was isolated in small amounts, it was decided that there was an 
insufficient amount of the purified recombinant available to advocate testing 
the antigenicity of the protein by the ELISA method. The protein also appeared 
to have co-purified with at least one other protein, thus conferring no 
advantage to using the purified preparations over whole cell lysates. It was 
therefore decided to proceed with the antigenicity studies that had been 
planned for purified B. forsythus hsp60 by screening whole cell lysates of 
induced transformants over-expressing B. forsythus hsp60 by the Western 
blotting method. This is described in Chapter 6.
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FIGURE 5.1. Plasmid map and features of pBAD-TOPO.
PCR Product
V5 epitope j(His)6 5StopEK Site
pBAD-TOPO, 
4.1 kb
Figure 5.1. Plasmid map and features of pBAD-TOPO. The map above shows 
features of the plasmid pBAD-TOPO which permits five-minute cloning of Taq 
polymerase amplified PCR products for regulated expression in E. coli. The 
metal binding domain encoded by the polyhistidine tag ((His)6) allows 
purification of recombinant protein by immobilised metal affinity 
chromatography.
Copyright 1997 Invitrogen Corporation, Carlsbad, CA, USA. All rights reserved. 
Used by permission.
FIGURE 5.2. Protein expression regulated by arabinose.
Protein expression regulated by arabinose. In the presence of arabinose 
expression from P Bad is turned on while the absence of arabinose permits 
only low levels of transcription from the P Bad promoter. Briefly, the regulatory 
functions as described below:
AraC dimer
No transcript ion
+ arabinose
Transcript ion
The araBAD promoter used in pBAD-TOPO is both positively and negatively 
regulated by the product of the araC gene, a transcriptional regulator. In the 
absence of arabinose the AraC dimer contacts the O2 and \^ \ sites of the 
araBAD operon, forming a DNA loop which prevents transcription. When 
arabinose is supplied, arabinose forms a complex with AraC and causes the 
regulator to release the 0 2 site due to a conformational change of the 
regulator, and binds the l2 site adjacent to the \^  site instead. This relaxes the 
DNA loop and permits transcription (Ogden et al, 1980).
FIGURE 5.3. Arabinose induction of recombinant B. forsythus hsp60
expression.
Figure 5.3. SDS-PAGE gel stained with Coomassie blue. Arabinose induction 
of recombinant B. forsythus hsp60 expression.
Molecular weight marker* (lane 1), recombinant culture induced with 
0.00002% arabinose, t=0 (lane 2), induced with 0.00002% arabinose, t=4 
hours (lane 3), induced with 0.0002% arabinose, t=0 (lane 4), induced with 
0.0002% arabinose, t=4 hours (lane 5), induced with 0.002% arabinose, t=0 
(lane 6), induced with 0.002% arabinose, t=4 hours (lane 7), induced with 
0.02% arabinose, t=0 (lane 8), induced with 0.02% arabinose, t=4 hours (lane 
9), induced with 0.2% arabinose, t=0 (lane 10), induced with 0.2% arabinose, 
t=4 hours (lane 11). The expression of a novel protein can be seen as the 
arabinose level increases (marked with the yellow arrows). The optimum 
arabinose concentration for expression of this inducible protein was taken to 
be 0.02% (lane 9), as this concentration produced the strongest inducible 
protein band as compared to other concentrations of arabinose.
1 2 3 4 5 6 7 8 9 10 11
*107-, 76-, 52-, 33-, 27-, 19-kDa.
FIGURE 5.4. Expression of recombinant B. forsythus hsp60, Southern
blotted with anti-groEL.
Figure 5.4. Recombinant protein expression was induced with arabinose, and 
electrophoresed proteins transferred to hybridisation membrane. Transferred 
protein was probed with commercially available anti-groEL (diluted 1:10,000). 
Recombinant B. f. hsp60 in E. coli TOP10 induced with 0.02% arabinose, t=0 
(lane 1), recombinant B. f.hsp60 induced with 0.02% arabinose, t=4 hours 
(lane 2), recombinant B. f. hsp60 induced with 0.2% arabinose, t=0 (lane 3), 
recombinant B.f. hsp60 induced with 0.2% arabinose, t=4 hours (lane 4).
An induced protein reactive with anti-groEL can be seen in lanes 2 and 4 
(yellow arrows). Endogenous E. coli hsp60 has also been stained in all lanes 
(black arrows).
FIGURE 5.5. Recombinant B. forsythus hsp60 purified with ProBond
resin and eluted with imidazole.
1 2 3 4
Figure 5.5. ProBond purified recombinant B. forsythus hsp60 protein was 
transferred to hybridisation membrane and probed with commercially 
available anti-groEL (diluted 1:10,000).
Recombinant protein eluted with 500mM imidazole (lane 1), eluted with 
350mM imidazole (lane 2), eluted with 200mM imidazole (lane 3), eluted with 
50mM imidazole (lane 4).
FIGURE 5.6. Recombinant B. forsythus hsp60 purified using TALON
prep.
Figure 5.6. TALON purified protein was transferred to hybridisation 
membrane following electrophoresis and probed with commercially available 
anti-groEL (diluted 1:10,000).
TALON purified recombinant protein from arabinose induced culture (lanes 1 
and 2), recombinant B. forsythus induced with 0.02% arbinose, t=4 hours 
(lane 3), recombinant B.f. hsp60 induced with 0.02% arabinose, t=0 (lane 4). 
Pre-stained molecular weight markers in lane 5 are indicated.
CHAPTER 6
Immunoreactivity of B . f o r s y t h u s  hsp60 tested against 
healthy and chronic adult periodontitis serum
INTRODUCTION
Many bacterial hsp60s have been shown to be immunogenic proteins, including 
the groEL homologues of Salmonella typhl (Tang et al, 1997; Panchanathan et 
al, 1998), Streptococcus pyogenes (Lemos etal, 1998), Helicobacter pylori 
(Amini etal, 1996), Campylobacter jejuni (Wu etal, 1994), Chlamydia 
trachomatis (Domeika et al, 1998; Peeling et al, 1997; Taylor et al, 1990) and 
Mycobacterium species (Buchanan et al, 1987; Debruyn et al, 1987; Kolk et al, 
1984; Thole et al, 1988). Hsp60s are clearly the targets of the host immune 
reponse in a broad range of infections, which may be related to the abundance 
of these proteins expressed in cells subject to stress. Increased synthesis of 
hsps following stress frequently incurs a drop in total cell synthesis of up to 40% 
(Lemos et al, 1998). Buchmeier and Heffron (1990) showed that the groEL 
homologue is one of the most abundant proteins expressed by Salmonella 
typhimurium in infected macrophages, and as the macrophage is a major 
antigen-presenting cell this may contribute to the immunodominance of hsps of 
pathogenic bacteria.
The significant immunoreactivity of hsp60s and their possible role in infectious 
diseases has been substantiated by studies which detected the presence of 
antibodies against bacterial hsp60 in the sera of affected patients. Antibodies 
against a heat-inducible 65 kDa protein of S. pyogenes were detected in the 
sera of patients with rheumatic fever, mild streptococcal disease, systemic 
lupus erythematosous (SLE) and rheumatoid arthritis, but not in the serum from 
healthy control subjects (Lemos etal, 1998). The anti-streptococcal hsp60 
antibodies are thought to possess a high level of species specificity, due to the 
fact that the serum that recognised streptococcal cell lysates was unable to bind
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any protein from E. coli cell lysates. This was unusual, as it is generally 
assumed that most samples of human serum will bear antibodies to E. coli that 
has been previously encountered by the host. The observation of a specific anti- 
streptococcal hsp60 response by Lemos is partially verified by a previous study 
by Bahr et al (1990), which found that sera from patients with rheumatic fever 
showed no significant binding to hsp60 of E. coli, M. tuberculosis or human 
cells.
The sera of patients with typhoid fever has been shown to be reactive with the 
hsp60 antigen of S. typhi(Tange etal, 1997). Heat-induced whole-cell extracts 
of S. typhi were immunoblotted with sera from 12 patients with typhoid fever, 
and nine samples bound 58-, 68- and 88-kDa hsps. None of 10 healthy serum 
samples recognised the hsps. E. coli groEL monoclonal antibodies also 
recognised the induced S. typhi protein, suggesting that the S. typhi and E. coli 
groEL homologues share antigenic epitopes.
Autoantibodies to human hsp60 have also been reported for a range of 
diseases, including dilated cardiac myopathy (Portig et al, 1997) rheumatoid 
arthritis (Boog etal, 1992; DeGraeff-Meeder etal, 1990; Kaufmann etal, 1990) 
and atherosclerosis (Xu etal, 1993). It has been suggested that the 
autoantibodies to human hsp60 are often cross-reactive and may have been 
initially raised against an infectious agent such as E. coli (Handley et al, 1996), 
mycobacteria (Gruber et al, 1996) or C. trachomatis (Yi et al, 1993).
With regards to periodontitis, serum and salivary antibodies have been found to 
be reactive with hsp60 proteins of bacterial origin. Levels of anti-hsp60 salivary 
antibodies were significantly raised in gingivitis patients as compared to healthy 
and periodontitis samples, whereas serum antibody levels against hsp60 were
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raised in periodontitis patients (Schett et al, 1997). Antibody titres to hsp60 of P. 
gingivalis and human hsp60 have been shown to be elevated as compared to 
healthy serum samples (Ando et al, 1995; Maeda et al, 1994; Tabeta et al, 
1999).
Antibodies to hsp60 antigens may contribute to the pathogenesis of disease by 
a number of different means. As stress proteins are known to reside on the 
surface of resting or activated cells (Jarjour et al, 1990; Kaufmann, 1994; Soltys 
and Gupta, 1996), anti-hsp60 antibodies may have a direct cytotoxic effect on 
stressed cells, sustaining inflammation of localised tissue. Anti-hsp60 antibodies 
may also disrupt the physiological function of chaperonins and render cells 
more vulnerable to hostile environmental conditions. Such a scenario was 
demonstrated by Riabowol et al (1988) when heat shock was shown to be lethal 
to fibroblasts micro-injected with antibodies against hsp70. Stress proteins are 
thought to be presented to healthy individuals constantly, in order to maintain a 
homeostatic regulation of the immune response against hsps (Cohen, 1992). 
This idea is supported by the finding that naturally processed peptides 
presented by human gene products are homologous to endogenous stress 
proteins (Jardetzky etal, 1991). Interference of this MHC presentation of 
peptides by hsp-specific antibodies may disrupt the homeostasis and lead to 
autoimmune disease.
Some data exists which argues against the level and significance of serum 
antibody levels to both human and bacterial hsp60s (Jarjour et al, 1991) and 
discrepancies are reported between studies examining similar subjects (Latif et 
al, 1993; Portig et al, 1997). The results of the immunoblot assays discussed in 
this chapter can be influenced by a number of variables, such as choice of
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antigenic substrate, amount of antigen analysed per lane on SDS gels and the 
amount of antigen successfully transferred to nitrocellulose prior to blotting, 
dilution concentration and length of incubation of both primary and secondary 
antibodies used in the immunoblots, and methods used to visualise reactive 
protein bands. As these variables are not constant between different studies, 
the interpretation of any immunoblot results and the ensuing inferences derived 
from the results should be viewed with an awareness of these study 
inconsistencies.
This study was designed to investigate the potential reactivity of IgG antibodies 
in sera from patients with rapidly progressive periodontitis against the hsp60 of
8. forsythus. It was decided to measure this IgG response as significantly 
elevated levels of IgG antibodies against the main periodontal pathogens have 
been reported in all forms of periodontitis (Murayama eta l, 1988). One­
dimensional immunoblotting was used to detect the anti-hsp60 antibodies, a 
procedure deemed as one of the most sensitive screening methods available 
(Stott, 1989). Lysates of induced E. coli TOP10 carrying the plasmid pBAD Bf, 
which expresses the recombinant hsp60 protein of 8. forsythus, were used as 
the antigenic substrates in immunoblots. Although this substrate would naturally 
be contaminated with the endogenous hsp60 of E. coli, the hsp60 of 8. 
forsythus, by virtue of its over-expression, is easily distinguishable from the E. 
coli homologue as the strongest band visualised on SDS-PAGE gels.
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MATERIALS AND METHODS
BCA protein assay
i) Samples
Cultures of E. coli TOP10 harbouring the plasmid pBAD Bf, which contained the 
B. forsythus hsp60 gene cloned in-frame into the pBAD TOPO expression 
plasmid, were incubated in L-broth with 0.1 mg/ml ampicillin at 37°C and 200 
rpm in an orbital incubator until an OD600 of 0.5 was attained. 0.02% arabinose 
was added to half the culture and incubated as before for a further 3hr 30 min. 
The remainder of the culture was incubated similarly in the absence of an 
inducer. Following this, a 1ml sample from both cultures was pelleted in a 
benchtop microcentrifuge for 30 sec, and the pellet then resuspended in 100jul 
distilled water. 2pl, 5^1, and 10pl samples from each were removed for assay, 
and the measurements plotted against the protein standard curve to determine 
the protein concentration in the samples, and to ensure that each serum sample 
was used to screen a controlled and constant amount of protein.
ii) BSA standard curve
A solution of 2mg/ml BSA was prepared by solubilising 0.2g BSA in 100ml 
distilled water. The A and B reagents of the Bicinchoninic Acid (BCA) protein 
assay were mixed at a 50:1 ratio to make 20ml. 1ml of this reagent pre-mix was 
mixed with the following volumes of BSA solution to result in an increasing 
range of final protein concentrations:
145
Vol A:B pre­
mix
1ml 1ml 1ml 1ml 1ml 1ml 1ml 1ml 1ml
Vol BSA 
solution
0 0.5pl 1pl 2 pi 4pl 6pl 8pl 10pl 20 pi
Final protein 
concentration
0 lug 2pg 4pg 8pg I2pg 16pg 20pg 40pg
At the same time, the A:B pre-mix was mixed with samples of the induced and 
uninduced cultures as below:
Vol. A:B pre-mix 1ml 1ml 1ml
Vol. sample 2f.il 5pl 10pl
All samples, including those for the BSA standard curve, were incubated at 
60°C for 30 min and the OD562 measured. The OD measurements from the 
BSA samples were plotted against the final concentration of each sample, and a 
standard curve drawn through the points. For those OD values from the test 
culture samples that were found to lie on the curve, the protein concentration 
could be determined.
SDS-PAGE
SDS gels comprising of a 4% stacking gel with a 12% lower acrylamide gel 
were used in a Mini-protean ® II Dual Slab cell (Bio-Rad), as described 
previously.
Induced samples of pBADBf to be screened with patient serum were adjusted to
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O D 6oo=0.5. 1 ml of sample was pelleted in a benchtop microcentrifuge for 30 
sec. The pellet was resuspended in 10Opil sample buffer and heated at 95°C for 
5 min. 10pl of this suspension was loaded per lane, which corresponded to 
approximately 40pg protein per lane.
Western blotting
After electrophoresis of the induced whole cell fraction, proteins were 
transferred to nitrocellulose membrane as previously described. Following 
transfer, the nitrocellulose was cut into strips of one-lane width with a sterile 
scalpel so that each lane could be screened with a different serum sample. 
Each induced culture sample strip was Western blotted following the procedure 
detailed in Chapter 5. The primary antibody was serum collected from healthy 
or diseased patients, and was used at a 1:500 dilution in 5ml blocking buffer 
(Table 5.4). The secondary antibody was an anti-human IgG alkaline 
phosphatase conjugate, and was used at a 1:10.000 dilution in a 5ml volume. 
Serum samples and secondary antibody were both incubated with individual 
strips for 2 hours. Bound secondary antibody was detected with the same 
chromogenic substrate mix as described in Chapter 5 (Table 5.4).
Serum samples
i) Patient samples
Patients included in the study had no medical contra-indications and had not 
received dental treatment or antibiotics in the previous six months. An initial 
dental examination then followed which consisted of a full mouth periodontal 
charting using a Brodontic constant pressure probe (25g) and a radiographic
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examination with orthopantomograms. Only those patients diagnosed as 
suffering from chronic adult periodontitis were included in the study.
A control group consisting of 13 healthy subjects were matched for age (+/- 5 
yrs), sex and race. The subjects demonstrated no clinical evidence of existing 
or previous periodontal disease. On clinical examination there was less than 
20% bleeding on probing and no periodontal pocket depths greater than 3mm. 
Subjects with systemic disease, pregnancy, long term medication or antibiotics 
in the 6 months prior to examination were excluded. Serum was collected and 
assigned a code number in the same manner as for the experimental patients.
ii) Serum collection
Approximately 30ml of blood was taken. Blood was collected into glass tubes 
using the Vacutainer system. The sera was separated by coagulating the 
samples and centrifuging at 3000 rev/min (Centaur 2, MSE centrifuge) for 5 
min. Sera samples were coded and stored at -40° until required.
Patient recruitment, clinical examination and characterisation and sera 
collection was kindly performed by Dr. A. Smith.
Hi) Pre-absorbing sera
Serum was pre-absorbed with disrupted whole E  coli TOP10 cells to reduce the 
level of background banding on the blots that would result from patient 
antibodies recognising and binding E. coli proteins. The cells were disrupted by 
adding 30% w/v glass beads prior to shaking the cultures in a disintegrator for 
30 min. The glass beads were then removed from the cell suspension by brief 
centrifugation and the supernatant was removed. Serum diluted 1:500 in 5ml
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blocking buffer was pre-absorbed with 750pl disrupted cells at room temp for 2 
hours.
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RESULTS
BCA assay
The standard protein concentration curve derived from the BCA assay was 
compiled, and using OD562 readings taken for uninduced and induced whole cell 
samples of pBADBf in TOP10 that had been similarly digested with assay 
reagents, the protein concentration of these samples could be determined from 
the graph. The uninduced samples contained protein at approximately 1 mg/ml 
and induced samples had a higher protein concentration of 4mg/ml.
Western blots
Serum samples from 13 healthy controls and 11 patients with chronic adult 
periodontitis were analysed. The Western blots of serum reacted with whole cell 
fractions of induced pBADBfin E. coli TOP 10 are shown in Fig 6.1. Of the 
serum samples taken from patients with rapidly progressive periodontitis, two 
samples reacted with the induced protein B. forsythus hsp60. The induced 
protein was identified by its apparent molecular weight, migrating as a 60-kDa 
protein as compared to molecular weight standards. The identification of the 
reactive proteins as induced B. forsythus hsp60 was verified in both cases by 
blotting an uninduced sample with the same serum samples that yielded the 
stained bands at 60-kDa. As the example shows, the protein was not detected 
by ‘reactive’ serum in the uninduced sample (Fig 6.2, lane 2).
To determine whether the patient antibodies that recognised the B. forsythus 
hsp60 were cross-reactive, a sample of patient serum that had been shown in 
Fig 6.1 to bind the induced protein was pre-absorbed with disrupted E. coli. This 
served to reduce the level of cross-reactive binding. As can be seen, the pre-
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absorbed serum did not bind the induced protein (Fig 6.2, lane 3). This 
indicated that the patient antibodies that were able to bind the induced B. 
forsythus protein were cross-reactive with E. coli hsp60. It is probable that either 
the antibodies were originally raised against E. coli and are able to recognise 
homologous sequences of the B. forsythus protein, or conversely, E. coli 
proteins were recognised by antibodies raised against B. forsythus. In both 
situations, the pre-adsorption of serum with E. coli hsp60 would result in the 
reduced ability of the hsp60 serum antibodies to bind B. forsythus hsp60.
Fig 6.3 demonstrates the ability of healthy human serum samples to bind B. 
forsythus hsp60. As can be seen, one of the 13 healthy samples carried 
antibodies reactive with the groEL gene product of B. forsythus. This study 
has shown that components of the human immune response raised against a 
cross-reactive epitope expressed by B. forsythus hsp60 are present in healthy 
and adult peridontitis patient serum samples.
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DISCUSSION
This chapter documents the immunoreactivity of the groEL protein of B. 
forsythus, which has been ascertained to further define the role of B. forsythus 
hsp60 as a pathogenicity factor in periodontal disease. The antigenicity of this 
protein was determined by screening whole cell extracts of arabinose-induced 
E. co//TOP 10 transformed with pBADBf by means of Western blotting. 
Electrophoresed cell extracts were screened with human sera collected from 11 
patients with chronic adult periodontitis, and 13 clinically healthy subjects. The 
main finding of this study was the demonstration that sera samples from both 
patient groups contained antibodies of the IgG class against B. forsythus hsp60. 
Anti-B. forsythus hsp60 antibodies were apparent in two out of 11 periodontitis 
patient samples, and in one out of 13 healthy samples. That the antibodies were 
primarily binding the over-expressed B. forsythus recombinant protein, and not 
endogenous E. coli hsp60, was verified by screening a B. forsythus hsp60 
positive serum sample from a diseased patient against an uninduced lysate of 
E. coli carrying the pBADBf plasmid as antigenic substrate. This resulted in an 
antibody-binding pattern that lacked the 60-kDa band. Furthermore, the 
antibodies against B. forsythus hsp60 carried by one patient were demonstrated 
to be cross-reactive, possibly raised against E. coli hsp60, by pre-absorbing the 
serum sample with disintegrated whole cell fractions of E. coli. Using pre­
absorbed serum resulted in a binding pattern that again displayed no antibody 
binding to a 60-kDa protein (Fig 6.2).
B. forsythus hsp60 has therefore been shown to be an immunogenic protein, 
against which some periodontitis patients and healthy individuals possess an 
IgG antibody response. With the size of the patient groups used in this study a
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significant difference in the antibody reponse between the diseased and control 
groups cannot be interpreted, although thus study provides a preliminary 
indication that an antibody reponse to B. forsythus hsp60 is not unique to 
patients with chronic adult periodontitis.
Similar to this study, Maeda et al (1994) performed an immunological analysis 
of recombinant P. gingivalis hsp60 by Western blotting, and found reactive 
antibodies to be present in sera from periodontitis patients and in healthy 
controls. However, another report on recombinant P. gingivalis hsp60 
documents no response to P. gingivalis hsp60 in healthy serum samples whilst 
finding a high percentage of periodontitis sufferers to be carrying P. gingivalis 
hsp60 antibodies (Tabeta et al, 1999). A report on A. actinomycetemcomitans 
hsp60 also found an antibody reponse in periodontitis patients, but none in 
healthy controls (Koga et al, 1993). As none of these studies use patient groups 
larger than 20, it is difficult to assess the significance of these early results. A 
harder task yet will be to understand the role of an immune response to 
bacterial and human hsp60 in the pathogenesis of periodontitis. A level of 
antibody reactivity to human hs60 in periodontitis gingival tissue has been 
reported (Ando et al, 1995; Tabeta et al, 1999) which could be a part of an 
autoimmune process, but whether this process is the healthy removal of 
infected host cells or the deleterious destruction of human tissue would be hard 
to prove. It may be that the anti-human hsp60 response is not pathogenic, but 
that hsp60 antibodies have a pathogenic effect on a tissue-specific antigen, 
such as periodontal ligament fibroblasts which have been shown to share a 
level of homology with hsp60 (Gemmell and Seymour, 1995). Alternatively, 
bacterial hsp60, rather than antibodies to it, may be a causative agent of bone
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resorption, as suggested by Kirby et al (1995), and further work investigating 
such aspects of these proteins remains to be done.
It is suggested that the identification of periodontitis patients with antibodies to 
hsp60 of periodontopathogenic bacteria may be of diagnostic value, and could 
highlight those patients who may benefit from specific anti-inflammatory 
treatment (Schett et al, 1997; Hinode etal, 1998).
Cross-reactive and species-specific antigenic regions of hsp60 homologues 
have been previously identified, with most work focused on characterising the 
antigenic determinants of the 65-kDa protein of Mycobacterium species (Ivanyi 
et al, 1983; Kolk etal, 1984; Mehra etal, 1986; Buchanan etal, 1987; Young et 
al, 1987; Anderson et al, 1988). The first report of the DNA sequence of an 
hsp60 homologue, the 65-kDa antigen of M. leprae, also reports a technique 
utilised to determine the amino acid sequences of epitopes recognised by M. 
leprae monoclonal antibodies (Mehra et al, 1986). After sequencing the entire 
M. leprae hsp65 gene, a sub-library containing fragments of the gene, formed 
by partial DNA digestion with DNase I, was constructed in a X bacteriophage 
vector. Recombinant clones forming the library were screened with M. leprae 
monoclonal antibodies to select those clones which expressed a fragment of 
epitope-coding sequence. The nucleotide sequence contained within reactive 
clones was then determined and mapped to the available sequence of the 
entire protein. Using this technique, six different antigenic determinants of the 
M. leprae 65kDa protein were identified, one of which was unique to M. leprae. 
A study following this work on immunogenic epitopes of hsp60 homologues 
continued to use the same monoclonal antibodies which recognised the 65-kDa 
protein of M. leprae, in addition with others to make a panel of 23 antibodies
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(Buchanan et al, 1987). 14 of these monoclonal antibodies were found to 
recognise distinct epitopes, as proven by cross-competition assays. Of these 
monoclonal antibodies, only one recognised an epitope unique to M. leprae, 
whereas all the others displayed a greater or lesser amount of cross-reactivity 
by binding anything from eight to 23 different mycobacterial species. This 
prompted closer examination of the epitopes involved on the mycobacterial 65- 
kDa protein, such as the study by Anderson et al (1988), which further 
characterised the monoclonal antibody binding sites. Anderson and colleagues 
synthesised peptide fragments of the 65-kDa antigen to elucidate which 
portions of the sequence were recognised by the monoclonal antibodies. Rather 
than construct small overlapping peptides to cover the sequence of the entire 
protein, they chose to synthesise fragments that corresponded to the 11 most 
pronounced hydrophilic peaks of the predicted amino acid sequence of the 
protein, as it was anticipated that these regions would likely be antigenic. By 
use of this procedure, 10 epitopes were characterised which bound the 
monoclonal antibodies, and seven of these epitopes occurred in hydrophilic 
domains. An M. leprae-unique epitope was identified (III E9) possessing the 
peptide sequence KLKLTGDEA. Since the analogous sequence of the 65-kDa 
protein from M. tuberculosis is ELKLEDGEA, it would appear that specific 
residue changes at a single site (in this instance a threonine substitution for 
lysine) can inter-convert an apparently well-conserved epitope into a uniquely 
specific one. This was also shown to be the situation with an epitope specific for 
Neisseria species (Pannekoek et al, 1995) in which a A/e/sser/a-specific 
antibody domain differed from the homologous sequence of M. tuberculosis at 
only one residue.
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Of the mycobacterial hsp60 monoclonal antibodies that were identified as cross­
reactive (Anderson etal, 1988), antibodies F67.13, IIIC8, Y1.2 and IIH9 bound 
synthetic mycobacterial peptide sequences that were well-conserved and 
homologous to the corresponding sequence of the B. forsythus hsp60 antigen. 
This can be seen in Fig 6.4, where the peptide sequences which bound 
mycobacterial hsp60 monoclonal antibodies are aligned with the corresponding 
sequence from E. coli and B. forsythus. The epitopes that appear to be best 
conserved are reactive with antibodies IIH9 and F67.13. Although the reactive 
sites for antibodies Y1.2 and IIC8 look less well conserved, it has been 
demonstrated that both these antibodies are cross-reactive with the E. coli 
sequence (Young et al, 1987) and would presumably be able to bind the B. 
forsythus homologue as well. The portion of the B. forsythus sequence that 
antibody IIIC8 would theoretically bind has already been identified as a region of 
the protein that is hydrophilic, and is predicted to be a surface-expressed 
antigen of the hsp60 protein (Discussion, Chapter 4), which further supports the 
notion that cross-reactive monoclonal antibody IIIC8 will recognise the B. 
forsythus sequence as well as that of E. coli and Mycobacteria. This again 
indicates that the amino acid sequence of an epitope is not always intrinsic for 
antibody binding, rather, the presence of perhaps only a few crucial residues 
facilitates antibody recognition of a binding site.
The sequence illustrated in Fig 6.4 shows regions of the S. forsythus hsp60 
sequence predicted to be hydrophilic which also have a high probability of being 
surface-expressed peptides, and as such are likely to be antigenic (predictions 
made using the PEPPLOT function of the GCG computer program package; 
see Chapter 4). As has been shown previously, there are limits as to how
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broadly cross-reactive some cross-reactive antibodies are. Thus some 
mycobacterial cross-reactive antibodies recognise eight different mycobacterial 
species whilst others recognise 23 different species (Buchanan etal, 1987). 
Likewise, it is plausible that there could be antibodies in periodontitis patient 
serum that recognise those regions of the B. forsythus sequence predicted to 
be antigenic, but that these antibodies would not recognise mycobacterial 
hsp65 domains, and therefore have not been identified or characterised 
previously. Certainly some of the most well-conserved and potentially most 
antigenic regions of the B. forsythus hsp60 sequence and other homologues 
have not as yet been identified as the antibody binding sites which they may 
well be.
Several monoclonal antibodies that are raised against mycobacterial species 
are able to bind the human mitochondrial homologue P1 and conversely, a 
polyclonal antibody raised against P1 showed some cross-reactivity with cell 
extracts from E. coli and Salmonella typhimurium (Dudani and Gupta, 1989).
The further ramifications of this are quite apparent with regards to autoimmune 
reactions. As the mycobacterial antibodies used in Dudani’s study are also likely 
able to bind the B. forsythus sequence due to the highly conserved nature of 
some of their epitopes, it is probable that antibodies that may be raised against 
these S. forsythus epitopes in periodontal disease will also be able to recognise 
human mitochondrial protein P1. Other workers who have studied hsp60 
proteins in periodontal pathogens (Maeda etal, 1994; Nakano etal, 1995; 
Hinode et al, 1998; Tabeta et al, 1999) postulate that cross-reactive antibodies 
raised against bacterial hsp60 may have a role in the pathogenesis of 
periodontitis via a mechanism involving autoimmune processes. If regions of B.
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forsythus hsp60 sequence were shown to bind the same cross-reactive 
antibodies that display such broad cross-reactivity as to recognise both human 
and mycobacterial antigens, this would go some way to supporting the 
hypothesis of B. forsythus hsp60 antigen being involved in autoimmune 
processes of periodontitis. However, the human mitochondrial protein is so 
widely expressed that there must be factors that limit the spread of the 
autoimmune reactions, i.e. there must be a degree of tissue specificity for this 
putative autoimmune disease. It may be that the immune reactions against 
hsp60 are only of pathogenic significance in areas where there are particularly 
high levels of hsp60 expression, and detrimental autoimmune responses to 
hsp60 are thus limited to sites of localised inflammation at the periodontium. 
Alternatively, it may be that hsp60-reactive antibodies are directed against cells 
or antigens which are periodontium specific, such as the periodontal ligament 
fibroblast which displays identity with hsp60 proteins (Gemmel and Seymour, 
1995).
The characterisation of species-specific epitopes of the hsp60 sequence of 
different aetiologic agents of disease can potentially lead to improved diagnosis 
of infections and the development of crucially targeted vaccines (Mehra et al, 
1986; Buchanan et al, 1987; Young et al, 1987), and will also further extend our 
knowledge of the aetiology of diseases. It is also important to appreciate which 
antigenic regions of the protein raise cross-reactive antibodies, as these 
antibodies may be significant in autoimmune processes.
It is important to note that whilst the majority of studies appear to competently 
demonstrate the high reactivity of monoclonal antibodies to linear hsp60/65 
epitopes, the nature of these studies and the experimental techniques utilised
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may bias the characterisation of linear epitopes only, and thus discontinuous 
epitopes are under-represented in these studies. Firstly, the protein 
preparations used to immunise mouse B cells for the production of monoclonal 
antibodies have usually been subjected to some procedure, such as heat-killing 
of cells or sonication, that results in partially or completely denatured antigen. 
Thus the laboratory animals are exposed to a large number of continuous 
epitopes, with many of the discontinuous epitopes disrupted. Secondly, after the 
animal has raised antibodies, the monoclonal antibodies are frequently 
identified by their reactivity with 60/65-kDa protein on Western blots. Again, the 
processing of proteins prior to Western blotting involves steps which are likely to 
denature the protein to a significant extent, such that any monoclonal antibodies 
that are detected by Western blots are those which can bind linear epitopes. 
These factors may account for the high proportion of monoclonal antibodies 
against hsp60/65 that have specificity for linear epitopes, despite the fact that it 
has previously been estimated that up to half of all antigenic sites on native 
proteins are composed of an assembly of primary structure segments of protein 
that have come together as a result of protein folding to be expressed on the 
protein surface as discontinuous epitopes, (Berzofsky, 1985; Barlow, 1986). 
Another possible explanation is that the 60/65-kDa hsps possess structural 
features that foster binding of antibodies to linear epitopes. This would be the 
case if the protein naturally adopted an unfolded configuration with continuous 
epitopes unconcealed on the protein surface. Many of the continuous epitopes 
currently appreciated appear to reside in hydrophilic peptide sequences, which 
are also anticipated to be stretches of the protein that are surface expressed. 
Also, there is some indication that the hsp60 protein is particularly vulnerable to
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proteolytic digestion (Young et al, 1987), and both these features are in 
accordance with the hsp60 protein possessing an unfolded structure that 
expresses a high proportion of linear epitopes.
Proposed work to follow the studies presented in this chapter on the initial 
identification of B. forsythus hsp60 as an antigenic protein recognised by 
antibodies in human serum would be to define the antigenic structure of B. 
forsythus hsp60. This could be achieved utilising a technique which several 
other groups have successfully employed to distinguish immunodominant 
epitopes, whereby overlapping peptide sequences are synthesised to represent 
the entire protein sequence. 9-mer peptides based on the groEL sequence of S. 
typhi were constructed, and the resulting 122 peptides used to coat the surface 
of polyethylene pins which were then screened with monoclonal antibodies to E. 
coli groEL and with sera from patients suffering from typhoid fever 
(Panchanathan et al, 1998). Three immunodominant epitopes were identified, 
one of which was recognised both by the sera samples and by an E. coli 
monoclonal antibody. The two other peptide sequences which bound serum 
antibodies corresponded to a well-conserved region of hsp60 homologues, at 
amino acid residues 180-205. Continuous B-cell epitopes in C. trachomatis 
hsp60 were identified by synthesising 553 12-mer peptides, that overlapped by 
all but one residue (Yi et al, 1993). The peptides were screened with serum 
from female patients infected with C. trachomatis and 13 major epitopes 
classified. Seven of the epitopes were matched to sequences of the human 
hsp60 protein, which had also been synthesised, and were able to bind the 
serum samples. Interestingly, it was noted that these binding sites did not 
always share good sequence identity between the bacterial and human
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homologue, and that amino acid differences could not be used to predict which 
epitopes were specific or cross-reactive. A study to characterise antigenic 
domains of 8. forsythus hsp60 could be performed by expressing sub-sections 
of the protein and determining their ability to bind patient serum antibodies to 
determine where epitopes lie. The sections of the protein to be expressed could 
be synthesised by constructing a 8. forsythus hsp60 sub-library from gene 
fragments. The sequence of the inserts of reactive clones could be determined, 
and the DNA sequence encoding an epitope attributed to sequences that are 
shared by multiple antibody-positive recombinant clones. A more efficicient 
method would be to generate hsp60 peptide fragments by PCR, using internal 
primers selected from the 8. forsythus hsp60 genomic sequence, and the PCR 
products then cloned into a suitable expression vector and screened with 
patient serum or with hsp60 monoclonal antibodies. This method has been 
previously used to identify epitopes of Neisserial hsp60 (Pannekoek et al,
1995). After immunogenic B-cell epitopes for 8. forsythus hsp60 have been 
identified, it would be a considerable task to raise monoclonal antibodies to 
these regions to determine whether the epitopes raise cross-reactive or 
species-specific antibodies. However, the panel of cross-reactive monoclonal 
antibodies commercially available could at least identify the conserved epitopes, 
and perhaps concurrently mark the epitopes likely to be species-specific.
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Figure 6.1. Western blots demonstrating reactivity of serum from 
patients with adult periodontitis with recombinant 8. forsythus 
hsp60. Electrophoresed whole cell fractions of 8. forsythus hsp60 
expressed in E. coli were screened with serum from 11 patients 
with adult periodontitis. The serum samples contained antibodies 
that reacted with endogenous E. coli proteins, seen as the multiple 
banding patterns above. Two serum samples, tested in lanes 2 and 
6, bear antibodies specific for a protein of approximately 60 kDa 
which is subject to arabinose control (see fig 6.3.)
FIGURE 6.1. Western blots demonstrating reactivity of serum
from patients with adult periodontitis with recombinant B.
forsythus hsp60.
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FIGURE 6.2. Western blot analysis of adult periodontitis serum
reactive with recombinant B. forsythus hsp60.
Figure 6.2. Western blot analysis of adult periodontitis serum 
reactive with recombinant B. forsythus hsp60. Serum sample bearing 
antibodies specific for a 60kDa protein (lane 1). The identity of this 
protein as recombinant B. forsythus hsp60 is conformed in lane 2, 
where the same reactive serum sample is used to blot an non­
induced cell fraction. Thus the immunoreactive protein in lane 1 is 
subject to inducer control. The same serum sample was pre­
absorbed with disrupted E. coli whole cells and used to screen an 
induced sample (lane 3). The disappearance of the band detected in 
lane 1 indicates that the patient antibodies recognising 8. forsythus 
hsp60 are cross-reactive with E. coli hsp60.
FIGURE 6.3. Western blots demonstrating reactivity of healthy
adult serum samples with recombinant B. forsythus hsp60.
Figure 6.3. Western blots demonstrating reactivity of healthy adult 
serum samples with recombinant B. forsythus hsp60. Whole cell 
fractions of B. forsythus hsp60 expressed in E. coli were screened 
with serum extracted from 13 healthy individuals. The serum 
samples contained antibodies that reacted variably with 
endogenous E. coli proteins. The serum sample in lane 5 has 
specificty for recombinant B. forsythus hsp60 (yellow arrow).
Figure 6.4. Conserved monoclonal antibody linear binding sites on hsp60 
amino acid sequences. Previously characterised mycobacterial monoclonal 
antibodies bound synthetic peptide sequences (Anderson et al, 1988) which 
share homology with corresponding sequences of B. forsythus (Bf) and E. coli 
(Ec). These monoclonal antibodies have been shown to be cross-reactive with 
E. coli hsp60 (Young et al, 1987), and are likely to be able to bind B. forsythus 
hsp60, high-lighting potential antigenic sites of the protein. 1= antibody Y1.2 
binding site, 2= IIH9 binding site, 3= F67-13 binding site, 4= IIIC8 binding site 
(all characterised in Anderson et al, 1988).
The boxed sequences are regions of the B. forsythus hsp60 sequence 
predicted to be hydrophilic and surface expressed (Chapter 4) and also 
therefore potentially antigenic.
FIGURE 6.4. Conserved monoclonal antibody linear binding sites on
hsp60 amino acid sequences
Bf --------------------------- MAKE IKFDMNARDLLKKGVDELA
Ec -------------------------- MAAKDVKFGNDARVKMLRGVNVLA
Mb 1 . ARRGLERGLNSLA
B f  NAVKVTLGPKGRNVILEKKFGAPQITKDGVTVAKEIELACPYENMGAQLV 
E c DAVKVTLGPKGRNWLDKSFGAPTITKDGVSVAREIELEDKFENMGAQMV 
Mb DAVK
B f  KEVASKTNDKAG DGTTTATVLAQAIIGVGLKNVTAGANPMDLKRGIDKAV 
E C ffCEVAEKANTDA A n n G lT T T A T V T  iAQAT ITEGLKAVAAGMNPMDLKRGIDKAV
Mb 2 . AAGANPLGLKRGIEKA
B f  SKWESIASQSEAVGTNMDRIEHVAKISANGDEGIGKLIAEAMQKVKKEG 
EC TAAVEELKALSVPC -  SDSKAIAQVGTISANSDETVGKLIAEAMDKVGKEG 
Mb
B f  VITVEEAKGTETTVEWEGMQFDRGYISAYFVTDTEKMETQFENPYILIY 
E c VITVEDGTGLQDELDWEGMQFDRGYLSPYFINKPETGAVELESPFILLA  
Mb
B f  DKKISVLKDLLPILEQMVQSGRALLIIAEDIDSEALATLWNRLRGGLKV  
E c DKKISNIREMLPVLEAVAKAGKPLLIIAEDVEGEALATAWNTIRGIVKV  
Mb
B f  CAVKAPGFGDRRKAMLEDIAILTGGTVITEE-KGMKLEDAKMDMLGSADK 
E c AAVKAPGFGDRRKAMLQDIATLTGGTVISEE-IGMELEKATLEDLGQAKR 
Mb
B f  VTVNKDNTTIVKGNGDKAAIESRIGQII 
EC W IN K D T T T I IDGVGEEAAIQGRVAQIf 
Mb
AQIETTTSDYDKEKLQERLAKL 
Q Q IE E A T S D Y D ’R E K T iQ E R V A K I i
B f
EC
Mb
AGGVAVLYVGAP 3 EVEMKEKKDRVDDALHATRAAIEEGTVPGGGVAYLRA
AGGVAVI KVGAAlTE VEMKE KKARVE DALHATRAAVE EGWAGGGVALIRV
3 . TEVELKERKHRIEDAVRNAK
B f  IPALEGLKGENEDETTG IEIVKRAIEEPLRQIVNNAGKEGAVWQKVKEG  
E c AS KXiADLRGQNEDQNizd IKVALRAMEAPLRQIVLN CGE E P S WANTVKGG 
Mb
B f  TGAFGYNARTDVYEDLSEAGWDPAKVTRIALENAASIAGMFLTTECWA  
E c DGNY GYNAATE EYGNMIDMGILDPTKVTRSALQYAASVAGLMITTECMVT 
Mb
B f  DKKEEAPAPPMNP- GMGGMGGMM 5 4 4
E c DLPKNDAADLGAAGGMGGMGGMGGMM 5 4  8
Mb 4 . DPTGGMGGMDF
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7 4
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CHAPTER 7
Construction and screening of a B . f o r s y t h u s  genomic library
INTRODUCTION
The bacterial population which accumulates at the gingival margin possesses 
a battery of antigens, some of which are capable of triggering a cascade of 
host-mediated immune reactions. The antigens of periodontal pathogens are 
therefore of interest to the researcher for two reasons:
i) antigens that elicit a strong host response may be protective, and 
characterisation of these proteins or protein fragments may lead to 
antimicrobial therapies or vaccine development for improved treatment 
of periodontitis.
ii) antigens expressed by periodontal pathogens can induce a chronic and 
deleterious immune response that results in tissue damage, and as 
such are directly implicated in the immunopathology of periodontal 
disease.
Thus as the microbial causative agents of periodontitis continue to be 
identified, attempts are made to determine which of the multitudinous antigens 
of the micro-organisms provoke the strongest response from the host, with the 
aim of further characterising these immunodominant antigens.
Proposed antigens of oral periodontopathic microorganisms have been 
identified by human antibody responses using sera collected from periodontitis 
patients. In many cases, the studies go no further than to identify serum- 
recognised proteins by molecular weight alone. Studying the outer membrane 
proteins of A. actinomycetemcomitans, two groups identified 13 to15 principal 
antigens to which human sera reacted ranging in size from 14-78 kDa 
(Califano et al, 1992; Page etal, 1992; Watanabe etal, 1989). Strains of A. 
actinomycetemcomitans have been differentiated into three serotypes
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(Zambon, 1985). Serum antibody levels to the serotype antigens were raised 
in infected patients. It was noted that each patient was infected with only one 
serotype, and that juvenile periodontitis patients reacted to serotype antigen b 
more frequently than to serotype antigens a or c. This would suggest that 
serotype b of the organism is the most pathogenic, but also highlights the fact 
that the antibodies a patient carries can be strain- or serotype-specific, and 
thus patients within the same disease group (i.e. periodontitis patients) may 
express different antibodies. This makes the task of determining common 
dominant antigens more difficult. A similar situation has been described for 
patients infected with P. gingivalis, whose antibody response is directed 
against the outer membrane proteins of this species (Papaioannu et al, 1991). 
Individual patients were shown to have raised antibody levels to one of the 
three serotypes of P. gingivalis (Ebersole and Steffen, 1995). More recently it 
has also been suggested that more than one serotype of B. forsythus exists 
which may be implicated in periodontal infections and, as has been 
demonstrated for A. actinomycetemcomitans and P. gingivalis, different 
strains appear to affect different patients, which results in serum samples from 
a range of patients recognising different antigens of the same species 
(Takemoto etal, 1997; Sims etal, 1998a and 1998b). With the potential for 
phenotypic variation between strains it is important to identify which antigens 
are common to all serotypes if the wider goal of developing treatment 
strategies for periodontitis is to be achieved.
Patient reactivity to outer membrane proteins has been widely demonstrated 
(Califano etal, 1992; Watanabe etal, 1989), but these antigenic determinants 
have generally remained uncharacterised. The nature of some of these
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dominant antigens can be elucidated by pre-absorbing patient serum with a 
known, characterised antigen and then using this serum to immunoblot a 
whole cell fraction of a suspected periodontal pathogen. This blot is then 
compared to the same protein array immuno-blotted with unabsorbed serum. 
Any band that disappears in the pre-absorbed blot can be assumed to be 
antigenic and corresponds to the same protein that was used to pre-absorb 
the serum. This technique has been used to show that lipopolysaccharide 
(LPS) may be a major antigen of P. gingivalis (Schenk, 1985; Boutsi, 1993). 
LPS is a component of the outer membrane of the cell wall of Gram negative 
bacteria, and is also referred to as bacterial endotoxin (Stephen and 
Pietrowski, 1986). The identification of LPS as an important antigen of P. 
gingivalis has been further bolstered by a report indicating that antibodies to P. 
gingivalis LPS are protective and prevent alveolar bone loss in experimental 
animals immunised with P. gingivalis (Vasel e ta l, 1996). Serum IgG antibody 
levels to LPS of A. actinomycetemcomitans have also been shown to be 
significantly increased in juvenile periodontitis patient groups.
Bacterial fimbriae, also referred to as pili, are deemed virulence factors due to 
the fact that deletion mutation studies demonstrate that afimbriate mutants are 
avirulent. P. gingivalis mutants which do not express fimbriae have been 
shown to have a reduced ability to adhere to human gingival tissue (Hamada 
et al, 1994). Western blot studies have demonstrated that serum antibody 
levels to the fimbriae of P. gingivalis are raised in some patients with 
periodontal disease (Yoshimura etal, 1987), indicating thatfimbrial proteins 
can be potent immunogens in some instances of disease.
Various other proteins of periodontal pathogens have been propounded
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as dominant antigens. These include assorted proteases that have been best 
characterised in P. gingivalis, although it is likely that this array of enzymes is 
not unique to P. gingivalis (Haffajee and Socransky, 1994). The proteases 
confer a variety of enzymatic actions, possessing the ability to degrade host 
structural components such as collagen and fibrinogen (Nitzan et al, 1978; 
Uitto et al, 1988; Lawson and Meyer, 1992; Scott et al, 1993) and 
immunoglobulins and complement factors (Sundqvist et al, 1985; Grenier et al, 
1989; Gregory et al, 1992). They are crucial to the bacteria for nutrition, 
adherence and aid survival of the bacterium by degrading opsonins 
accumulating at the bacterial cell surface. The proteases are evidently 
important virulence factors, whose foreign nature marks them for recognition 
by the host humoral immune response. An elevated level of antibodies 
against them is expected due to their abundance at a site of periodontal 
infection.
Some Gram negative bacteria express secreted proteins which are bacterial 
exotoxins of the RTX (‘repeats in toxin’) family. The family of toxins have in 
common a glycine-rich tandem repeat in the C-terminal domain of the amino 
acid sequence. The RTX toxins also differ between species with regards to 
their target cell specificity. The RTX toxin of E. coli has a wide range of cellular 
targets for example, whereas the A. actinomycetemcomitans RTX toxin has a 
narrow range of targets and affects leukocytes and macrophages of human 
origin. The toxins damage target cell membranes by forming transmembrane 
pores, resulting in cell lysis (Stephen and Pietrowski, 1986). The RTX toxin of
A. actinomycetemcomitans has been shown to be an important virulence 
factor; >80% of A. actinomycetecomitans isolates from the healthy population
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are toxin deficient, whereas 75% of patients with periodontal disease carry 
RTX+ strains. Elevated antibody levels to the RTX toxin of A. 
actinomycetemcomitans has been repeatedly demonstrated in localised early 
onset periodontitis patients as compared to healthy controls (Ebersole et al, 
1983; McArthur et al, 1981).
Another group of proteins expressed by periodontal bacteria that are believed 
to be important immunogens are the heat shock proteins. The immune 
response to the hsp60s of the periodontal pathogens A. 
actinomycetemcomitans, P. gingivalis and B. forsythus has been shown to be 
elevated in patient serum samples as compared to healthy controls (Ando et 
al, 1995; Hinode etal, 1998; Tabeta etal, 1999). Regardless of whether or not 
the hsp60s are the triggers of autoimmune responses in periodontal disease 
as has been suggested, immune reactivity to hsp60 is potentially an important 
component of the immune response to pathogenic organisms implicated in 
periodontitis.
In an attempt to identify the protein antigens of B. forsythus which elicit a 
strong antibody response in human periodontitis patients, this chapter 
describes the construction of a genomic library of B. forsythus and the 
screening of the expression library with serum from a patient previously 
characterised as being a high responder to B. forsythus.
A genomic library ideally contains relatively short lengths of DNA sequences 
that are representative of an entire genome, such that the complete population 
of recombinant clones should yield overlapping sequences that span the 
genome. The cloned fragments should be sufficiently large to carry complete 
genes and their immediate flanking sequences that may encode promoters.
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The size of the inserts is intrinsic to the construction of a good library. The 
vector is usually the size limiting denominator for fragments in a library, thus if 
some fragments are too large to insert into the chosen vector, stretches of the 
genome are not represented in the library and the library has essentially failed. 
It is equally important that fragments should not be too small either, as this 
would result in an unmanageable number of clones to analyse and a high 
proportion of the clones would only carry gene portions from which proteins 
could not be expressed.
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MATERIALS AND METHODS 
Construction of the genomic library
i) Purification of genomic DNA
B. forsythus genomic DNA was isolated from bacteria as described in Chapter 
2.
ii) Establishing conditions for partial digestion of genomic DNA
B. forsythus chromosomal DNA was partially digested with various 
concentrations of the restriction endonuclease Sau3A to establish the 
optimum concentration of enzyme required to produce DNA fragments in the 
size range 2-10 kb. A protocol for this optimisation assay was derived from a 
previously described method (Glover and Hames, 1995). Serial dilutions of an 
endonuclease reaction mix were performed to give a range of enzyme 
concentrations. The reaction mix comprised 10pg B. forsythus DNA, 15pl 
buffer B (Promega), 1.5pl BSA (Promega) and sufficient distilled water to bring 
the volume to 150pl. Nine tubes were labelled and 30pl of the reaction mix 
dispensed into tube 1 and 15jnl into tubes 2 to 9. 5U Sau3A was added to tube 
1, mixed thoroughly, and 15pl of this mix added to tube 2. This two-fold serial 
dilution was repeated through tubes 2 to 8. Tube 9 remained as an undigested 
control. All tubes were incubated at 37°C for 60 min and the digestion stopped 
by adding 3pl 0.1M EDTA and 2pl gel loading solution. The same Sau3A 
digests of B. forsythus DNA were also constructed as above and incubated at 
37°C for 75 min and 90 min. 15pl samples of each digest were 
electrophoresed on a 0.6% TAE gel and the DNA visualised with UV light.
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iii) Partial digest scale-up
The digestion conditions that yielded the best range of DNA fragment sizes 
was selected, and the digestion scaled up two-fold. The partially digested DNA 
was cleaned using a Wizard™ DNA Clean-Up Kit (Promega) following the 
manufacturer’s instructions. DNA was resuspended in 60pl distilled water and 
2 jllI electrophoresed on a 0.8% TBE gel. This served to both quantitate the 
DNA concentration and to check that the sizes of the fragments generated 
were in the correct range.
Ligation
Purified digested DNA was ligated to the vector pUC18 digested with BamH\ 
and dephosphorphylated to prevent re-ligation (Amersham Pharamacia 
Biotech). As the DNA inserts are on average twice the size of the vector, an 
insert to vector (w/w) ratio of 6:1 was required to give a molar ratio of 3:1, 
which is the optimal ratio for ligation reactions. Thus 10Ong of vector was 
ligated to 600ng of partially digested B. forsythus DNA, using 3U T4 DNA 
ligase. The ligation was allowed to proceed at 14°C overnight.
Transformation
2pl of the ligation reaction was used to transform competent E. coli TOP10 
cells as previously described (Chapter 3). Transformants were spread on L- 
agar plates containing 0.1 mg/ml ampicillin, and plates were incubated 
overnight at 37°C.
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Cloning controls
The level of background recombination of the cloning vector was ascertained 
by transforming host E. coli TOP10, as previously described, with un-ligated 
vector. A sample of transformed cells was then plated onto L-agar plates with 
ampicillin and incubated as described.
Mini-prep analysis of transformant DNA
24 recombinant colonies were inoculated into 5ml L-broth containing 0.1 mg/ml 
ampicillin and incubated overnight at 37°C. These cultures were screened by 
mini-prep and EcoRI digestion following the procedures described previously 
(Chapter 2). Digestion with EcoRI linearised the recombinant plasmid which 
could then be analysed by size after electrophoresis.
Immunological screening by colony lift
This procedure was performed essentially following a protocol previously 
described (Sambrook et al, 1989). To analyse large numbers of clones, 300pl 
of each transformation was spread on 145mm plates of L-agar containing 
0.1 mg/ml ampicillin. Master copies of the library were grown on nitrocellulose 
filters which enabled the library to be transferred onto fresh growth medium to 
sustain clones. Replicas of the library were made by transferring the colonies 
via the colony lift technique onto fresh nitrocellulose filters. Generally no more 
than two replicas could be made from each master plate.
Colonies on the replica plates were lysed to expose internal as well as 
surface-expressed antigens and screened with the serum of a patient 
previously characterised as a high responder to B. forsythus, as determined by
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ELISA. The antiserum used to detect bound patient serum was anti-human 
IgG alkaline phosphatase conjugate (Sigma). Clones that reacted on the 
replica filters could be matched to those on the corresponding master plate 
and recovered for further analysis. Typically, approximately 1000 colonies 
were obtained on each plate following transformation.
i) Preparation of master and replica plates
Nitrocellulose filters were sterilised prior to use, and cut to fit the base of a 
145mm petri dish. Each filter was soaked in distilled water and sandwiched 
between layers of dry 3MM Whatman paper. The stack of filters and Whatman 
papers was wrapped and sealed in aluminium foil, and autoclaved as liquid 
(1 Olb/sq. in). Using sterile blunt forceps, a sterile filter was placed onto a L- 
agar plate containing ampicillin (100pg/ml). Transformant bacteria were plated 
onto the filter, the plate inverted and incubated overnight at 37°C. Another filter 
was dampened by placing it on a fresh agar plate containing ampicillin and 
IPTG to induce expression of the inserted genes under control of a lac 
promoter (in case the inserted gene did not carry its own promoter). The 
master filter with grown colonies was removed from its plate and placed 
colony-side-up on a stack of 3MM Whatman paper. The wet replica filter was 
carefully placed on top of the master filter and the filters pressed together, with 
care taken not to move the filters. Using a sterile needle, the filters were 
pierced around the border in an asymmetrical pattern whilst they were 
sandwiched together to allow later orientation of the replica plate with the 
master plate. The filters were gently peeled apart and placed, colony side up, 
onto fresh plates (the replica plate agar containing IPTG).
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Both replica and master plate were incubated at 37°C for several hours until 
colonies 1-2mm in diameter appeared. After this, the master plate was 
wrapped in foil and stored at 4°C until the screening results were available. 
The replica filter was processed for screening as described below.
ii) Processing filters prior to screening
In a fume hood, the replica filters were lifted from the agar plates and placed 
onto damp paper towels. The filters were covered with a plastic box and a 
glass dish containing chloroform placed within the box. The colonies were 
exposed to chloroform for 15min. After this, the filter was placed in a 145mm 
petri dish with 15ml lysis buffer (Table 7.1) and rotated at room temp 
overnight. The filters were then washed in a glass dish with TNT for 2x30 min 
and then screened.
Serum
Filters were screened with serum from a patient with adult periodontitis who 
had previously been characterised as a high responder to B. forsythus by 
ELISA (serum provided and characterised by I. Darby, Glasgow Dental 
Hospital and School). The serum was pre-absorbed with disrupted E. coli and 
used at a 1:200 dilution. The protocol for screening the filters was the same as 
that described for Western blotting in Chapter 5.
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Pre-absorbed serum
On a sterile nitrocellulose filter sitting on L-agar, bacterial colonies of the host 
transformant strain (E. coli TOP10) were established. A replica was made as 
described above and the colonies lysed as for the processing of filters prior to 
screening. Lysed colonies were incubated with diluted serum (1:500) for 2 
hours. The serum was then collected and 0.05% sodium azide added as a 
preservative. The preabsorbed serum was stored at 4°C until required.
Immunological screening by Western blot
SDS gels with a 4% upper and 12% lower gel were poured as described in 
Chapter 4. Transformant colonies to be screened were inoculated into 5ml L- 
broth with 0.1 mg/ml ampicillin and incubated overnight at 37°C with shaking at 
200rpm. The cultures were adjusted such that the OD6oo =0.5. 1ml of each 
adjusted culture was pelleted by centrifuging for 30 sec in a benchtop 
microcentrifuge. The resulting pellet was resuspended in 10Opil sample buffer 
and heated at 95°C for 5min prior to electrophoresis. 20jnl of each sample was 
loaded onto the gel, with the protein in the sample at a concentration of 
1 mg/ml as determined by a BCA protein assay (see Chapter 6).
After electrophoresis, the gels were transferred to nitrocellulose membranes 
as previously described, and blotted with the same high responder patient 
serum that was used to screen the genomic library by the colony lift technique. 
The serum was again pre-absorbed with E. co//TOP 10 whole cells, as 
described above.
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Sequence analysis of recombinant ciones
Recombinant clones carrying inserted DNA sequences of approximately 4-8kb 
were previously identified by restriction endonuclease digestion analysis. Of 
these clones, three were selected randomly to be further characterised by 
sequencing the DNA inserts. Cultures were grown in L-broth with 100pg/ml 
ampicillin as previously described and 3ml of this overnight culture used to 
perform a Wizard Plus™ Plasmid Mini Prep, as outlined in Chapter 4. Purified 
plasmid was used as template DNA for sequencing reactions following a 
protocol for automated sequencing (Chapter 4). Commercially available 
consensus primers M13 Forward and M13 Reverse were utilised to generate 
sequence data. Retrieved sequence data for each reaction was transformed 
into FASTA format and used to search on-line database sets via use of BLAST 
searches. The information retrieved from the database sets was preliminary 
sequence data which was obtained from the Institute for Genomic Research 
website at http://www.tigr.org.
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Table 7.1: Cell lysis buffer
content: for 20ml:
100mM Tris 2ml
150mM NaCI 0.18g
5mM MgCb 0.01g
1.5% BSA 0.3g
1 (ig/ml Dnase 20^g
40mg/ml lysozyme 80jaI of a 10mg/ml
solution
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RESULTS
Partial digestion of B. forsythus chromosomal DNA
B. forsythus chromosomal DNA was digested with a range of different enzyme 
concentrations and for varying incubation times to determine the optimum 
conditions to yield DNA fragments of 2-10kb, illustrated in Fig 7.1.
Cloning controls
The level of background recombination of the linearised vector was found to 
be minimal; a 200pl sample of transformed cells incubated overnight on agar 
plates yielded less than 30 colonies.
Mini-prep analysis of recombinant clones
To ascertain the percentage of recombinant clones which contained DNA 
inserts within the desired size range, randomly selected colonies were 
subjected to restriction endonuclease digestion to release the inserted 
fragments, the size of which could be determined by agarose gel 
electrophoresis. 24 colonies were picked and seeded into 5ml L-broth 
containing 100pg/ml ampicillin. The cultures were incubated overnight at 37°C 
with shaking at 200rpm and plasmid DNA extracted using the boiling method 
described in Chapter 2. Resuspended plasmid DNA was digested with BamH\ 
for three hours, and electrophoresed on a 0.8% agarose gel.
From this analysis, it could be seen that only one in six transformants were 
carrying a DNA fragment of the desired size (Fig 7.2).
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Immunoscreening of the genomic library
i) Colony lift
Approximately 10,000 E. coli transformants were screened for expression of B. 
forsythus protein antigens using the colony lift technique. Following screening 
with periodontitis patient serum from a high responder to B. forsythus, one 
clone reacted positively with the serum in duplicate (Fig 7.3). The positive 
clone was selected from the master plate and a sub-culture grown to be 
screened once more. However, a preliminary Gram stain of the isolated sub­
culture revealed that the organism was a Gram positive coccus, and was 
therefore a contaminant that had grown on the master plate.
Of all the other plates screened, no positive clones were identified.
ii) Western blot
To increase the sensitivity of the immunoscreening procedure, transformant 
colonies were screened by Western blotting to detect the presence of any 
novel protein expression in transformant E. coli clones. Using the original 
master plates of maintained transformants which had been used for colony lift 
screening, 98 colonies were selected and screened with pre-absorbed serum 
as detailed previously in this chapter.
Representative blots of the transformants can be seen in Fig 7.4. No novel 
protein bands were expressed by any of the clones analysed. The bands that 
were visualised are endogenous E. coli proteins, which constitute a relatively 
weak background binding due to the use of serum pre-absorbed with 
disintegrated whole cells of E. coli.
m
iii) Sequence analysis
Three representative clones carrying B. forsythus DNA of 4-8kb in size were 
sequenced from both ends using M13 Forward and Reverse primers. Together 
these reactions yielded sequence information of approximately 1.5kb of the B. 
forsythus sequence. On-line DNA and protein sequence databases were 
searched for matches with the B. forsythus sequence to identify genes that the 
recombinant clones carried. Two clones carried DNA that appeared to 
spuriously match genome sequences from other species; as the sequence 
matches ran for no more than 30 bases these identities were not thought to be 
significant. The third clone analysed yielded sequence data that shared a high 
level of homology with sequence from a number of different species, and when 
the B. forsythus inserted DNA sequence was translated to permit a protein 
sequence search, the clone was found to represent part of the lac operon of 
genes belonging to B. forsythus. The ubiquitous nature of the lac genes 
accounts for the homology the recombinant sequence shared with a variety of 
bacterial species. The sequence data from this clone is displayed in Fig 7.5.
An alignment of the putatively identified gene of the B. forsythus lac operon 
with the DNA sequence from another species is shown in Fig 7.6. The 
sequence alignment was generated using BLAST searches made available by 
the Institute for Genomic Research through their web-site at 
http://www.tigr.org.
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DISCUSSION
With the aim of identifying immunodominant protein antigens of B. forsythus, a 
genomic library was constructed in E. coli TOP10, using the plasmid vector 
pUC18. This is the first report of the construction of a genomic library for B. 
forsythus. As the transformant colonies were exposed to the inducer effects of 
IPTG, the requisite that protein-coding inserts were expressed with their own 
promoter was removed.
Of 10,000 colonies screened by colony lift (of which it can be estimated that 
approximately 1670 carried an inserted gene of the desired size), and 98 
subjected to screening via Western blotting, no recombinants were identified 
that expressed immuno-reactive proteins of B. forsythus.
Despite the large number of colonies screened to no apparent avail, the library 
can not be regarded as a failure statistically until approximately 30,000 clones 
have been screened. This figure was arrived at using the following equation:
P= size of coding region of gene of interest (kb) / size of genome (kb) x 6,
where P is the probability of forming a recombinant clone that contains the 
sequence of the gene of interest in the correct reading frame and orientation 
for expression. If the average size of the genes that it was aimed were to be 
expressed in this library can be taken as 6 kb, and the approximate size of the 
B. forsythus genome is 4,500 kb, then P=0.00022, i.e. there is one clone in 
4545 expressing a B. forsythus protein. This probability becomes slimmer (1 in 
27,270) when the low rate of recombinant carrying inserts, as surmised by 
restriction endonuclease analysis, is considered. However, as this library was
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being screened for any number of different genes that may have been cloned 
into the library, and not just one particular gene at 6kb, it was anticipated that 
the chances of detecting a reactive clone would be increased above 1 chance 
in 27,270. It was therefore thought plausible that a gene of the desired size 
could have been carried in the 10,000 clones that were analysed.
Around 10,000 clones were screened by the colony lift technique, with no 
recombinant displaying a significant positive reaction with the patient serum. 
As it had been determined that this number of clones could contain expressed 
genes of 8. forsythus, there was some indication that the expression of 8. 
forsythus DNA in E. coli TOP10 was poor. This low level of expression of 8. 
forsythus proteins may be attributable to differences in synthetic and post- 
transcriptional pathways that exist between E. coli and 8. forsythus.
Thus a more sensitive assay, Western blotting, was used to detect antigens. 
Western blotting had previously been shown to detect antigens in a genomic 
library when whole colony screening was found not to be sensitive enough 
(Thole et al, 1985). Applying this technique to the 8. forsythus genomic library 
constructed in this study, 98 recombinant lysates were screened with 
periodontitis patient serum pre-absorbed with E. coli TOP10 lysates. No 
exogenous reactive proteins were identified using this technique. Analysis of a 
greater numbers of clones using the colony lift technique, or further Western 
blots studying recombinant cell lysates, may in time identify an 
immunoreactive clone. However, the success of both these procedures is 
entirely limited by the antibodies present in the patient serum sample being 
used in these studies and if anti-hsp60 antibodies are not present in sufficient 
numbers no amount of screening will yield a clone or protein band that will
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stain positively. Despite the fact that the serum being used in this study had 
been identified previously as a sample from a periodontitis patient who 
possessed a strong antibody response to B. forsythus, this does not guarantee 
that the patient carries a high level of antibodies to hsp60. One possible way 
of circumnavigating this dependency upon one patient serum sample would be 
to use pooled serum samples which would indubitably increase the antibody 
repertoire available to recognise B. forsythus immunogens. Alternatively, the 
potential of raising hyper-immune B. forsythus sera by repeated immunisation 
of a laboratory animal should be investigated. Hyper-immune mycobaterial 
serum was used by Thole et al (1985) to screen genomic library Western 
blots expressing recombinant mycobacterial proteins, but even so, the 
antigens were reported to stain weakly, close to the detection level, and 
positive antigen binding was not always reproducible. Thole et al attributed the 
low level of mycobacterial antigen expression to differences in E. coli and 
mycobacterial expression machinery. Nonetheless, altering the serum used for 
screening would be a desirable step to take when carrying out further work 
with the B. forsythus genomic library.
As no immunogenic clones were identified throughout the screening 
procedures, it was felt that information may be derived from the genomic 
library by sequencing the DNA inserted in some of the clones, which is 
perhaps the ultimate analysis to perform on constituents of a library. 
Sequencing random recombinant colonies is also a demonstration of the 
further analysis that would have been performed on an immunoreactive clone 
had one been identified, using the same sequencing techniques and database 
searches that would have been applied to an unknown immunogenic protein of
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B. forsythus. Preliminary sequence analysis of three recombinant clones from 
the genomic library, all known to be carrying a DNA insert of 4-8kb, was 
performed. Approximately 1.5kb of DNA sequence was obtained for each 
clone, having sequenced each from both ends of the insert. Two of the clones 
yielded sequence which appeared to only spuriously match sequences 
contained within SwissProt and EMBL databases, thus it may be speculated 
that these inserts carry gene sequences that have yet to be characterised. As 
there was no shared homology with the entire genomic sequence of E. co//, 
these genes may also be species unique. The third clone analysed contained 
B. forsythus DNA sequence that was homologous to 350-base length 
sequences from a diverse range of prokaryotic species, including Caulobacter 
crescentus, Enterococcus faecalis and Clostridium difficile. Translated, the 
same inserted sequence was used to search protein sequence databases, 
and homology was found to exist with the lac operon genes of E. coli. It can be 
assumed that the inserted genes carried by this recombinant clone represent 
some of the lac operon genes of B. forsythus. As these genes code for a 
metabolic system common to many species, the high level of homology this 
recombinant clone shared with a varied range of eukaryotic species is 
explained.
It is possible that further screening of this genomic library using patient serum 
may identify immunoreactive protein antigens of B. forsythus as similar 
procedures have been successfully adopted to identify the protein antigens of 
P. gingivalis (Hayakawa et al, 1992). It is possible that there is some amount 
of digestion of B. forsythus proteins by endogenous E. coli proteases and that 
the incorporation of a protease inhibitor at a stage in the procedure may be
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beneficial (Weidner et al, 1996). Alternatively, protein specific probes could be 
designed to search the library. Immunodominant antigens that share sequence 
homology in other species could be used to design specific PCR primers, and 
these primers used with a B. forsythus template to generate a PCR product 
that could be labelled to use as a probe as described in Chapter 3. As the 
vector used in this library is an expression vector, the library could also be 
screened for recombinant digestion enzyme activity by incorporating a 
substrate such as casein into SDS-PAGE gels. Cell lysates analysed on these 
gels that carried a proteolytic enzyme would digest the casein and would be 
detectable upon silver-staining of the gels.
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FIGURE 7.1. Establishing conditions for partial digestion of B. 
forsythus chromosomal DNA.
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Figure 7.1. Establishing conditions for partial digestion of B. 
forsythus chromosomal DNA. Chromosomal DNA was partially 
cleaved with Sau3A to determine optimum conditions for the 
production of DNA fragments in a size range of 2-1 Okb. /-7/nd111 
digested X DNA fragments were used as size markers (lanes 1a 
and 10b). Decreasing amounts of restriction endonuclease 
ranging from 2.5U/pg DNA in lanes 2a and 1b to 0.02U/pg DNA in 
lanes 9a and 8b were incubated with samples and 
electrophoresed. Lanes 10a and 9b are undigested controls. Gel 
a) was incubated at 37°C for 1 hour, gel b) for 1 hour 15 min. DNA 
samples cleaved in lane 6b embrace the optimum conditions, 
yielding fragments in the correct size range (2-1 Okb). A 
subsequent larger scale reaction was performed and cleaved DNA 
cloned into the vector pUC18.
FIGURE 7.2. Mini-prep analysis of recombinant clones from a
B. forsythus genomic library.
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S
Figure 7.2. Mini-prep analysis of recombinant clones from a B. 
forsythus genomic library. Recombinant clones were selected from 
the library and plasmid DNA purified using the small-scale boiling 
method. Plasmid DNA was digested with EcoRI and released DNA 
inserts analysed by electrophoresis. /7/ndlll digested X DNA 
fragments were used as size markers (lane 1; 23.1, 9.42, 6.56, 
2.32 and 2.01 kb) and digested DNA electrophoresed in lanes 2-12. 
Recombinant clones carrying a DNA insert in a size range of 2- 
10kb are seen in lanes 3 and 7 (arrows).
FIGURE 7.3. Screening the B. forsythus genomic library by 
the colony lift technique.
Figure 7.3. Screening the B. forsythus genomic library by colony lift 
technique. Samples of the genomic library were grown on 
nitrocellulose disks on top of L-agar containing IPTG and ampicillin. 
Replica plates were cultured by imprinting the colonies onto 
another nitrocellulose disk. The replica colonies were lysed and 
blotted with serum from a periodontitis patient previously 
characterised as a high-responder to B. forsythus. The serum was 
pre-absorbed with disrupted E. coli whole cells to reduce serum 
avidity for endogenous host-cell proteins expressed by 
transformants.
No colonies on the plate illustrated have bound sufficient antibody 
to indicate expression of a novel immunoreactive B. forsythus 
protein.
FIGURE 7.4. Screening the B. forsythus genomic library by
Western blotting.
Figure 7.4. Screening the B. forsythus genomic library by Western 
blotting. Clones from a genomic library were selected and grown in 
liquid culture in the presence of IPTG and ampicillin. Cells were 
harvested and lysed prior to SDS-PAGE. Electrophoresed proteins 
were then Western blotted with serum from a periodontitis patient 
previously characterised as a high-responder to B. forsythus. The 
serum was pre-absorbed with disrupted E. coli whole cells to 
reduce serum avidity for endogenous host-cell proteins expressed 
by transformants. 7 samples from the library were analysed per blot 
(two different blots are shown here, A and B). Expression of a 
cloned B. forsythus gene by a library member would be seen as the 
production of a novel protein band that was not detectable in other 
samples. As all samples here display similar protein banding 
patterns, no representative of the library appears to be expressing 
B. forsythus genes.
CHAPTER 8
General discussion
GENERAL DISCUSSION
Periodontal disease describes a range of conditions that affect the supporting 
tissues of the teeth, which range from mild inflammation of the gingiva 
(gingivitis) to advanced periodontitis, in which the deterioration and destruction 
of tooth attachment ligaments and alveolar bone ultimately results in tooth loss 
(Kinane, 1997). With the infection and inflammation of the periodontium, a break 
in the peripheral body defenses is constituted which permits the oral microbial 
population access to the internal body compartment. As such, periodontal 
disease may have a significant effect on systemic health, and it has been 
associated with cardiovascular disease and premature low birth-weight babies 
(Desvarieux et al, 1999; Offenbacher, 1996; Offenbacher et al, 1999). With the 
likelihood that periodontal disease will be linked to further systemic diseases in 
the future, the need to understand the pathology of periodontitis is now perhaps 
greater than ever.
A major part of the studies presented in this thesis were concerned with the 
heat shock protein 60 of the periodontal pathogen Bacteroides forsythus. Hsp60 
is a molecular chaperone whose function is to aid correct protein folding, 
assembly and translocation within cells (Craig et al, 1993; Ellis and Vandervies, 
1991). The importance of hsp60 in cells is reflected by the fact that virtually all 
cell types are known to express a hsp60 homologue and constitutive expression 
of hsp60 is essential for cell viability. Synthesis of hsp60 increases upon cell 
stress, and this is to cope with the increased number of denatured proteins that 
typically results from cellular stress. Hsp60 is highly immunogenic (Kaufmann, 
1990; Kaufmann, 1992a) and therefore is an important antigen, acting as a flag 
protein for marking invading micro-organisms (stressed as a result of
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encountering a foreign environment or immune attack) and infected, 
traumatised or aberrant host cells alike for immune recognition and subsequent 
removal. The immune response to hsp60, as a result of constant priming, is 
rapid and effective. However, it could quickly become a catastrophic auto­
immune response if hsp60-reactive T cells and antibodies recruited to a site of 
local infection or inflammation were to attack healthy host cells expressing 
hsp60. To prevent this situation from arising, a network of effector mechanisms 
to control and down-regulate anti-hsp60 responses is thought to exist (Cohen 
and Young, 1991; Cohen, 1992). The immune system is not infallible though, 
and the potential failure of it as a result of chronic exposure of the immune 
system to hsp60 at sites of infection, or as a result of a breakdown in the 
regulation of anti-hsp60 responses, causes hsp60 to be widely studied as a 
possible pathogenic agent in a diverse range of infections and diseases; from 
bacterial infections (Kaufmann, 1991; Kaufmnn et al, 1991; Shinnick, 1991), 
inflammatory diseases (Amini etal, 1996; Gaston et al, 1990; Kaufmann etal, 
1990; Morrison et al, 1989) and cardiovascular disease (Desvarieux etal, 1999; 
Hopplicher et al, 1996) to autoimmune disorders (Jones et al, 1993; Kaufmann, 
1994), neurological disorders (Astarloa et al, 1996; Hamos et al, 1991; Raine et 
al, 1996) and cancer (Hsu and Hsu, 1998; Ito etal, 1998).
Despite the wealth of studies on hsp60, it is only recently that these proteins 
have become a topic of interest in periodontal research. Various periodontal 
pathogens are now known to respond to thermal shock (usually inflicted on cells 
In vitro by moving them from a 37°C environment to 42°C for 15 min) by the 
increased production of hsp60. Oral bacteria shown to respond in this manner 
include A. actlnomycetemcomitans (Lokensgard etal, 1994; Koga et al, 1993),
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P. gingivalis (Lu and McBride, 1994; Vayssier etal, 1994), T. denticola (Stamm 
etal, 1991), B. forsythus, P. oralis, P. intermedia, F. nucleatum, Actinomyces 
viscosus and P. buccae (Vayssier et al, 1994). Stresses other than thermal 
shock, such as pH decrease and increase in oxygen concentration have also 
been shown to induce the synthesis of hsp60 in oral bacteria (Vayssier et al, 
1994). Environmental conditions in the periodontal pocket reflect those stresses 
that have been used in the laboratory to induce hsp60 synthesis in cells: the 
subgingival temperature is slightly higher at diseased sites as compared to 
healthy ones, (Kung etal, 1990), pH decreases with increasing pocket depth 
and degree of host inflammatory response (Bickel and Cimasoni, 1985) and 
phagocytosis of infecting organisms generally exposes the bacteria to a range 
of reactive oxygen species (Buchmeier and Heffron, 1990). Thus the 
periodontal pocket is likely to be a site of significantly increased hsp60 
expression.
Although hsp60s are typical cytosolic proteins that lack the leader sequence 
required for transport of the proteins to the cell surface (Kaufmann and Schoel,
1994), it has become apparent that their cellular localisation is not limited to 
internal cellular compartments, but that hsp60 can also be found on cell 
surfaces (Jarjour et al, 1990; Soltys and Gupta, 1996). Whether this is as a 
result of an as yet unknown translocation mechanism, or whether cytoplasmic 
hsp60 is removed to the cell surface via a MHC processing pathway (Jardetzky 
etal, 1991) or is co-translated with an unrelated hsp60-bound protein 
(Kaufmann and Schoel, 1994) is unclear. What is increasingly clear though is 
that these proteins are widely available for recognition by the host immune 
response.
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With regards to the hsp60s of periodontal pathogens, characterisation of patient 
immune responses to these proteins has followed on from studies that have 
cloned and sequenced the hsp60 genes of the major periodontal pathogens A. 
actinomycetemcomitans and P. gingivalis (Nakano et al, 1995 and Maeda et al, 
1994 respectively). Antibodies recognising hsp60s from oral bacteria have been 
shown to be widely cross-reactive (Ando et al, 1995; Hinode et al, 1998), 
although it is important to stress that the level of cross-reactivity is entirely 
dependent on the epitope to which the antibodies were raised. Certainly 
Nakano’s study (1995) illustrates that monoclonal antibodies raised against the 
64kDa antigen of A. actinomycetemcomitans did not react with any cellular 
proteins from a range of oral bacteria. Also, the level of cross-reactivity an 
epitope may stimulate cannot be estimated by the level of sequence identity 
which that epitope shares with other homologues alone (Yi et al, 1993). That the 
antibody response to hsp60 may be of significance in the periodontal disease 
process has been suggested by studies that demonstrate that the level of hsp60 
reactive antibodies in the serum of periodontitis patients is higher than it is in 
healthy controls (Tabeta et al, 1999; Schett et al, 1997; Ando et al, 1995;
Maeda et al, 1994). Samples taken from patients with adult periodontitis and 
rapidly progressive periodontitis have also been seen to possess antibodies 
reactive with the human homologue of hsp60 (Tabeta et al, 1999; Ando et al,
1995), and have initially been taken to indicate the occurrence of an autoimmue 
response. Hsp60 reactive antibodies may perform as components of disease 
processes in a number of ways. Firstly, as hsp60 has been shown to reside on 
the surface of cells, hsp60 antibodies may have a direct cytotoxic effect, and 
could help maintain inflammatory processes by perpetuating a high level of host
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cell death. Secondly, hsp60 antibodies bound to hsp60 molecules may impede 
the proteins’ ability to function, and thus render cells more susceptible to death 
due to the cell’s inability to cope with changes in the immediate surrounding 
environment (Riabowol et a/, 1988). Lastly, several authors now share the 
opinion that the demonstration of healthy serum samples carrying antibodies to 
hsp60 can be explained by the supposition that hsp60 antigens are presented 
to individuals constantly, to prime the immune system to respond to infecting 
organisms and aberrant host cells effficiently and to ensure that a level of 
regulation of the immune response to hsp60 is constantly maintained (Cohen 
1992; Cohen and Young, 1991; Kaufmann, 1994).
As hsp60 is a ubiquitous and constitutively expressed antigen, it is evident that 
a level of control of the immune response to this protein is fundamental, 
otherwise the host would rapidly become involved in a programme of 
autoimmune self-destruction upon initiation of any infection or inflammatory 
process. Homeostatic regulation of the immune reponse to hsp60 would 
presumably be achieved by suppressor T-cells specific for hsp60, or anti- 
idiotypic T-cells, whose sustainment would be dependant on hsp60 presentation 
to T-cells, possibly via the MHC gene products (Jardetzky et al, 1991). Elevated 
levels of antibodies against hsp60 could feasibly interfere with this presentation 
of hsp60 by MHC to control elements of the immune reponse. As a result, 
hsp60 antibodies would disrupt the homeostasis, and autoimmune disease 
could ensue. If this last theory was applied to explain the auotimmune 
component of periodontitis, the leading question ensuing from this idea is why is 
periodontitis, like other autoimmune diseases in which reactivity to hsp60 has 
been implicated, a localised disease? Surely the collapse of a homeostatic
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network that down-regulates the immune response to hsp60 would result in the 
cataclysmic self-destruction that the regulatory pathways strive to defend 
against? It may be that the autoimmune reaction is directed against a localised 
tissue-specific hsp60 antigen (Jones et al, 1993), which would presumably only 
be expressing high levels of hsp60 at the site of inflammation.
The data supporting or disproving these theories has yet to materialise, as the 
studies on hsps in periodontitis to date have only examined small patient groups 
of around 20 subjects. Whilst the idea of hsp60 being involved in autoimmune 
process of periodontitis is an attractive one, seemingly supported by the finding 
of human-hsp60 reactive antibodies (Ando et al, 1995; Tabeta et al, 1999), it 
should be borne in mind that the identification of self-reactive anti-hsp60 
antibodies need not signify autoimmune disease. Rather, these may be normal, 
healthy autoimmune reactions in which hsp60 production has marked a 
stressed host cell for immune surveillance. This notion of an immune 
surveillance system primed to rapidly respond to hsp60 ‘flags’ is supported by 
findings that significant proportions of y/8 T-cells, thought to have a function as 
surveillant cells of the immune system due to their extra thymic development 
and ability to recognise only a limited antigenic repertoire (Haas et al, 1993; 
Haas and Tonegawa, 1992), have been shown to recognise hsp60 (Fisch et al, 
1990; Haregewoin et al, 1989; Kaufmann and Kabelitz, 1991).
Hsp60 molecules of some species are considered to be virulence factors. As 
such, the hsp60 molecules could be implicated more directly with the infective 
state of diseases. Buchmeier and Heffron (1990) demonstrated that hsp60 
induced in S. typhimurium was able to stabilise bacterial macromolecular 
complexes after they had been exposed to toxic and degradative products upon
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digestion by macrophages, indicating that the resistance of S. typhimurium to 
phagocytic killing is attributable to the increased production of bacterial hsp60 
upon phagocytosis . The 60-kDa hsp of S. typhimurium has also been shown to 
be responsible for the binding of the bacterium to intestinal mucus (Ensgraber 
and Loos, 1992).
Determining the means by which hsp60 of oral pathogens contributes to 
disease mechanisms of periodontitis, if at all, is beyond the scope of current 
research results in this field. Even if it should transpire that hsp60 is not the 
harbinger of disease that some currently think it is, benefits can still be drawn 
from the work already done on hsp60s in periodontitis. For example, Schett et al 
(1997) have suggested that levels of hsp60 antibodies present in the saliva and 
serum of patients could be used as a diagnostic aid for gingivitis and 
periodontitis. Hsp60 antibody titres have been widely proposed as diagnostic 
tools to mark patient sub-populations within different groups (Gruber et al, 1996; 
Portig et al, 1997; Prakken etal, 1996; Peeling etal, 1997). Secondly, hsp60 of 
bacterial origin are a possible target for vaccine development against 
periodontitis.
The development of a vaccine effective against periodontitis is perhaps, to the 
minds of many, the ultimate goal of research ongoing in this field of dentistry 
today. Many argue that periodontitis is frequently a self-inflicted result of poor 
dental hygiene in the individual, and adhere to the doctrine that prevention is 
better than cure, and can easily be attained with improved standards of oral 
care. However, the need to provide a vaccine against infections of the 
periodontium is a very real one, for a number of reasons.
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It is now apparent that individuals possess genetic factors that may pre-dispose 
them to periodontal disease (Genco, 1996). Evidence exists which relates 
human leukocyte antigen phenotype distribution with the prevalence of 
periodontal disease types (Amer et al, 1988; Reinholdt et al, 1977). Localised 
juvenile periodontitis is suggested to be a familial disease, inherited via an 
autosomal mode of transmission, (Hart et al, 1992) which causes an 
abnormality in neutrophil function (Van Dyke et al, 1985). As genetic control 
plays an important role in many instances of periodontitis, the development of a 
vaccine to treat disease would be a vital tool to treat those of an afflicted 
lineage, for whom periodontal disease might otherwise be an inevitable 
consequence.
Oral diseases are being widely investigated now as a source of bacterial 
infection that may incur systemic disease at sites distal to the oral cavity in an 
affected host. In particular, recent studies have found an association between 
periodontal disease and cardiovascular disease, including myocardial infarction 
(Mattila et al, 1989; Wu et al, 1999), ischemic stroke (Young et al, 1999; Veber 
et al, 1999) and atherosclerosis (Matilla et al, 1993; De Stefano et al, 1993; 
Schett et al, 1997; Desvarieux et al, 1999). Of interest is the finding that B. 
forsythus specifically, along with P. gingivalis, is associated with an increased 
risk for myocardial infarction (Wu et al, 1999). Hsp molecules too have been 
specifically implicated: elevated serum antibody levels to hsp60 have been 
correlated with a high incidence of carotid and coronary atherosclerosis 
(Hopplicher et al, 1996). These antibodies may be cytotoxic to stressed human 
endothelial cells, such that antibodies induced by oral infection may be a cause 
of endothelial cell damage. This would suggest that dental infection may be a
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condition that favours the development of cardiovascular disease, and as one of 
the most significant causes of mortality in the Western world, the ability to 
vaccinate against a contributing factor to heart disease would have unequivocal 
benefits.
Lastly, well-publicised current opinion holds that the antibiotic era in which the 
20th century population has thrived is on the wane. Antibiotic resistance in B. 
forsythus has already been recorded (Maiden et al, 1994; van Winkelhoff et al,
1997). This necessitates the development of a new generation of drugs to 
combat infection, and it is likely that these will be sophisticated modulators of 
our own immune response that will adapt our available immune components to 
target specific infectious agents. These are, in short, vaccines. Traditionally 
vaccines originally consisted of killed whole orgainsms, or serum factors raised 
against an infectious agent in an animal host. Formalin killed whole P. gingivalis 
has been used as a vaccine which was protective against ligature-induced 
periodontitis in non-human primates (Persson etal, 1994). However, whole 
Gram-negative bacteria are considered to be unsuitable human vaccine 
components due to the risk of possible side effects (Ishikawa et al, 1997) which 
can counter balance the benefits of this vaccine and others developed in a 
similar manner. However, the advent of modern techniques that can create 
synthetic non-harmful components of antigenic organisms, and the use of 
human cell lines to culture immune factors, will expand the technology of 
vaccine development immensely, and the problems faced in this science 20 
years ago can now be largely overcome.
The idea that immunisation may be an effective means to prevent and control 
periodontal disease has been bolstered by findings that show that patients with
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high serum antibody titres to suspected periodontal pathogens have less severe 
disease than patients with low titres of the same antibodies (Ranney et al, 1992; 
Gunsolley et al, 1987). High titre sera has been demonstrated in vivo to 
opsonise and enhance killing of periodontal pathogens by polymorphonuclear 
leukocytes in the presence of complement (Underwood etal, 1993). However, 
periodontitis offers particular problems that hinder the production of a 
successful vaccine. Firstly, periodontal disease is not attributable to any one 
organism, but is an infection by a mixed population of bacteria, the majority of 
which are Gram-negative anaerobes (Moore and Moore, 1994). Although this 
group has been well defined and patterns of multiple infections have been 
characterised for different disease groups (Haffajee et al, 1988a; Haffajee et al, 
1988b; Haffajee and Socransky, 1994) it remains that no two infections are 
identical, and microbial populations vary from host to host, and even from site to 
site in the same host. Thus the elimination of no single target organism could 
guarantee the eradication of disease. Furthermore, a significant amount of 
variation in strains within species makes for difficulties when selecting a vaccine 
target. A recent study has shown that at least 10 genetically distinct forms of 8. 
forsythus exist (Takemoto et al, 1997), illustrating the potential for phenotypic 
variation.
The development of a successful vaccine therefore requires the identification of 
strain variable components, so that vaccines will not be targeted against these 
antigens which cannot offer broad-spectrum protection against infection. 
Similarly, the identification of antigens shared amongst different species could 
allow immunisation by one species that could induce cross-reactive antibodies 
that may confer protection against infection by other Gram-negative species.
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With the aim of identifying antigenic components of B. forsythus clinical isolates, 
Sims et al (1998a) screened 10 isolates with the sera from 10 patients with 
early onset rapidly progressive periodontitis. Their study showed the dominant 
strain-variable components of B. forsythus were non-protein, whilst high 
molecular weight proteins (200 and 210kDa) were the major cross-reactive 
components. Sims suggests that both these antigenic factors are associated 
with the surface layer (S-layer) of S. forsythus, with the proteinase-resistant non 
conserved material possibly being oligosaccharide released from S-layer 
proteins (similar structures in other organisms are known to be glycosylated) 
and the conserved proteinaceous immunogen perhaps being a structural sub­
unit of the S-layer. The S-layer of B. forsythus is a crystalline protein or 
glycoprotein structure, consisting of serrated subunits forming a tetragonal 
pattern, that lies outside the outer membrane (Kerosuo, 1988). S-layer proteins 
may be serologically important in B. forsythus as the constituents are amongst 
the most abundant proteins expressed by the organism, and form the outer­
most surface of the bacterium. The S-layer proteins of B. forsythus have been 
shown to be immunogenic by a pre-absorption study in which sera was pre­
absorbed with purified S-layer proteins, and a corresponding drop in antibody 
titre, of as much as 98%, was observed (Sims et al 1994).
Another study suggests that the lipopolysaccharide (LPS) of S. forsythus may 
be a good target antigen for a periodontitis vaccine. An antigen was shown to 
be cross-reactive with P. gingivalis and B. forsythus by immunising monkeys 
with P. gingivalis, and then demonstrating that the antibodies raised against P. 
gingivalis recognised 10 different S. forsythus isolates (Vasel et al, 1996).
These potentially protective antibodies bound epitopes in lipid A and possibly in
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the core carbohydrate of LPS. Again this antigen is non-protein, and it is 
important to note that screening for immunodominant antigens expressed in a 
genomic library, as was performed in this thesis (Chapter 7) precludes serum 
reactivity with carbohydrate antigens, which may be the truly dominant antigens. 
A pertinent observation recorded in the results of this study was that different 
individuals afflicted with the same condition (ie. adult periodontitis) possess 
varied antibody responses. Of 11 serum samples collected from rapidly 
progressive periodontitis patients, 3 displayed a strong antibody reactivity to 8. 
forsythus hsp60. That the other patients did not display reactivity with 8. 
forsythus hsp60 does not necessarily mean that these patients were not 
infected with B. forsythus, in fact recent data would suggest that these patients 
are likely to be carrying the organism. Rather, it indicates that each individual’s 
ability to respond to antigens is unique, and reflects the random manner in 
which the antigen recognition repertoire is formed. A similar finding was 
reported by Sims et al (1998a; 1998b). Also performing a study with serum from 
patients with rapidly progressive periodontitis, serum samples were screened 
against 10 different 8. forsythus clinical isolates, and a widely divergent IgG 
binding profile was demonstrated amongst the patients. One serum sample 
would stain heavily for IgG binding to an isolate that another serum sample only 
weakly recognised. Thus patients seem to be infected by, and respond to, 
different 8. forsythus serotypes.
Their universal conservation and cross-reactivity makes hsp60 molecules 
attractive candidates for the development of vaccines against various diseases. 
However, the very features that make hsp60 proteins promising vaccine 
aspirants may pose problems with regards to vaccine target specificty, and
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ultimately rule-out the effective beneficial use of vaccines against hsp60. 
Furthermore, it has been suggested that increased antibody titres to hsp60 
antigens may play an intrinsic part in disease pathogenesis, and the antibody 
response has been directly implicated in causing disease. Clearly a vaccine that 
raised these very same antibody titres would have an adverse effect on the 
individual.
The data presented in this thesis reports the identification and DNA sequence 
determination of the hsp60 gene of B. forsythus, and the partial sequence of the 
hsp60 gene of P. intermedia. Analysis of the predicted amino acid sequences of 
these proteins and comparison with available sequences of hsp60 homologues 
from other species demonstrated that the proteins possess highly conserved 
primary and predicted secondary structures. Further to this, recombinant B. 
forsythus hsp60 was synthesised in E. coii and the immunoreactivity of this 
protein assessed by screening healthy and chronic adult periodontitis patient 
serum samples for the presence of reactive antibodies. A low frequency of 
samples from both groups recognised B. forsythus hsp60, indicating that the 
protein is immunogenic, but probably not pathogenic. The results of the 
immunological analysis of B. forsythus hsp60 presented here are comparable 
with studies on hsp60 from other oral pathogens. Maeda et al (1994) reported 
antibodies reactive with recombinant P. gingivalis hsp60 in periodontitis and 
healthy patient serum samples, and antibodies reactive with hsp60 of A. 
actinomycetemcomitans, F. nucleatum and P. nigrescens have also been 
recorded in periodontitis serum (Ando et al, 1995). Two other reports differ in 
that no hsp60 antibody reactivity to A. actinomycetemcomitans or P.gingivalis 
hsp60 is reported in healthy serum samples, although it is detected in
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periodontitis patient samples (Koga e ta l, 1993; Tabeta e ta l, 1999). 
Interpretation of any of these results, which essentially represent preliminary 
reports, is limited by the small size of patient sample numbers analysed. For 
larger numbers of samples to be studied, it would be of significant benefit to 
procure a protocol for purifying recombinant B. forsythus hsp60, and this would 
be the most desirable ‘next-step’ to follow work done on this thesis.
Whether the immune response against hsp60s is protective, destructive or 
inconsequential to the progression of disease is unknown. On the one hand, it 
has been suggested that high levels of hsp60 antibodies are indicative of 
disease (Peeling et al, 1997; Prakken et al, 1996; Schett et al, 1997) whilst in 
direct contradiction to this, low levels of hsp60 antibodies has also been 
suggested to indicate disease as a result of ineffective immune recognition of 
micro-organisms (NEW). Neither is it evident why a higher proportion of patients 
do not recognise hsp60 antigens, as they have been consistently illustrated as 
extremely immunogenic, and are the dominant protein expressed by stressed 
cells. With the nature of our immune response to hsp60 apparently so 
ambiguous, much work remains to be done if we are to fully understand the 
nature of these evolutionarily ancient proteins and the significance of our 
immune response to them.
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